BPG is committed to discovery and dissemination of knowledge
Cited by in F6Publishing
For: Quail DF, Joyce JA. Microenvironmental regulation of tumor progression and metastasis. Nat Med. 2013;19:1423-1437. [PMID: 24202395 DOI: 10.1038/nm.3394] [Cited by in Crossref: 3187] [Cited by in F6Publishing: 3136] [Article Influence: 398.4] [Reference Citation Analysis]
Number Citing Articles
1 Gondal MN, Chaudhary SU. Navigating Multi-Scale Cancer Systems Biology Towards Model-Driven Clinical Oncology and Its Applications in Personalized Therapeutics. Front Oncol 2021;11:712505. [PMID: 34900668 DOI: 10.3389/fonc.2021.712505] [Reference Citation Analysis]
2 Dowling CM, Herranz Ors C, Kiely PA. Using real-time impedance-based assays to monitor the effects of fibroblast-derived media on the adhesion, proliferation, migration and invasion of colon cancer cells. Biosci Rep 2014;34:e00126. [PMID: 24935351 DOI: 10.1042/BSR20140031] [Cited by in Crossref: 53] [Cited by in F6Publishing: 34] [Article Influence: 6.6] [Reference Citation Analysis]
3 Joyce JA, Fearon DT. T cell exclusion, immune privilege, and the tumor microenvironment. Science. 2015;348:74-80. [PMID: 25838376 DOI: 10.1126/science.aaa6204] [Cited by in Crossref: 939] [Cited by in F6Publishing: 879] [Article Influence: 134.1] [Reference Citation Analysis]
4 Zhang L, Song M, Zhang F, Yuan H, Chang W, Yu G, Niu Y. Accumulation of Nicotinamide N-Methyltransferase (NNMT) in Cancer-associated Fibroblasts: A Potential Prognostic and Predictive Biomarker for Gastric Carcinoma. J Histochem Cytochem 2021;69:165-76. [PMID: 33283625 DOI: 10.1369/0022155420976590] [Cited by in Crossref: 2] [Cited by in F6Publishing: 3] [Article Influence: 1.0] [Reference Citation Analysis]
5 Wu YW, Huang CC, Changou CA, Lu LS, Goubran H, Burnouf T. Clinical-grade cryopreserved doxorubicin-loaded platelets: role of cancer cells and platelet extracellular vesicles activation loop. J Biomed Sci 2020;27:45. [PMID: 32200762 DOI: 10.1186/s12929-020-00633-2] [Cited by in Crossref: 5] [Cited by in F6Publishing: 6] [Article Influence: 2.5] [Reference Citation Analysis]
6 Liu J, Nie S, Wu Z, Jiang Y, Wan Y, Li S, Meng H, Zhou S, Cheng W. Exploration of a novel prognostic risk signatures and immune checkpoint molecules in endometrial carcinoma microenvironment. Genomics 2020;112:3117-34. [DOI: 10.1016/j.ygeno.2020.05.022] [Cited by in Crossref: 8] [Cited by in F6Publishing: 10] [Article Influence: 4.0] [Reference Citation Analysis]
7 NguyenHoang S, Liu Y, Xu L, Zhou L, Chang Y, Fu Q, Liu Z, Lin Z, Xu J. High truncated-O-glycan score predicts adverse clinical outcome in patients with localized clear-cell renal cell carcinoma after surgery. Oncotarget 2017;8:80083-92. [PMID: 29108390 DOI: 10.18632/oncotarget.15900] [Reference Citation Analysis]
8 Wei R, Liu S, Zhang S, Min L, Zhu S. Cellular and Extracellular Components in Tumor Microenvironment and Their Application in Early Diagnosis of Cancers. Anal Cell Pathol (Amst) 2020;2020:6283796. [PMID: 32377504 DOI: 10.1155/2020/6283796] [Cited by in Crossref: 18] [Cited by in F6Publishing: 14] [Article Influence: 9.0] [Reference Citation Analysis]
9 Rosati A, Basile A, D'Auria R, d'Avenia M, De Marco M, Falco A, Festa M, Guerriero L, Iorio V, Parente R, Pascale M, Marzullo L, Franco R, Arra C, Barbieri A, Rea D, Menichini G, Hahne M, Bijlsma M, Barcaroli D, Sala G, di Mola FF, di Sebastiano P, Todoric J, Antonucci L, Corvest V, Jawhari A, Firpo MA, Tuveson DA, Capunzo M, Karin M, De Laurenzi V, Turco MC. BAG3 promotes pancreatic ductal adenocarcinoma growth by activating stromal macrophages. Nat Commun 2015;6:8695. [PMID: 26522614 DOI: 10.1038/ncomms9695] [Cited by in Crossref: 56] [Cited by in F6Publishing: 50] [Article Influence: 8.0] [Reference Citation Analysis]
10 Wilhelm J, Quiñones-Pérez M, Wang J, Wang X, Basava VS, Gao J. Antigen folding improves loading efficiency and antitumor efficacy of PC7A nanoparticle vaccine. J Control Release 2021;329:353-60. [PMID: 33301836 DOI: 10.1016/j.jconrel.2020.11.056] [Cited by in Crossref: 2] [Cited by in F6Publishing: 2] [Article Influence: 1.0] [Reference Citation Analysis]
11 Xia X, Wang S, Ni B, Xing S, Cao H, Zhang Z, Yu F, Zhao E, Zhao G. Hypoxic gastric cancer-derived exosomes promote progression and metastasis via MiR-301a-3p/PHD3/HIF-1α positive feedback loop. Oncogene 2020;39:6231-44. [PMID: 32826951 DOI: 10.1038/s41388-020-01425-6] [Cited by in Crossref: 10] [Cited by in F6Publishing: 13] [Article Influence: 5.0] [Reference Citation Analysis]
12 Leftin A, Ben-Chetrit N, Klemm F, Joyce JA, Koutcher JA. Iron imaging reveals tumor and metastasis macrophage hemosiderin deposits in breast cancer. PLoS One 2017;12:e0184765. [PMID: 28898277 DOI: 10.1371/journal.pone.0184765] [Cited by in Crossref: 17] [Cited by in F6Publishing: 15] [Article Influence: 3.4] [Reference Citation Analysis]
13 Karsch-Bluman A, Amoyav B, Friedman N, Shoval H, Schwob O, Ella E, Wald O, Benny O. High mobility group box 1 antagonist limits metastatic seeding in the lungs via reduction of cell-cell adhesion. Oncotarget 2017;8:32706-21. [PMID: 28415753 DOI: 10.18632/oncotarget.16188] [Cited by in Crossref: 8] [Cited by in F6Publishing: 7] [Article Influence: 2.0] [Reference Citation Analysis]
14 Jeon J, Lee S, Kim H, Kang H, Youn H, Jo S, Youn B, Kim HY. Revisiting Platinum-Based Anticancer Drugs to Overcome Gliomas. Int J Mol Sci 2021;22:5111. [PMID: 34065991 DOI: 10.3390/ijms22105111] [Reference Citation Analysis]
15 Li JM, Jiang GM, Zhao L, Yang F, Yuan WQ, Wang H, Luo YQ. Dehydrogenase/reductase SDR family member 2 silencing sensitizes an oxaliplatin‑resistant cell line to oxaliplatin by inhibiting excision repair cross‑complementing group 1 protein expression. Oncol Rep 2019;42:1725-34. [PMID: 31436301 DOI: 10.3892/or.2019.7291] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 0.3] [Reference Citation Analysis]
16 Zhu S, Luo Z, Li X, Han X, Shi S, Zhang T. Tumor-associated macrophages: role in tumorigenesis and immunotherapy implications. J Cancer 2021;12:54-64. [PMID: 33391402 DOI: 10.7150/jca.49692] [Cited by in Crossref: 4] [Cited by in F6Publishing: 5] [Article Influence: 4.0] [Reference Citation Analysis]
17 Chitty JL, Filipe EC, Lucas MC, Herrmann D, Cox TR, Timpson P. Recent advances in understanding the complexities of metastasis. F1000Res 2018;7:F1000 Faculty Rev-1169. [PMID: 30135716 DOI: 10.12688/f1000research.15064.2] [Cited by in Crossref: 6] [Cited by in F6Publishing: 1] [Article Influence: 1.5] [Reference Citation Analysis]
18 Benedicto A, Sanz E, Márquez J. Ocoxin as a complement to first line treatments in cancer. Int J Med Sci 2021;18:835-45. [PMID: 33437220 DOI: 10.7150/ijms.50122] [Cited by in Crossref: 1] [Article Influence: 1.0] [Reference Citation Analysis]
19 Berg A, Fasmer KE, Mauland KK, Ytre-Hauge S, Hoivik EA, Husby JA, Tangen IL, Trovik J, Halle MK, Woie K, Bjørge L, Bjørnerud A, Salvesen HB, Werner HM, Krakstad C, Haldorsen IS. Tissue and imaging biomarkers for hypoxia predict poor outcome in endometrial cancer. Oncotarget 2016;7:69844-56. [PMID: 27634881 DOI: 10.18632/oncotarget.12004] [Cited by in Crossref: 18] [Cited by in F6Publishing: 19] [Article Influence: 4.5] [Reference Citation Analysis]
20 Lee SY, Jeong EK, Ju MK, Jeon HM, Kim MY, Kim CH, Park HG, Han SI, Kang HS. Induction of metastasis, cancer stem cell phenotype, and oncogenic metabolism in cancer cells by ionizing radiation. Mol Cancer 2017;16:10. [PMID: 28137309 DOI: 10.1186/s12943-016-0577-4] [Cited by in Crossref: 163] [Cited by in F6Publishing: 176] [Article Influence: 32.6] [Reference Citation Analysis]
21 Chen S, El-Heliebi A, Kroneis T. Biological and Molecular Characterization of Circulating Tumor Cells: A Creative Strategy for Precision Medicine? Adv Clin Chem 2017;82:71-103. [PMID: 28939214 DOI: 10.1016/bs.acc.2017.06.001] [Cited by in Crossref: 2] [Cited by in F6Publishing: 2] [Article Influence: 0.4] [Reference Citation Analysis]
22 Norton KA, Gong C, Jamalian S, Popel AS. Multiscale Agent-Based and Hybrid Modeling of the Tumor Immune Microenvironment. Processes (Basel) 2019;7:37. [PMID: 30701168 DOI: 10.3390/pr7010037] [Cited by in Crossref: 46] [Cited by in F6Publishing: 38] [Article Influence: 15.3] [Reference Citation Analysis]
23 Kim K, Lee S. Remission of Unresectable Lung Metastases from Rectal Cancer After Herbal Medicine Treatment: A Case Report. EXPLORE 2016;12:259-62. [DOI: 10.1016/j.explore.2016.04.005] [Cited by in Crossref: 3] [Cited by in F6Publishing: 3] [Article Influence: 0.5] [Reference Citation Analysis]
24 Andrieu G, Tran AH, Strissel KJ, Denis GV. BRD4 Regulates Breast Cancer Dissemination through Jagged1/Notch1 Signaling. Cancer Res 2016;76:6555-67. [PMID: 27651315 DOI: 10.1158/0008-5472.CAN-16-0559] [Cited by in Crossref: 63] [Cited by in F6Publishing: 47] [Article Influence: 10.5] [Reference Citation Analysis]
25 Barbazán J, Matic Vignjevic D. Cancer associated fibroblasts: is the force the path to the dark side? Current Opinion in Cell Biology 2019;56:71-9. [DOI: 10.1016/j.ceb.2018.09.002] [Cited by in Crossref: 51] [Cited by in F6Publishing: 54] [Article Influence: 17.0] [Reference Citation Analysis]
26 Eble JA, Niland S. The extracellular matrix in tumor progression and metastasis. Clin Exp Metastasis 2019;36:171-98. [PMID: 30972526 DOI: 10.1007/s10585-019-09966-1] [Cited by in Crossref: 116] [Cited by in F6Publishing: 118] [Article Influence: 38.7] [Reference Citation Analysis]
27 Yadav S, Pandey SK, Goel Y, Temre MK, Singh SM. Diverse Stakeholders of Tumor Metabolism: An Appraisal of the Emerging Approach of Multifaceted Metabolic Targeting by 3-Bromopyruvate. Front Pharmacol 2019;10:728. [PMID: 31333455 DOI: 10.3389/fphar.2019.00728] [Cited by in Crossref: 5] [Cited by in F6Publishing: 5] [Article Influence: 1.7] [Reference Citation Analysis]
28 Oros-peusquens A, Loução R, Zimmermann M, Langen K, Shah N. Methods for molecular imaging of brain tumours in a hybrid MR-PET context: Water content, T 2 ∗ , diffusion indices and FET-PET. Methods 2017;130:135-51. [DOI: 10.1016/j.ymeth.2017.07.025] [Cited by in Crossref: 8] [Cited by in F6Publishing: 5] [Article Influence: 1.6] [Reference Citation Analysis]
29 Bhanumathi R, Manivannan M, Thangaraj R, Kannan S. Drug-Carrying Capacity and Anticancer Effect of the Folic Acid- and Berberine-Loaded Silver Nanomaterial To Regulate the AKT-ERK Pathway in Breast Cancer. ACS Omega 2018;3:8317-28. [PMID: 30087941 DOI: 10.1021/acsomega.7b01347] [Cited by in Crossref: 27] [Cited by in F6Publishing: 13] [Article Influence: 6.8] [Reference Citation Analysis]
30 Kotecha R, Takami A, Espinoza JL. Dietary phytochemicals and cancer chemoprevention: a review of the clinical evidence. Oncotarget 2016;7:52517-29. [PMID: 27232756 DOI: 10.18632/oncotarget.9593] [Cited by in Crossref: 186] [Cited by in F6Publishing: 163] [Article Influence: 46.5] [Reference Citation Analysis]
31 Kim BG, Kang S, Han HH, Lee JH, Kim JE, Lee SH, Cho NH. Transcriptome-wide analysis of compression-induced microRNA expression alteration in breast cancer for mining therapeutic targets. Oncotarget 2016;7:27468-78. [PMID: 27027350 DOI: 10.18632/oncotarget.8322] [Cited by in Crossref: 15] [Cited by in F6Publishing: 17] [Article Influence: 3.8] [Reference Citation Analysis]
32 Zhao T, Ding X, Yan C, Du H. Endothelial Rab7 GTPase mediates tumor growth and metastasis in lysosomal acid lipase-deficient mice. J Biol Chem 2017;292:19198-208. [PMID: 28924047 DOI: 10.1074/jbc.M116.773093] [Cited by in Crossref: 5] [Cited by in F6Publishing: 5] [Article Influence: 1.0] [Reference Citation Analysis]
33 Adamo HH, Halin Bergström S, Bergh A. Characterization of a Gene Expression Signature in Normal Rat Prostate Tissue Induced by the Presence of a Tumor Elsewhere in the Organ. PLoS One 2015;10:e0130076. [PMID: 26076453 DOI: 10.1371/journal.pone.0130076] [Cited by in Crossref: 10] [Cited by in F6Publishing: 10] [Article Influence: 1.4] [Reference Citation Analysis]
34 Cheng WC, Liao TT, Lin CC, Yuan LE, Lan HY, Lin HH, Teng HW, Chang HC, Lin CH, Yang CY, Huang SC, Jiang JK, Yang SH, Yang MH, Hwang WL. RAB27B-activated secretion of stem-like tumor exosomes delivers the biomarker microRNA-146a-5p, which promotes tumorigenesis and associates with an immunosuppressive tumor microenvironment in colorectal cancer. Int J Cancer. 2019;145:2209-2224. [PMID: 30980673 DOI: 10.1002/ijc.32338] [Cited by in Crossref: 39] [Cited by in F6Publishing: 40] [Article Influence: 13.0] [Reference Citation Analysis]
35 Hu W, Wang T, Yang Y, Zheng S. Tumor heterogeneity uncovered by dynamic expression of long noncoding RNA at single-cell resolution. Cancer Genet 2015;208:581-6. [PMID: 26556691 DOI: 10.1016/j.cancergen.2015.09.005] [Cited by in Crossref: 12] [Cited by in F6Publishing: 11] [Article Influence: 1.7] [Reference Citation Analysis]
36 Vivas-García Y, Falletta P, Liebing J, Louphrasitthiphol P, Feng Y, Chauhan J, Scott DA, Glodde N, Chocarro-Calvo A, Bonham S, Osterman AL, Fischer R, Ronai Z, García-Jiménez C, Hölzel M, Goding CR. Lineage-Restricted Regulation of SCD and Fatty Acid Saturation by MITF Controls Melanoma Phenotypic Plasticity. Mol Cell 2020;77:120-137.e9. [PMID: 31733993 DOI: 10.1016/j.molcel.2019.10.014] [Cited by in Crossref: 28] [Cited by in F6Publishing: 25] [Article Influence: 9.3] [Reference Citation Analysis]
37 Kumar N, Gupta S, Dabral S, Singh S, Sehrawat S. Role of exchange protein directly activated by cAMP (EPAC1) in breast cancer cell migration and apoptosis. Mol Cell Biochem 2017;430:115-25. [PMID: 28210903 DOI: 10.1007/s11010-017-2959-3] [Cited by in Crossref: 31] [Cited by in F6Publishing: 30] [Article Influence: 6.2] [Reference Citation Analysis]
38 Nakaoka HJ, Tanei Z, Hara T, Weng JS, Kanamori A, Hayashi T, Sato H, Orimo A, Otsuji K, Tada K, Morikawa T, Sasaki T, Fukayama M, Seiki M, Murakami Y, Sakamoto T. Mint3-mediated L1CAM expression in fibroblasts promotes cancer cell proliferation via integrin α5β1 and tumour growth. Oncogenesis 2017;6:e334. [PMID: 28504692 DOI: 10.1038/oncsis.2017.27] [Cited by in Crossref: 14] [Cited by in F6Publishing: 14] [Article Influence: 2.8] [Reference Citation Analysis]
39 Partel G, Wählby C. Spage2vec: Unsupervised representation of localized spatial gene expression signatures. FEBS J 2021;288:1859-70. [PMID: 32976679 DOI: 10.1111/febs.15572] [Cited by in Crossref: 3] [Cited by in F6Publishing: 3] [Article Influence: 1.5] [Reference Citation Analysis]
40 Wang Y, Yang B, Zhao J, Yu X, Liu X, Zhang L, Zhang Y, Li X, Zhai Z. Epithelial‑mesenchymal transition induced by bone morphogenetic protein 9 hinders cisplatin efficacy in ovarian cancer cells. Mol Med Rep 2019;19:1501-8. [PMID: 30628686 DOI: 10.3892/mmr.2019.9814] [Cited by in Crossref: 2] [Cited by in F6Publishing: 4] [Article Influence: 0.7] [Reference Citation Analysis]
41 Ghodsinia AA, Lego JMT, Garcia RL. Mutation-Associated Phenotypic Heterogeneity in Novel and Canonical PIK3CA Helical and Kinase Domain Mutants. Cells 2020;9:E1116. [PMID: 32365913 DOI: 10.3390/cells9051116] [Cited by in F6Publishing: 1] [Reference Citation Analysis]
42 Dossou AS, Sabnis N, Nagarajan B, Mathew E, Fudala R, Lacko AG. Lipoproteins and the Tumor Microenvironment. Adv Exp Med Biol 2020;1272:93-116. [PMID: 32845504 DOI: 10.1007/978-3-030-48457-6_6] [Reference Citation Analysis]
43 Hao L, Rohani N, Zhao RT, Pulver EM, Mak H, Kelada OJ, Ko H, Fleming HE, Gertler FB, Bhatia SN. Microenvironment-triggered multimodal precision diagnostics. Nat Mater 2021. [PMID: 34267368 DOI: 10.1038/s41563-021-01042-y] [Cited by in F6Publishing: 1] [Reference Citation Analysis]
44 Han JH, Yoon JS, Chang DY, Cho KG, Lim J, Kim SS, Suh-Kim H. CXCR4-STAT3 Axis Plays a Role in Tumor Cell Infiltration in an Orthotopic Mouse Glioblastoma Model. Mol Cells 2020;43:539-50. [PMID: 32597394 DOI: 10.14348/molcells.2020.0098] [Cited by in F6Publishing: 2] [Reference Citation Analysis]
45 Lee KB, Kelbauskas L, Brunner A, Meldrum DR. A versatile method for dynamically controlled patterning of small populations of epithelial cells on substrates via non-contact piezoelectric inkjet printing. PLoS One 2017;12:e0176079. [PMID: 28445488 DOI: 10.1371/journal.pone.0176079] [Cited by in Crossref: 6] [Cited by in F6Publishing: 4] [Article Influence: 1.2] [Reference Citation Analysis]
46 Sharma A, Yang WL, Matsuo S, Wang P. Differential alterations of tissue T-cell subsets after sepsis. Immunol Lett 2015;168:41-50. [PMID: 26362089 DOI: 10.1016/j.imlet.2015.09.005] [Cited by in Crossref: 23] [Cited by in F6Publishing: 23] [Article Influence: 3.3] [Reference Citation Analysis]
47 Kasashima H, Yashiro M, Nakamae H, Masuda G, Kinoshita H, Morisaki T, Fukuoka T, Hasegawa T, Nakane T, Hino M, Hirakawa K, Ohira M. Clinicopathologic significance of the CXCL1-CXCR2 axis in the tumor microenvironment of gastric carcinoma. PLoS One 2017;12:e0178635. [PMID: 28575019 DOI: 10.1371/journal.pone.0178635] [Cited by in Crossref: 11] [Cited by in F6Publishing: 10] [Article Influence: 2.2] [Reference Citation Analysis]
48 Cuiffo BG, Karnoub AE. Silencing FOXP2 in breast cancer cells promotes cancer stem cell traits and metastasis. Mol Cell Oncol 2016;3:e1019022. [PMID: 27314063 DOI: 10.1080/23723556.2015.1019022] [Cited by in Crossref: 7] [Cited by in F6Publishing: 10] [Article Influence: 1.0] [Reference Citation Analysis]
49 Meng Y, Zhang H, Li Q, Xing P, Liu F, Cao K, Fang X, Li J, Yu J, Feng X, Ma C, Wang L, Jiang H, Lu J, Bian Y, Shao C. Noncontrast Magnetic Resonance Radiomics and Multilayer Perceptron Network Classifier: An approach for Predicting Fibroblast Activation Protein Expression in Patients With Pancreatic Ductal Adenocarcinoma. J Magn Reson Imaging 2021. [PMID: 33890347 DOI: 10.1002/jmri.27648] [Cited by in Crossref: 1] [Cited by in F6Publishing: 2] [Article Influence: 1.0] [Reference Citation Analysis]
50 Kasahara Y, Shirota H, Umegaki S, Ishioka C. Contribution of Fcγ receptor IIB to creating a suppressive tumor microenvironment in a mouse model. Cancer Immunol Immunother 2019;68:1769-78. [PMID: 31616964 DOI: 10.1007/s00262-019-02413-w] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 0.3] [Reference Citation Analysis]
51 Liu D, Steins A, Klaassen R, van der Zalm AP, Bennink RJ, van Tienhoven G, Besselink MG, Bijlsma MF, van Laarhoven HWM. Soluble Compounds Released by Hypoxic Stroma Confer Invasive Properties to Pancreatic Ductal Adenocarcinoma. Biomedicines 2020;8:E444. [PMID: 33105540 DOI: 10.3390/biomedicines8110444] [Cited by in Crossref: 2] [Cited by in F6Publishing: 1] [Article Influence: 1.0] [Reference Citation Analysis]
52 Huo J, Wu L, Zang Y, Dong H, Liu X, He F, Zhang X. Eight-gene metabolic signature related with tumor-associated macrophages predicting overall survival for hepatocellular carcinoma. BMC Cancer 2021;21:31. [PMID: 33413205 DOI: 10.1186/s12885-020-07734-z] [Cited by in Crossref: 5] [Cited by in F6Publishing: 7] [Article Influence: 5.0] [Reference Citation Analysis]
53 Wu S, Wen F, Li Y, Gao X, He S, Liu M, Zhang X, Tian D. PIK3CA and PIK3CB silencing by RNAi reverse MDR and inhibit tumorigenic properties in human colorectal carcinoma. Tumour Biol. 2016;37:8799-8809. [PMID: 26747178 DOI: 10.1007/s13277-015-4691-5] [Cited by in Crossref: 5] [Cited by in F6Publishing: 4] [Article Influence: 0.8] [Reference Citation Analysis]
54 Brands RC, Köhler O, Rauthe S, Hartmann S, Ebhardt H, Seher A, Linz C, Kübler AC, Müller-Richter UDA. The prognostic value of GLUT-1 staining in the detection of malignant transformation in oral mucosa. Clin Oral Investig 2017;21:1631-7. [PMID: 27631596 DOI: 10.1007/s00784-016-1954-5] [Cited by in Crossref: 8] [Cited by in F6Publishing: 6] [Article Influence: 1.3] [Reference Citation Analysis]
55 Wang L, Huo M, Chen Y, Shi J. Tumor Microenvironment‐Enabled Nanotherapy. Adv Healthcare Mater 2018;7:1701156. [DOI: 10.1002/adhm.201701156] [Cited by in Crossref: 76] [Cited by in F6Publishing: 64] [Article Influence: 15.2] [Reference Citation Analysis]
56 Pantziarka P. Emergent properties of a computational model of tumour growth. PeerJ 2016;4:e2176. [PMID: 27413638 DOI: 10.7717/peerj.2176] [Cited by in Crossref: 6] [Cited by in F6Publishing: 5] [Article Influence: 1.0] [Reference Citation Analysis]
57 Sun T, Kang Y, Liu J, Zhang Y, Ou L, Liu X, Lai R, Shao L. Nanomaterials and hepatic disease: toxicokinetics, disease types, intrinsic mechanisms, liver susceptibility, and influencing factors. J Nanobiotechnology 2021;19:108. [PMID: 33863340 DOI: 10.1186/s12951-021-00843-2] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 1.0] [Reference Citation Analysis]
58 Goodarzi A, Khanmohammadi M, Ai A, Khodayari H, Ai A, Farahani MS, Khodayari S, Ebrahimi-Barough S, Mohandesnezhad S, Ai J. Simultaneous impact of atorvastatin and mesenchymal stem cells for glioblastoma multiform suppression in rat glioblastoma multiform model. Mol Biol Rep 2020;47:7783-95. [PMID: 32981013 DOI: 10.1007/s11033-020-05855-z] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 0.5] [Reference Citation Analysis]
59 Mannavola F, Salerno T, Passarelli A, Tucci M, Internò V, Silvestris F. Revisiting the Role of Exosomes in Colorectal Cancer: Where Are We Now?. Front Oncol 2019;9:521. [PMID: 31275854 DOI: 10.3389/fonc.2019.00521] [Cited by in Crossref: 17] [Cited by in F6Publishing: 15] [Article Influence: 5.7] [Reference Citation Analysis]
60 Mccuaig R, Wu F, Dunn J, Rao S, Dahlstrom JE. The biological and clinical significance of stromal-epithelial interactions in breast cancer. Pathology 2017;49:133-40. [DOI: 10.1016/j.pathol.2016.10.009] [Cited by in Crossref: 14] [Cited by in F6Publishing: 17] [Article Influence: 2.8] [Reference Citation Analysis]
61 Doldi V, Callari M, Giannoni E, D’Aiuto F, Maffezzini M, Valdagni R, Chiarugi P, Gandellini P, Zaffaroni N. Integrated gene and miRNA expression analysis of prostate cancer associated fibroblasts supports a prominent role for interleukin-6 in fibroblast activation. Oncotarget. 2015;6:31441-31460. [PMID: 26375444 DOI: 10.18632/oncotarget.5056] [Cited by in Crossref: 46] [Cited by in F6Publishing: 46] [Article Influence: 7.7] [Reference Citation Analysis]
62 Aggarwal S, Gabrovsek L, Langeberg LK, Golkowski M, Ong SE, Smith FD, Scott JD. Depletion of dAKAP1-protein kinase A signaling islands from the outer mitochondrial membrane alters breast cancer cell metabolism and motility. J Biol Chem 2019;294:3152-68. [PMID: 30598507 DOI: 10.1074/jbc.RA118.006741] [Cited by in Crossref: 9] [Cited by in F6Publishing: 5] [Article Influence: 2.3] [Reference Citation Analysis]
63 Jablonska J, Lang S, Sionov RV, Granot Z. The regulation of pre-metastatic niche formation by neutrophils. Oncotarget 2017;8:112132-44. [PMID: 29340117 DOI: 10.18632/oncotarget.22792] [Cited by in Crossref: 49] [Cited by in F6Publishing: 50] [Article Influence: 9.8] [Reference Citation Analysis]
64 Wang Y, Shi W, Kuss M, Mirza S, Qi D, Krasnoslobodtsev A, Zeng J, Band H, Band V, Duan B. 3D Bioprinting of Breast Cancer Models for Drug Resistance Study. ACS Biomater Sci Eng 2018;4:4401-11. [DOI: 10.1021/acsbiomaterials.8b01277] [Cited by in Crossref: 37] [Cited by in F6Publishing: 30] [Article Influence: 9.3] [Reference Citation Analysis]
65 Zhang X, Li X, Sun S, Wang P, Ma X, Hou R, Liang X. Anti-Tumor Metastasis via Platelet Inhibitor Combined with Photothermal Therapy under Activatable Fluorescence/Magnetic Resonance Bimodal Imaging Guidance. ACS Appl Mater Interfaces 2021;13:19679-94. [PMID: 33876926 DOI: 10.1021/acsami.1c02302] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 1.0] [Reference Citation Analysis]
66 Kumar JD, Kandola S, Tiszlavicz L, Reisz Z, Dockray GJ, Varro A. The role of chemerin and ChemR23 in stimulating the invasion of squamous oesophageal cancer cells. Br J Cancer 2016;114:1152-9. [PMID: 27092781 DOI: 10.1038/bjc.2016.93] [Cited by in Crossref: 25] [Cited by in F6Publishing: 27] [Article Influence: 4.2] [Reference Citation Analysis]
67 Seidlitz T, Stange DE. Gastrointestinal cancer organoids-applications in basic and translational cancer research. Exp Mol Med 2021;53:1459-70. [PMID: 34663939 DOI: 10.1038/s12276-021-00654-3] [Cited by in Crossref: 1] [Article Influence: 1.0] [Reference Citation Analysis]
68 Lin LY, Du LM, Cao K, Huang Y, Yu PF, Zhang LY, Li FY, Wang Y, Shi YF. Tumour cell-derived exosomes endow mesenchymal stromal cells with tumour-promotion capabilities. Oncogene 2016;35:6038-42. [PMID: 27132512 DOI: 10.1038/onc.2016.131] [Cited by in Crossref: 45] [Cited by in F6Publishing: 50] [Article Influence: 7.5] [Reference Citation Analysis]
69 Sarfraz M, Roa W, Bou-Chacra N, Löbenberg R. Inflammation Caused by Nanosized Delivery Systems: Is There a Benefit? Mol Pharm 2016;13:3270-8. [PMID: 27540750 DOI: 10.1021/acs.molpharmaceut.6b00530] [Cited by in Crossref: 3] [Cited by in F6Publishing: 3] [Article Influence: 0.5] [Reference Citation Analysis]
70 Kuol N, Stojanovska L, Apostolopoulos V, Nurgali K. Role of the nervous system in cancer metastasis. J Exp Clin Cancer Res 2018;37:5. [PMID: 29334991 DOI: 10.1186/s13046-018-0674-x] [Cited by in Crossref: 47] [Cited by in F6Publishing: 47] [Article Influence: 11.8] [Reference Citation Analysis]
71 Ahluwalia P, Ahluwalia M, Mondal AK, Sahajpal N, Kota V, Rojiani MV, Rojiani AM, Kolhe R. Immunogenomic Gene Signature of Cell-Death Associated Genes with Prognostic Implications in Lung Cancer. Cancers (Basel) 2021;13:E155. [PMID: 33466402 DOI: 10.3390/cancers13010155] [Cited by in Crossref: 3] [Cited by in F6Publishing: 4] [Article Influence: 3.0] [Reference Citation Analysis]
72 He X, Qi Y, Zhang X, Liu X, Li X, Li S, Wu Y, Zhang Q. Current landscape of tumor-derived exosomal ncRNAs in glioma progression, detection, and drug resistance. Cell Death Dis 2021;12:1145. [PMID: 34887381 DOI: 10.1038/s41419-021-04430-z] [Reference Citation Analysis]
73 Ahmed Z, Gravel S. Intratumor Heterogeneity and Circulating Tumor Cell Clusters. Mol Biol Evol 2018;35:2135-44. [PMID: 29897504 DOI: 10.1093/molbev/msy115] [Cited by in Crossref: 8] [Cited by in F6Publishing: 7] [Article Influence: 1.6] [Reference Citation Analysis]
74 Davern M, Donlon NE, Power R, Hayes C, King R, Dunne MR, Reynolds JV. The tumour immune microenvironment in oesophageal cancer. Br J Cancer 2021;125:479-94. [PMID: 33903730 DOI: 10.1038/s41416-021-01331-y] [Reference Citation Analysis]
75 Man S, Lu Y, Yin L, Cheng X, Ma L. Potential and promising anticancer drugs from adenosine and its analogs. Drug Discov Today 2021;26:1490-500. [PMID: 33639248 DOI: 10.1016/j.drudis.2021.02.020] [Cited by in Crossref: 2] [Cited by in F6Publishing: 1] [Article Influence: 2.0] [Reference Citation Analysis]
76 He R, Wang Z, Shi W, Yu L, Xia H, Huang Z, Liu S, Zhao X, Xu Y, Yam JWP, Cui Y. Exosomes in hepatocellular carcinoma microenvironment and their potential clinical application value. Biomed Pharmacother 2021;138:111529. [PMID: 34311529 DOI: 10.1016/j.biopha.2021.111529] [Cited by in Crossref: 1] [Article Influence: 1.0] [Reference Citation Analysis]
77 Freitas JT, Lopez J, Llorian C, Boroni M, Kos L. The immunosuppressive role of Edn3 overexpression in the melanoma microenvironment. Pigment Cell Melanoma Res 2021. [PMID: 34288510 DOI: 10.1111/pcmr.13002] [Reference Citation Analysis]
78 Offer S, Menard JA, Pérez JE, de Oliveira KG, Chandran VI, Johansson MC, Bång-Rudenstam A, Siesjö P, Ebbesson A, Hedenfalk I, Sundgren PC, Darabi A, Belting M. Extracellular lipid loading augments hypoxic paracrine signaling and promotes glioma angiogenesis and macrophage infiltration. J Exp Clin Cancer Res 2019;38:241. [PMID: 31174567 DOI: 10.1186/s13046-019-1228-6] [Cited by in Crossref: 7] [Cited by in F6Publishing: 6] [Article Influence: 2.3] [Reference Citation Analysis]
79 Ouzounova M, Lee E, Piranlioglu R, El Andaloussi A, Kolhe R, Demirci MF, Marasco D, Asm I, Chadli A, Hassan KA, Thangaraju M, Zhou G, Arbab AS, Cowell JK, Korkaya H. Monocytic and granulocytic myeloid derived suppressor cells differentially regulate spatiotemporal tumour plasticity during metastatic cascade. Nat Commun 2017;8:14979. [PMID: 28382931 DOI: 10.1038/ncomms14979] [Cited by in Crossref: 162] [Cited by in F6Publishing: 151] [Article Influence: 32.4] [Reference Citation Analysis]
80 Kracht MJL, Zaldumbide A, Roep BO. Neoantigens and Microenvironment in Type 1 Diabetes: Lessons from Antitumor Immunity. Trends Endocrinol Metab 2016;27:353-62. [PMID: 27094501 DOI: 10.1016/j.tem.2016.03.013] [Cited by in Crossref: 15] [Cited by in F6Publishing: 14] [Article Influence: 2.5] [Reference Citation Analysis]
81 Ko JH, Um JY, Lee SG, Yang WM, Sethi G, Ahn KS. Conditioned media from adipocytes promote proliferation, migration, and invasion in melanoma and colorectal cancer cells. J Cell Physiol 2019;234:18249-61. [PMID: 30851074 DOI: 10.1002/jcp.28456] [Cited by in Crossref: 18] [Cited by in F6Publishing: 17] [Article Influence: 6.0] [Reference Citation Analysis]
82 Salvador E, Burek M, Förster CY. Tight Junctions and the Tumor Microenvironment. Curr Pathobiol Rep 2016;4:135-45. [PMID: 27547510 DOI: 10.1007/s40139-016-0106-6] [Cited by in Crossref: 38] [Cited by in F6Publishing: 38] [Article Influence: 6.3] [Reference Citation Analysis]
83 Gerwing M, Herrmann K, Helfen A, Schliemann C, Berdel WE, Eisenblätter M, Wildgruber M. The beginning of the end for conventional RECIST - novel therapies require novel imaging approaches. Nat Rev Clin Oncol 2019;16:442-58. [PMID: 30718844 DOI: 10.1038/s41571-019-0169-5] [Cited by in Crossref: 45] [Cited by in F6Publishing: 40] [Article Influence: 15.0] [Reference Citation Analysis]
84 Hongu T, Yamauchi Y, Funakoshi Y, Katagiri N, Ohbayashi N, Kanaho Y. Pathological functions of the small GTPase Arf6 in cancer progression: Tumor angiogenesis and metastasis. Small GTPases 2016;7:47-53. [PMID: 26909552 DOI: 10.1080/21541248.2016.1154640] [Cited by in Crossref: 22] [Cited by in F6Publishing: 19] [Article Influence: 3.7] [Reference Citation Analysis]
85 Wang YY, Chen HD, Lo S, Chen YK, Huang YC, Hu SC, Hsieh YC, Hung AC, Hou MF, Yuan SF. Visfatin Enhances Breast Cancer Progression through CXCL1 Induction in Tumor-Associated Macrophages. Cancers (Basel) 2020;12:E3526. [PMID: 33256011 DOI: 10.3390/cancers12123526] [Cited by in Crossref: 1] [Cited by in F6Publishing: 2] [Article Influence: 0.5] [Reference Citation Analysis]
86 Tulotta C, He S, van der Ent W, Chen L, Groenewoud A, Spaink HP, Snaar-Jagalska BE. Imaging Cancer Angiogenesis and Metastasis in a Zebrafish Embryo Model. Adv Exp Med Biol 2016;916:239-63. [PMID: 27165357 DOI: 10.1007/978-3-319-30654-4_11] [Cited by in Crossref: 12] [Cited by in F6Publishing: 18] [Article Influence: 2.0] [Reference Citation Analysis]
87 Ouahoud S, Hardwick JCH, Hawinkels LJAC. Extracellular BMP Antagonists, Multifaceted Orchestrators in the Tumor and Its Microenvironment. Int J Mol Sci 2020;21:E3888. [PMID: 32486027 DOI: 10.3390/ijms21113888] [Cited by in Crossref: 2] [Cited by in F6Publishing: 2] [Article Influence: 1.0] [Reference Citation Analysis]
88 Weng Qiaoyou, Chen Minjiang, Li Maoquan, Zheng Yong-Fa, Shao Guoliang, Fan Weijun, Xu Xi-Ming, Ji Jiansong. Global microarray profling identifed hsa_ circ_0064428 as a potential immune-associated prognosis biomarker for hepatocellular carcinoma. J Med Genet. 2018;0:1-7. [PMID: 30120213 DOI: 10.1136/jmedgenet-2018-105440] [Cited by in Crossref: 28] [Cited by in F6Publishing: 31] [Article Influence: 7.0] [Reference Citation Analysis]
89 Somasundaram A, Rothenberger NJ, Stabile LP. The Impact of Estrogen in the Tumor Microenvironment. Adv Exp Med Biol 2020;1277:33-52. [PMID: 33119863 DOI: 10.1007/978-3-030-50224-9_2] [Cited by in Crossref: 5] [Cited by in F6Publishing: 6] [Article Influence: 5.0] [Reference Citation Analysis]
90 Zheng H, Liu H, Li H, Dou W, Wang X. Weighted Gene Co-expression Network Analysis Identifies a Cancer-Associated Fibroblast Signature for Predicting Prognosis and Therapeutic Responses in Gastric Cancer. Front Mol Biosci 2021;8:744677. [PMID: 34692770 DOI: 10.3389/fmolb.2021.744677] [Reference Citation Analysis]
91 Zhang Y, Xu J, Zhang N, Chen M, Wang H, Zhu D. Targeting the tumour immune microenvironment for cancer therapy in human gastrointestinal malignancies. Cancer Letters 2019;458:123-35. [DOI: 10.1016/j.canlet.2019.05.017] [Cited by in Crossref: 15] [Cited by in F6Publishing: 13] [Article Influence: 5.0] [Reference Citation Analysis]
92 Irani S. Emerging insights into the biology of metastasis: A review article. Iran J Basic Med Sci 2019;22:833-47. [PMID: 31579438 DOI: 10.22038/ijbms.2019.32786.7839] [Cited by in F6Publishing: 7] [Reference Citation Analysis]
93 Safari Yazd H, Yang Y, Li L, Yang L, Li X, Pan X, Chen Z, Jiang J, Cui C, Tan W. Precise Deposition of Polydopamine on Cancer Cell Membrane as Artificial Receptor for Targeted Drug Delivery. iScience 2020;23:101750. [PMID: 33367224 DOI: 10.1016/j.isci.2020.101750] [Cited by in Crossref: 2] [Article Influence: 1.0] [Reference Citation Analysis]
94 Ören B, Urosevic J, Mertens C, Mora J, Guiu M, Gomis RR, Weigert A, Schmid T, Grein S, Brüne B, Jung M. Tumour stroma-derived lipocalin-2 promotes breast cancer metastasis. J Pathol 2016;239:274-85. [PMID: 27038000 DOI: 10.1002/path.4724] [Cited by in Crossref: 47] [Cited by in F6Publishing: 48] [Article Influence: 7.8] [Reference Citation Analysis]
95 Yang Q, Ji G, Li J. STEAP2 is down-regulated in breast cancer tissue and suppresses PI3K/AKT signaling and breast cancer cell invasion in vitro and in vivo. Cancer Biol Ther 2020;21:278-91. [PMID: 31696760 DOI: 10.1080/15384047.2019.1685290] [Cited by in Crossref: 5] [Cited by in F6Publishing: 6] [Article Influence: 1.7] [Reference Citation Analysis]
96 Zhou C, Shen S, Moran R, Deng N, Marbán E, Melmed S. Pituitary somatotroph adenoma-derived exosomes: characterization of nonhormonal actions. J Clin Endocrinol Metab 2021:dgab651. [PMID: 34467411 DOI: 10.1210/clinem/dgab651] [Reference Citation Analysis]
97 Peláez R, Ochoa R, Pariente A, Villanueva-Martínez Á, Pérez-Sala Á, Larráyoz IM. Sterculic Acid Alters Adhesion Molecules Expression and Extracellular Matrix Compounds to Regulate Migration of Lung Cancer Cells. Cancers (Basel) 2021;13:4370. [PMID: 34503180 DOI: 10.3390/cancers13174370] [Reference Citation Analysis]
98 Shao S, Zhao L, An G, Zhang L, Jing X, Luo M, Li W, Meng D, Ning Q, Zhao X, Lei J. Metformin suppresses HIF-1α expression in cancer-associated fibroblasts to prevent tumor-stromal cross talk in breast cancer. FASEB J 2020;34:10860-70. [PMID: 32592239 DOI: 10.1096/fj.202000951RR] [Cited by in Crossref: 4] [Cited by in F6Publishing: 4] [Article Influence: 2.0] [Reference Citation Analysis]
99 He K, Liu S, Xia Y, Xu J, Liu F, Xiao J, Li Y, Ding Q, Lu L, Xiang G, Zhan M. CXCL12 and IL7R as Novel Therapeutic Targets for Liver Hepatocellular Carcinoma Are Correlated With Somatic Mutations and the Tumor Immunological Microenvironment. Front Oncol 2020;10:574853. [PMID: 33344233 DOI: 10.3389/fonc.2020.574853] [Reference Citation Analysis]
100 Zhang Y, Ho S, Li B, Nie G, Li S. Modulating the tumor microenvironment with new therapeutic nanoparticles: A promising paradigm for tumor treatment. Med Res Rev 2020;40:1084-102. [DOI: 10.1002/med.21644] [Cited by in Crossref: 10] [Cited by in F6Publishing: 9] [Article Influence: 3.3] [Reference Citation Analysis]
101 Moga MA, Bălan A, Anastasiu CV, Dimienescu OG, Neculoiu CD, Gavriș C. An Overview on the Anticancer Activity of Azadirachta indica (Neem) in Gynecological Cancers. Int J Mol Sci 2018;19:E3898. [PMID: 30563141 DOI: 10.3390/ijms19123898] [Cited by in Crossref: 19] [Cited by in F6Publishing: 12] [Article Influence: 4.8] [Reference Citation Analysis]
102 Dou YN, Chaudary N, Chang MC, Dunne M, Huang H, Jaffray DA, Milosevic M, Allen C. Tumor microenvironment determines response to a heat-activated thermosensitive liposome formulation of cisplatin in cervical carcinoma. J Control Release 2017;262:182-91. [PMID: 28760449 DOI: 10.1016/j.jconrel.2017.07.039] [Cited by in Crossref: 8] [Cited by in F6Publishing: 8] [Article Influence: 1.6] [Reference Citation Analysis]
103 Gleave AM, Ci X, Lin D, Wang Y. A synopsis of prostate organoid methodologies, applications, and limitations. Prostate 2020;80:518-26. [PMID: 32084293 DOI: 10.1002/pros.23966] [Cited by in Crossref: 7] [Cited by in F6Publishing: 6] [Article Influence: 3.5] [Reference Citation Analysis]
104 Siljamäki E, Rappu P, Riihilä P, Nissinen L, Kähäri VM, Heino J. H-Ras activation and fibroblast-induced TGF-β signaling promote laminin-332 accumulation and invasion in cutaneous squamous cell carcinoma. Matrix Biol 2020;87:26-47. [PMID: 31655292 DOI: 10.1016/j.matbio.2019.09.001] [Cited by in Crossref: 10] [Cited by in F6Publishing: 11] [Article Influence: 3.3] [Reference Citation Analysis]
105 Sciancalepore D, Musci S, Fracella MR, D'Alesio G, Sportelli A, Ingravallo G, Vacca A, Ria R. Extramedullary Plasmacytoma Mimicking Pancreatic Cancer: An Unusual Presentation. Case Rep Oncol Med 2016;2016:6919210. [PMID: 27847663 DOI: 10.1155/2016/6919210] [Cited by in F6Publishing: 1] [Reference Citation Analysis]
106 Luo Q, He F, Cao J. A stromal and immune cell infiltration-based score model predicts prognosis and chemotherapy effect in colorectal cancer. Int Immunopharmacol 2021;99:107940. [PMID: 34242996 DOI: 10.1016/j.intimp.2021.107940] [Reference Citation Analysis]
107 Patwa A, Yamashita R, Long J, Risom T, Angelo M, Keren L, Rubin DL. Multiplexed imaging analysis of the tumor-immune microenvironment reveals predictors of outcome in triple-negative breast cancer. Commun Biol 2021;4:852. [PMID: 34244605 DOI: 10.1038/s42003-021-02361-1] [Reference Citation Analysis]
108 Brown GT, Murray GI. Current mechanistic insights into the roles of matrix metalloproteinases in tumour invasion and metastasis. J Pathol. 2015;237:273-281. [PMID: 26174849 DOI: 10.1002/path.4586] [Cited by in Crossref: 148] [Cited by in F6Publishing: 150] [Article Influence: 21.1] [Reference Citation Analysis]
109 Hirayama D, Iida T, Nakase H. The Phagocytic Function of Macrophage-Enforcing Innate Immunity and Tissue Homeostasis. Int J Mol Sci 2017;19:E92. [PMID: 29286292 DOI: 10.3390/ijms19010092] [Cited by in Crossref: 121] [Cited by in F6Publishing: 125] [Article Influence: 24.2] [Reference Citation Analysis]
110 Zheng H, Siddharth S, Parida S, Wu X, Sharma D. Tumor Microenvironment: Key Players in Triple Negative Breast Cancer Immunomodulation. Cancers (Basel) 2021;13:3357. [PMID: 34283088 DOI: 10.3390/cancers13133357] [Reference Citation Analysis]
111 Mosaad EO, Futrega K, Seim I, Gloss B, Chambers KF, Clements JA, Doran MR. Constraints to counting bioluminescence producing cells by a commonly used transgene promoter and its implications for experimental design. Sci Rep 2019;9:11334. [PMID: 31383876 DOI: 10.1038/s41598-019-46916-z] [Cited by in Crossref: 3] [Cited by in F6Publishing: 2] [Article Influence: 1.0] [Reference Citation Analysis]
112 Cohen O, Betzer O, Elmaliach-Pnini N, Motiei M, Sadan T, Cohen-Berkman M, Dagan O, Popovtzer A, Yosepovich A, Barhom H, Michaeli S, Popovtzer R. 'Golden' exosomes as delivery vehicles to target tumors and overcome intratumoral barriers: in vivo tracking in a model for head and neck cancer. Biomater Sci 2021;9:2103-14. [PMID: 33475633 DOI: 10.1039/d0bm01735c] [Cited by in F6Publishing: 1] [Reference Citation Analysis]
113 Turner CJ, Edwards CM. The Role of the Microenvironment in Prostate Cancer-Associated Bone Disease. Curr Osteoporos Rep 2016;14:170-7. [DOI: 10.1007/s11914-016-0323-2] [Cited by in Crossref: 6] [Cited by in F6Publishing: 5] [Article Influence: 1.0] [Reference Citation Analysis]
114 Jinushi M, Komohara Y. Tumor-associated macrophages as an emerging target against tumors: Creating a new path from bench to bedside. Biochim Biophys Acta 2015;1855:123-30. [PMID: 25595840 DOI: 10.1016/j.bbcan.2015.01.002] [Cited by in Crossref: 32] [Cited by in F6Publishing: 61] [Article Influence: 4.6] [Reference Citation Analysis]
115 Okła K, Czerwonka A, Wawruszak A, Bobiński M, Bilska M, Tarkowski R, Bednarek W, Wertel I, Kotarski J. Clinical Relevance and Immunosuppressive Pattern of Circulating and Infiltrating Subsets of Myeloid-Derived Suppressor Cells (MDSCs) in Epithelial Ovarian Cancer. Front Immunol 2019;10:691. [PMID: 31001284 DOI: 10.3389/fimmu.2019.00691] [Cited by in Crossref: 27] [Cited by in F6Publishing: 28] [Article Influence: 9.0] [Reference Citation Analysis]
116 Langer EM, Allen-Petersen BL, King SM, Kendsersky ND, Turnidge MA, Kuziel GM, Riggers R, Samatham R, Amery TS, Jacques SL, Sheppard BC, Korkola JE, Muschler JL, Thibault G, Chang YH, Gray JW, Presnell SC, Nguyen DG, Sears RC. Modeling Tumor Phenotypes In Vitro with Three-Dimensional Bioprinting. Cell Rep 2019;26:608-623.e6. [PMID: 30650355 DOI: 10.1016/j.celrep.2018.12.090] [Cited by in Crossref: 65] [Cited by in F6Publishing: 60] [Article Influence: 32.5] [Reference Citation Analysis]
117 Dos Reis DC, Damasceno KA, de Campos CB, Veloso ES, Pêgas GRA, Kraemer LR, Rodrigues MA, Mattos MS, Gomes DA, Campos PP, Ferreira E, Russo RC, Cassali GD. Versican and Tumor-Associated Macrophages Promotes Tumor Progression and Metastasis in Canine and Murine Models of Breast Carcinoma. Front Oncol 2019;9:577. [PMID: 31334111 DOI: 10.3389/fonc.2019.00577] [Cited by in Crossref: 13] [Cited by in F6Publishing: 14] [Article Influence: 4.3] [Reference Citation Analysis]
118 Yue S, Luo M, Liu H, Wei S. Recent Advances of Gold Compounds in Anticancer Immunity. Front Chem 2020;8:543. [PMID: 32695747 DOI: 10.3389/fchem.2020.00543] [Cited by in Crossref: 7] [Cited by in F6Publishing: 5] [Article Influence: 3.5] [Reference Citation Analysis]
119 Li J, Ouyang T, Li M, Hong T, Alriashy M, Meng W, Zhang N. CBX7 is Dualistic in Cancer Progression Based on its Function and Molecular Interactions. Front Genet 2021;12:740794. [PMID: 34659360 DOI: 10.3389/fgene.2021.740794] [Reference Citation Analysis]
120 Peters PN, Schryver EM, Lengyel E, Kenny H. Modeling the Early Steps of Ovarian Cancer Dissemination in an Organotypic Culture of the Human Peritoneal Cavity. J Vis Exp 2015;:e53541. [PMID: 26780294 DOI: 10.3791/53541] [Cited by in Crossref: 6] [Cited by in F6Publishing: 6] [Article Influence: 0.9] [Reference Citation Analysis]
121 Hu C, Liu X, Ran W, Meng J, Zhai Y, Zhang P, Yin Q, Yu H, Zhang Z, Li Y. Regulating cancer associated fibroblasts with losartan-loaded injectable peptide hydrogel to potentiate chemotherapy in inhibiting growth and lung metastasis of triple negative breast cancer. Biomaterials 2017;144:60-72. [PMID: 28823844 DOI: 10.1016/j.biomaterials.2017.08.009] [Cited by in Crossref: 65] [Cited by in F6Publishing: 66] [Article Influence: 13.0] [Reference Citation Analysis]
122 von Locquenghien M, Rozalén C, Celià-Terrassa T. Interferons in cancer immunoediting: sculpting metastasis and immunotherapy response. J Clin Invest 2021;131:143296. [PMID: 33393507 DOI: 10.1172/JCI143296] [Cited by in Crossref: 2] [Cited by in F6Publishing: 2] [Article Influence: 2.0] [Reference Citation Analysis]
123 Zhao Y, Sun H, Zheng J, Shao C. Analysis of RNA m6A methylation regulators and tumour immune cell infiltration characterization in prostate cancer. Artif Cells Nanomed Biotechnol 2021;49:407-35. [PMID: 33905280 DOI: 10.1080/21691401.2021.1912759] [Reference Citation Analysis]
124 Navashenaq JG, Shabgah AG, Banach M, Jamialahmadi T, Penson PE, Johnston TP, Sahebkar A. The interaction of Helicobacter pylori with cancer immunomodulatory stromal cells: New insight into gastric cancer pathogenesis. Semin Cancer Biol 2021:S1044-579X(21)00248-0. [PMID: 34600095 DOI: 10.1016/j.semcancer.2021.09.014] [Cited by in Crossref: 1] [Article Influence: 1.0] [Reference Citation Analysis]
125 Fozzatti L, Alamino VA, Park S, Giusiano L, Volpini X, Zhao L, Stempin CC, Donadio AC, Cheng SY, Pellizas CG. Interplay of fibroblasts with anaplastic tumor cells promotes follicular thyroid cancer progression. Sci Rep 2019;9:8028. [PMID: 31142771 DOI: 10.1038/s41598-019-44361-6] [Cited by in Crossref: 5] [Cited by in F6Publishing: 8] [Article Influence: 1.7] [Reference Citation Analysis]
126 Schaper F, van Spriel AB. Antitumor Immunity Is Controlled by Tetraspanin Proteins. Front Immunol 2018;9:1185. [PMID: 29896201 DOI: 10.3389/fimmu.2018.01185] [Cited by in Crossref: 17] [Cited by in F6Publishing: 14] [Article Influence: 4.3] [Reference Citation Analysis]
127 Chen W, Xie Y, Wang T, Wang L. New insights into Epstein‑Barr virus‑associated tumors: Exosomes (Review). Oncol Rep 2022;47:13. [PMID: 34779497 DOI: 10.3892/or.2021.8224] [Reference Citation Analysis]
128 Glass L, Wente SR. Gle1 mediates stress granule-dependent survival during chemotoxic stress. Adv Biol Regul 2019;71:156-71. [PMID: 30262214 DOI: 10.1016/j.jbior.2018.09.007] [Cited by in Crossref: 7] [Cited by in F6Publishing: 5] [Article Influence: 1.8] [Reference Citation Analysis]
129 Pacitto R, Gaeta I, Swanson JA, Yoshida S. CXCL12-induced macropinocytosis modulates two distinct pathways to activate mTORC1 in macrophages. J Leukoc Biol 2017;101:683-92. [PMID: 28250113 DOI: 10.1189/jlb.2A0316-141RR] [Cited by in Crossref: 26] [Cited by in F6Publishing: 19] [Article Influence: 4.3] [Reference Citation Analysis]
130 Jiang Y, Lu J, Wang Y, Zeng F, Wang H, Peng H, Huang M, Jiang H, Luo C, Huang Y. Molecular-dynamics-simulation-driven design of a protease-responsive probe for in-vivo tumor imaging. Adv Mater 2014;26:8174-8. [PMID: 25338710 DOI: 10.1002/adma.201403547] [Cited by in Crossref: 16] [Cited by in F6Publishing: 17] [Article Influence: 2.0] [Reference Citation Analysis]
131 Wang Y, Shang K, Zhang N, Zhao J, Cao B. Tumor-Associated Macrophage-Derived Exosomes Promote the Progression of Gastric Cancer by Regulating the P38MAPK Signaling Pathway and the Immune Checkpoint PD-L1. Cancer Biother Radiopharm 2021. [PMID: 34698510 DOI: 10.1089/cbr.2021.0218] [Reference Citation Analysis]
132 Sato K, Nishiyama K, Taguchi K, Jiromaru R, Yamamoto H, Matsunaga A, Nagata R, Rikimaru F, Toh S, Higaki Y, Oda S, Nakagawa T, Masuda M. Genetic and transcriptomic analyses in a rare case of human papillomavirus-related oropharyngeal squamous-cell carcinoma combined with small-cell carcinoma. Cold Spring Harb Mol Case Stud 2021;7:a006102. [PMID: 34462366 DOI: 10.1101/mcs.a006102] [Reference Citation Analysis]
133 Zhang B, Wu Q, Li B, Wang D, Wang L, Zhou YL. m6A regulator-mediated methylation modification patterns and tumor microenvironment infiltration characterization in gastric cancer. Mol Cancer 2020;19:53. [PMID: 32164750 DOI: 10.1186/s12943-020-01170-0] [Cited by in Crossref: 86] [Cited by in F6Publishing: 104] [Article Influence: 43.0] [Reference Citation Analysis]
134 Zhuang Y, Han S, Fang Y, Huang H, Wu J. Multidimensional transitional metal-actuated nanoplatforms for cancer chemodynamic modulation. Coordination Chemistry Reviews 2022;455:214360. [DOI: 10.1016/j.ccr.2021.214360] [Reference Citation Analysis]
135 Bates JP, Derakhshandeh R, Jones L, Webb TJ. Mechanisms of immune evasion in breast cancer. BMC Cancer 2018;18:556. [PMID: 29751789 DOI: 10.1186/s12885-018-4441-3] [Cited by in Crossref: 63] [Cited by in F6Publishing: 64] [Article Influence: 15.8] [Reference Citation Analysis]
136 Gómez-Valenzuela F, Escobar E, Pérez-Tomás R, Montecinos VP. The Inflammatory Profile of the Tumor Microenvironment, Orchestrated by Cyclooxygenase-2, Promotes Epithelial-Mesenchymal Transition. Front Oncol 2021;11:686792. [PMID: 34178680 DOI: 10.3389/fonc.2021.686792] [Reference Citation Analysis]
137 Liso A, Capitanio N, Gerli R, Conese M. From fever to immunity: A new role for IGFBP-6? J Cell Mol Med 2018;22:4588-96. [PMID: 30117676 DOI: 10.1111/jcmm.13738] [Cited by in Crossref: 4] [Cited by in F6Publishing: 5] [Article Influence: 1.0] [Reference Citation Analysis]
138 Yazdani S, Bansal R, Prakash J. Drug targeting to myofibroblasts: Implications for fibrosis and cancer. Advanced Drug Delivery Reviews 2017;121:101-16. [DOI: 10.1016/j.addr.2017.07.010] [Cited by in Crossref: 69] [Cited by in F6Publishing: 70] [Article Influence: 13.8] [Reference Citation Analysis]
139 Salimifard S, Masjedi A, Hojjat-Farsangi M, Ghalamfarsa G, Irandoust M, Azizi G, Mohammadi H, Keramati MR, Jadidi-Niaragh F. Cancer associated fibroblasts as novel promising therapeutic targets in breast cancer. Pathol Res Pract 2020;216:152915. [PMID: 32146002 DOI: 10.1016/j.prp.2020.152915] [Cited by in Crossref: 12] [Cited by in F6Publishing: 10] [Article Influence: 6.0] [Reference Citation Analysis]
140 Patel SA, Rodrigues P, Wesolowski L, Vanharanta S. Genomic control of metastasis. Br J Cancer 2021;124:3-12. [PMID: 33144692 DOI: 10.1038/s41416-020-01127-6] [Cited by in Crossref: 3] [Cited by in F6Publishing: 3] [Article Influence: 1.5] [Reference Citation Analysis]
141 Matte BF, Kumar A, Placone JK, Zanella VG, Martins MD, Engler AJ, Lamers ML. Matrix stiffness mechanically conditions EMT and migratory behavior of oral squamous cell carcinoma. J Cell Sci 2019;132:jcs224360. [PMID: 30559248 DOI: 10.1242/jcs.224360] [Cited by in Crossref: 25] [Cited by in F6Publishing: 24] [Article Influence: 8.3] [Reference Citation Analysis]
142 Mezawa Y, Orimo A. The roles of tumor- and metastasis-promoting carcinoma-associated fibroblasts in human carcinomas. Cell Tissue Res 2016;365:675-89. [PMID: 27506216 DOI: 10.1007/s00441-016-2471-1] [Cited by in Crossref: 61] [Cited by in F6Publishing: 57] [Article Influence: 10.2] [Reference Citation Analysis]
143 Su Z, Yang Z, Xu Y, Chen Y, Yu Q. Apoptosis, autophagy, necroptosis, and cancer metastasis. Mol Cancer. 2015;14:48. [PMID: 25743109 DOI: 10.1186/s12943-015-0321-5] [Cited by in Crossref: 314] [Cited by in F6Publishing: 324] [Article Influence: 44.9] [Reference Citation Analysis]
144 Lee C, Geng S, Zhang Y, Rahtes A, Li L. Programming and memory dynamics of innate leukocytes during tissue homeostasis and inflammation. J Leukoc Biol 2017;102:719-26. [PMID: 28476750 DOI: 10.1189/jlb.6MR0117-027RR] [Cited by in Crossref: 6] [Cited by in F6Publishing: 4] [Article Influence: 1.2] [Reference Citation Analysis]
145 Peng H, Wang JH, Guo F, Zhu FF, Wen ZJ, Zhong HJ, Liang DS. Legumain protease-activated tuftsin-functionalized nanoparticles for dual-targeting TAMs and cancer chemotherapy. Colloids Surf B Biointerfaces 2021;197:111442. [PMID: 33166937 DOI: 10.1016/j.colsurfb.2020.111442] [Cited by in Crossref: 2] [Cited by in F6Publishing: 2] [Article Influence: 1.0] [Reference Citation Analysis]
146 Yang Y, Chen X, Saravelos SH, Liu Y, Huang J, Zhang J, Li TC. HOXA-10 and E-cadherin expression in the endometrium of women with recurrent implantation failure and recurrent miscarriage. Fertil Steril 2017;107:136-143.e2. [PMID: 27793380 DOI: 10.1016/j.fertnstert.2016.09.016] [Cited by in Crossref: 27] [Cited by in F6Publishing: 23] [Article Influence: 4.5] [Reference Citation Analysis]
147 Narkhede AA, Shevde LA, Rao SS. Biomimetic strategies to recapitulate organ specific microenvironments for studying breast cancer metastasis. Int J Cancer 2017;141:1091-109. [PMID: 28439901 DOI: 10.1002/ijc.30748] [Cited by in Crossref: 16] [Cited by in F6Publishing: 17] [Article Influence: 3.2] [Reference Citation Analysis]
148 Portillo-Lara R, Annabi N. Microengineered cancer-on-a-chip platforms to study the metastatic microenvironment. Lab Chip 2016;16:4063-81. [PMID: 27605305 DOI: 10.1039/c6lc00718j] [Cited by in Crossref: 67] [Cited by in F6Publishing: 32] [Article Influence: 16.8] [Reference Citation Analysis]
149 Vandeven N, Nghiem P. Rationale for immune-based therapies in Merkel polyomavirus-positive and -negative Merkel cell carcinomas. Immunotherapy 2016;8:907-21. [PMID: 27381685 DOI: 10.2217/imt-2016-0009] [Cited by in Crossref: 17] [Cited by in F6Publishing: 14] [Article Influence: 3.4] [Reference Citation Analysis]
150 Kuang Y, Wang S, Tang L, Hai J, Yan G, Liao L. Cluster of differentiation 147 mediates chemoresistance in breast cancer by affecting vacuolar H+-ATPase expression and activity. Oncol Lett 2018;15:7279-90. [PMID: 29731886 DOI: 10.3892/ol.2018.8199] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 0.3] [Reference Citation Analysis]
151 Takayama Y, Kusamori K, Tsukimori C, Shimizu Y, Hayashi M, Kiyama I, Katsumi H, Sakane T, Yamamoto A, Nishikawa M. Anticancer drug-loaded mesenchymal stem cells for targeted cancer therapy. J Control Release 2021;329:1090-101. [PMID: 33098911 DOI: 10.1016/j.jconrel.2020.10.037] [Cited by in Crossref: 6] [Cited by in F6Publishing: 5] [Article Influence: 3.0] [Reference Citation Analysis]
152 Lo YH, Karlsson K, Kuo CJ. Applications of Organoids for Cancer Biology and Precision Medicine. Nat Cancer 2020;1:761-73. [PMID: 34142093 DOI: 10.1038/s43018-020-0102-y] [Cited by in Crossref: 15] [Cited by in F6Publishing: 11] [Article Influence: 7.5] [Reference Citation Analysis]
153 Gionfriddo G, Plastina P, Augimeri G, Catalano S, Giordano C, Barone I, Morelli C, Giordano F, Gelsomino L, Sisci D, Witkamp R, Andò S, van Norren K, Bonofiglio D. Modulating Tumor-Associated Macrophage Polarization by Synthetic and Natural PPARγ Ligands as a Potential Target in Breast Cancer. Cells 2020;9:E174. [PMID: 31936729 DOI: 10.3390/cells9010174] [Cited by in Crossref: 17] [Cited by in F6Publishing: 15] [Article Influence: 8.5] [Reference Citation Analysis]
154 Hou J, Zhu S, Zhao Z, Shen J, Chao J, Shi J, Li J, Wang L, Ge Z, Li Q. Programming cell communications with pH-responsive DNA nanodevices. Chem Commun (Camb) 2021;57:4536-9. [PMID: 33956003 DOI: 10.1039/d1cc00875g] [Cited by in Crossref: 1] [Article Influence: 1.0] [Reference Citation Analysis]
155 Kitamura T, Pollard JW. Therapeutic potential of chemokine signal inhibition for metastatic breast cancer. Pharmacol Res 2015;100:266-70. [PMID: 26275794 DOI: 10.1016/j.phrs.2015.08.004] [Cited by in Crossref: 35] [Cited by in F6Publishing: 35] [Article Influence: 5.0] [Reference Citation Analysis]
156 Salarian M, Yang H, Turaga RC, Tan S, Qiao J, Xue S, Gui Z, Peng G, Han H, Mittal P, Grossniklaus HE, Yang JJ. Precision detection of liver metastasis by collagen-targeted protein MRI contrast agent. Biomaterials 2019;224:119478. [DOI: 10.1016/j.biomaterials.2019.119478] [Cited by in Crossref: 8] [Cited by in F6Publishing: 7] [Article Influence: 2.7] [Reference Citation Analysis]
157 Guo Y, Hu J, Zhao Z, Zhong G, Gong J, Cai D. Identification of a Prognostic Model Based on 2-Gene Signature and Analysis of Corresponding Tumor Microenvironment in Alcohol-Related Hepatocellular Carcinoma. Front Oncol 2021;11:719355. [PMID: 34646769 DOI: 10.3389/fonc.2021.719355] [Reference Citation Analysis]
158 李伟东, 孙学英. 恶性肿瘤缺氧酸性微环境对免疫治疗影响机制的研究进展. 世界华人消化杂志 2017; 25(21): 1934-1944 [DOI: 10.11569/wcjd.v25.i21.1934] [Cited by in CrossRef: 1] [Cited by in F6Publishing: 1] [Article Influence: 0.2] [Reference Citation Analysis]
159 Ou B, Liu Y, Yang X, Xu X, Yan Y, Zhang J. C5aR1-positive neutrophils promote breast cancer glycolysis through WTAP-dependent m6A methylation of ENO1. Cell Death Dis 2021;12:737. [PMID: 34312368 DOI: 10.1038/s41419-021-04028-5] [Reference Citation Analysis]
160 Yan X, Xie Y, Yang F, Hua Y, Zeng T, Sun C, Yang M, Huang X, Wu H, Fu Z, Li W, Jiao S, Yin Y. Comprehensive description of the current breast cancer microenvironment advancements via single-cell analysis. J Exp Clin Cancer Res 2021;40:142. [PMID: 33906694 DOI: 10.1186/s13046-021-01949-z] [Cited by in Crossref: 1] [Cited by in F6Publishing: 2] [Article Influence: 1.0] [Reference Citation Analysis]
161 Katsoulakis E, Yu Y, Apte AP, Leeman JE, Katabi N, Morris L, Deasy JO, Chan TA, Lee NY, Riaz N, Hatzoglou V, Oh JH. Radiomic analysis identifies tumor subtypes associated with distinct molecular and microenvironmental factors in head and neck squamous cell carcinoma. Oral Oncol 2020;110:104877. [PMID: 32619927 DOI: 10.1016/j.oraloncology.2020.104877] [Cited by in Crossref: 6] [Cited by in F6Publishing: 7] [Article Influence: 3.0] [Reference Citation Analysis]
162 Han Z, Liu S, Lin H, Trivett AL, Hannifin S, Yang, Oppenheim JJ. Inhibition of murine hepatoma tumor growth by cryptotanshinone involves TLR7-dependent activation of macrophages and induction of adaptive antitumor immune defenses. Cancer Immunol Immunother 2019;68:1073-85. [PMID: 31161238 DOI: 10.1007/s00262-019-02338-4] [Cited by in Crossref: 18] [Cited by in F6Publishing: 18] [Article Influence: 6.0] [Reference Citation Analysis]
163 Burz C, Pop VV, Buiga R, Daniel S, Samasca G, Aldea C, Lupan I. Circulating tumor cells in clinical research and monitoring patients with colorectal cancer. Oncotarget 2018;9:24561-71. [PMID: 29849961 DOI: 10.18632/oncotarget.25337] [Cited by in Crossref: 24] [Cited by in F6Publishing: 22] [Article Influence: 6.0] [Reference Citation Analysis]
164 Lou X, Li J, Yu D, Wei YQ, Feng S, Sun JJ. Comprehensive analysis of five long noncoding RNAs expression as competing endogenous RNAs in regulating hepatoma carcinoma. Cancer Med 2019;8:5735-49. [PMID: 31392826 DOI: 10.1002/cam4.2468] [Cited by in Crossref: 8] [Cited by in F6Publishing: 11] [Article Influence: 2.7] [Reference Citation Analysis]
165 Shi R, Tang Y, Miao H. Metabolism in tumor microenvironment: Implications for cancer immunotherapy. MedComm 2020;1:47-68. [DOI: 10.1002/mco2.6] [Cited by in Crossref: 8] [Cited by in F6Publishing: 1] [Article Influence: 4.0] [Reference Citation Analysis]
166 Yuan Y, Jiang JY, Wang JM, Sun J, Li C, Liu BQ, Yan J, Meng XN, Wang HQ. BAG3-positive pancreatic stellate cells promote migration and invasion of pancreatic ductal adenocarcinoma. J Cell Mol Med 2019;23:5006-16. [PMID: 31119886 DOI: 10.1111/jcmm.14352] [Cited by in Crossref: 7] [Cited by in F6Publishing: 8] [Article Influence: 2.3] [Reference Citation Analysis]
167 Sun X, Peng Y, Zhao J, Xie Z, Lei X, Tang G. Discovery and development of tumor glycolysis rate-limiting enzyme inhibitors. Bioorg Chem 2021;112:104891. [PMID: 33940446 DOI: 10.1016/j.bioorg.2021.104891] [Cited by in F6Publishing: 1] [Reference Citation Analysis]
168 De Silva L, Chuah LH, Meganathan P, Fu JY. Tocotrienol and cancer metastasis. Biofactors 2016;42:149-62. [PMID: 26948691 DOI: 10.1002/biof.1259] [Cited by in Crossref: 26] [Cited by in F6Publishing: 24] [Article Influence: 4.3] [Reference Citation Analysis]
169 Oshima G, Wightman SC, Uppal A, Stack ME, Pitroda SP, Oskvarek JJ, Huang X, Posner MC, Hellman S, Weichselbaum RR, Khodarev NN. Imaging of tumor clones with differential liver colonization. Sci Rep 2015;5:10946. [PMID: 26094901 DOI: 10.1038/srep10946] [Cited by in Crossref: 5] [Cited by in F6Publishing: 5] [Article Influence: 0.7] [Reference Citation Analysis]
170 Wan PK, Ryan AJ, Seymour LW. Beyond cancer cells: Targeting the tumor microenvironment with gene therapy and armed oncolytic virus. Mol Ther 2021;29:1668-82. [PMID: 33845199 DOI: 10.1016/j.ymthe.2021.04.015] [Cited by in F6Publishing: 1] [Reference Citation Analysis]
171 Lyu C, Lopez-Ichikawa M, Rubinsky B, Chang TT. Normal and fibrotic liver parenchyma respond differently to irreversible electroporation. HPB (Oxford) 2019;21:1344-53. [PMID: 30879992 DOI: 10.1016/j.hpb.2019.01.019] [Cited by in Crossref: 3] [Cited by in F6Publishing: 3] [Article Influence: 1.0] [Reference Citation Analysis]
172 Morrot A, da Fonseca LM, Salustiano EJ, Gentile LB, Conde L, Filardy AA, Franklim TN, da Costa KM, Freire-de-Lima CG, Freire-de-Lima L. Metabolic Symbiosis and Immunomodulation: How Tumor Cell-Derived Lactate May Disturb Innate and Adaptive Immune Responses. Front Oncol 2018;8:81. [PMID: 29629338 DOI: 10.3389/fonc.2018.00081] [Cited by in Crossref: 40] [Cited by in F6Publishing: 35] [Article Influence: 10.0] [Reference Citation Analysis]
173 Duan W, Wang K, Duan Y, Chen X, Chu X, Hu P, Xiong B. Combined Analysis of RNA Sequence and Microarray Data Reveals a Competing Endogenous RNA Network as Novel Prognostic Markers in Malignant Pleural Mesothelioma. Front Oncol 2021;11:615234. [PMID: 33968720 DOI: 10.3389/fonc.2021.615234] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 1.0] [Reference Citation Analysis]
174 Guo D, Xu S, Huang Y, Jiang H, Yasen W, Wang N, Su Y, Qian J, Li J, Zhang C, Zhu X. Platinum(IV) complex-based two-in-one polyprodrug for a combinatorial chemo-photodynamic therapy. Biomaterials 2018;177:67-77. [PMID: 29885587 DOI: 10.1016/j.biomaterials.2018.05.052] [Cited by in Crossref: 44] [Cited by in F6Publishing: 42] [Article Influence: 11.0] [Reference Citation Analysis]
175 Babajanyan SG, Koonin EV, Cheong KH. Can Environmental Manipulation Help Suppress Cancer? Non-Linear Competition Among Tumor Cells in Periodically Changing Conditions. Adv Sci (Weinh) 2020;7:2000340. [PMID: 32832349 DOI: 10.1002/advs.202000340] [Cited by in Crossref: 3] [Cited by in F6Publishing: 1] [Article Influence: 1.5] [Reference Citation Analysis]
176 Fitzgerald S, Espina V, Liotta L, Sheehan KM, O'Grady A, Cummins R, O'Kennedy R, Kay EW, Kijanka GS. Stromal TRIM28-associated signaling pathway modulation within the colorectal cancer microenvironment. J Transl Med 2018;16:89. [PMID: 29631612 DOI: 10.1186/s12967-018-1465-z] [Cited by in Crossref: 3] [Cited by in F6Publishing: 4] [Article Influence: 0.8] [Reference Citation Analysis]
177 Sadras F, Stewart TA, Robitaille M, Peters AA, Croft PK, Soon PS, Saunus JM, Lakhani SR, Roberts-Thomson SJ, Monteith GR. Altered Calcium Influx Pathways in Cancer-Associated Fibroblasts. Biomedicines 2021;9:680. [PMID: 34208665 DOI: 10.3390/biomedicines9060680] [Reference Citation Analysis]
178 Wagner J, Rapsomaniki MA, Chevrier S, Anzeneder T, Langwieder C, Dykgers A, Rees M, Ramaswamy A, Muenst S, Soysal SD, Jacobs A, Windhager J, Silina K, van den Broek M, Dedes KJ, Rodríguez Martínez M, Weber WP, Bodenmiller B. A Single-Cell Atlas of the Tumor and Immune Ecosystem of Human Breast Cancer. Cell 2019;177:1330-1345.e18. [PMID: 30982598 DOI: 10.1016/j.cell.2019.03.005] [Cited by in Crossref: 203] [Cited by in F6Publishing: 192] [Article Influence: 67.7] [Reference Citation Analysis]
179 Zhou J, Liu L, Yang T, Lu B. Prognostic and therapeutic value of CD103+ cells in renal cell carcinoma. Exp Ther Med 2018;15:4979-86. [PMID: 29805521 DOI: 10.3892/etm.2018.6025] [Cited by in F6Publishing: 3] [Reference Citation Analysis]
180 Liu Y, Ren H, Zhou Y, Shang L, Zhang Y, Yang F, Shi X. The hypoxia conditioned mesenchymal stem cells promote hepatocellular carcinoma progression through YAP mediated lipogenesis reprogramming. J Exp Clin Cancer Res 2019;38:228. [PMID: 31142342 DOI: 10.1186/s13046-019-1219-7] [Cited by in Crossref: 16] [Cited by in F6Publishing: 18] [Article Influence: 5.3] [Reference Citation Analysis]
181 Qiao YM, Zhang Y. Immunotherapy for esophageal cancer: Current studies and future perspectives. Shijie Huaren Xiaohua Zazhi 2016; 24(36): 4739-4751 [DOI: 10.11569/wcjd.v24.i36.4739] [Reference Citation Analysis]
182 Hunt PJ, Kabotyanski KE, Calin GA, Xie T, Myers JN, Amit M. Interrupting Neuron-Tumor Interactions to Overcome Treatment Resistance. Cancers (Basel) 2020;12:E3741. [PMID: 33322770 DOI: 10.3390/cancers12123741] [Reference Citation Analysis]
183 De Sanctis F, Solito S, Ugel S, Molon B, Bronte V, Marigo I. MDSCs in cancer: Conceiving new prognostic and therapeutic targets. Biochim Biophys Acta 2016;1865:35-48. [PMID: 26255541 DOI: 10.1016/j.bbcan.2015.08.001] [Cited by in Crossref: 32] [Cited by in F6Publishing: 44] [Article Influence: 4.6] [Reference Citation Analysis]
184 Zhou Z, Zhou Q, Wu X, Xu S, Hu X, Tao X, Li B, Peng J, Li D, Shen L, Cao Y, Yang L. VCAM-1 secreted from cancer-associated fibroblasts enhances the growth and invasion of lung cancer cells through AKT and MAPK signaling. Cancer Lett 2020;473:62-73. [PMID: 31904479 DOI: 10.1016/j.canlet.2019.12.039] [Cited by in Crossref: 19] [Cited by in F6Publishing: 19] [Article Influence: 9.5] [Reference Citation Analysis]
185 Coffelt SB, Kersten K, Doornebal CW, Weiden J, Vrijland K, Hau CS, Verstegen NJM, Ciampricotti M, Hawinkels LJAC, Jonkers J, de Visser KE. IL-17-producing γδ T cells and neutrophils conspire to promote breast cancer metastasis. Nature 2015;522:345-8. [PMID: 25822788 DOI: 10.1038/nature14282] [Cited by in Crossref: 758] [Cited by in F6Publishing: 707] [Article Influence: 108.3] [Reference Citation Analysis]
186 Hernandez-Vargas H, Goldsmith C, Mathot P, Dante R. Stromal-associated cytokines bias the interplay between gene expression and DNA methylation in human breast cancers. Epigenetics 2020;15:511-23. [PMID: 31838945 DOI: 10.1080/15592294.2019.1699893] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 0.3] [Reference Citation Analysis]
187 Yin S, Wang N, Riabov V, Mossel DM, Larionova I, Schledzewski K, Trofimova O, Sevastyanova T, Zajakina A, Schmuttermaier C, Gratchev A, Flatley A, Kremmer E, Zavyalova M, Cherdyntseva N, Simon-Keller K, Marx A, Klüter H, Goerdt S, Kzhyshkowska J. SI-CLP inhibits the growth of mouse mammary adenocarcinoma by preventing recruitment of tumor-associated macrophages. Int J Cancer 2020;146:1396-408. [PMID: 31525266 DOI: 10.1002/ijc.32685] [Cited by in Crossref: 7] [Cited by in F6Publishing: 7] [Article Influence: 2.3] [Reference Citation Analysis]
188 Zhang W, Lin Y. The Mechanism of Asparagine Endopeptidase in the Progression of Malignant Tumors: A Review. Cells 2021;10:1153. [PMID: 34068767 DOI: 10.3390/cells10051153] [Reference Citation Analysis]
189 Gu J, Zhang Y, Han Z, Gao L, Cui J, Sun Y, Niu Y, You B, Huang CP, Chang C, Wang X, Yeh S. Targeting the ERβ/Angiopoietin-2/Tie-2 signaling-mediated angiogenesis with the FDA-approved anti-estrogen Faslodex to increase the Sunitinib sensitivity in RCC. Cell Death Dis 2020;11:367. [PMID: 32409702 DOI: 10.1038/s41419-020-2486-0] [Cited by in Crossref: 3] [Cited by in F6Publishing: 4] [Article Influence: 1.5] [Reference Citation Analysis]
190 De Ponte Conti B, Miluzio A, Grassi F, Abrignani S, Biffo S, Ricciardi S. mTOR-dependent translation drives tumor infiltrating CD8+ effector and CD4+ Treg cells expansion. Elife 2021;10:e69015. [PMID: 34787568 DOI: 10.7554/eLife.69015] [Reference Citation Analysis]
191 Rijal G. Understanding the Role of Fibroblasts following a 3D Tumoroid Implantation for Breast Tumor Formation. Bioengineering (Basel) 2021;8:163. [PMID: 34821729 DOI: 10.3390/bioengineering8110163] [Reference Citation Analysis]
192 Li X, Song Q, Guo X, Wang L, Zhang Q, Cao L, Ren Y, Wu X, Meng Z, Xu K. The Metastasis Potential Promoting Capacity of Cancer-Associated Fibroblasts Was Attenuated by Cisplatin via Modulating KRT8. Onco Targets Ther 2020;13:2711-23. [PMID: 32280245 DOI: 10.2147/OTT.S246235] [Cited by in Crossref: 3] [Cited by in F6Publishing: 3] [Article Influence: 1.5] [Reference Citation Analysis]
193 Qin W, Tian Y, Zhang J, Liu W, Zhou Q, Hu S, Yang F, Lu L, Lu H, Cui S, Wen L, Wei S. The double inhibition of PDK1 and STAT3-Y705 prevents liver metastasis in colorectal cancer. Sci Rep 2019;9:12973. [PMID: 31506552 DOI: 10.1038/s41598-019-49480-8] [Cited by in Crossref: 5] [Cited by in F6Publishing: 7] [Article Influence: 1.7] [Reference Citation Analysis]
194 Sagini MN, Zepp M, Bergmann F, Bozza M, Harbottle R, Berger MR. The expression of genes contributing to pancreatic adenocarcinoma progression is influenced by the respective environment. Genes Cancer 2018;9:114-29. [PMID: 30108682 DOI: 10.18632/genesandcancer.173] [Cited by in Crossref: 6] [Cited by in F6Publishing: 6] [Article Influence: 1.5] [Reference Citation Analysis]
195 Zhang ZQ, Cao Z, Liu C, Li R, Wang WD, Wang XY. MiRNA-Embedded ShRNAs for Radiation-Inducible LGMN Knockdown and the Antitumor Effects on Breast Cancer. PLoS One 2016;11:e0163446. [PMID: 27656894 DOI: 10.1371/journal.pone.0163446] [Cited by in Crossref: 1] [Cited by in F6Publishing: 3] [Article Influence: 0.2] [Reference Citation Analysis]
196 Gu C, Lu H, Qian Z. Matrine reduces the secretion of exosomal circSLC7A6 from cancer-associated fibroblast to inhibit tumorigenesis of colorectal cancer by regulating CXCR5. Biochem Biophys Res Commun 2020;527:638-45. [PMID: 32423804 DOI: 10.1016/j.bbrc.2020.04.142] [Cited by in Crossref: 4] [Cited by in F6Publishing: 4] [Article Influence: 2.0] [Reference Citation Analysis]
197 Wang J, Shen S, Li J, Cao Z, Yang X. Precise Depletion of Tumor Seed and Growing Soil with Shrinkable Nanocarrier for Potentiated Cancer Chemoimmunotherapy. ACS Nano 2021;15:4636-46. [PMID: 33651592 DOI: 10.1021/acsnano.0c08996] [Cited by in Crossref: 3] [Cited by in F6Publishing: 1] [Article Influence: 3.0] [Reference Citation Analysis]
198 Cen S, Liu K, Zheng Y, Shan J, Jing C, Gao J, Pan H, Bai Z, Liu Z. BRAF Mutation as a Potential Therapeutic Target for Checkpoint Inhibitors: A Comprehensive Analysis of Immune Microenvironment in BRAF Mutated Colon Cancer. Front Cell Dev Biol 2021;9:705060. [PMID: 34381786 DOI: 10.3389/fcell.2021.705060] [Cited by in F6Publishing: 1] [Reference Citation Analysis]
199 Zhou D, Chen Y, Bu W, Meng L, Wang C, Jin N, Chen Y, Ren C, Zhang K, Sun H. Modification of Metal-Organic Framework Nanoparticles Using Dental Pulp Mesenchymal Stem Cell Membranes to Target Oral Squamous Cell Carcinoma. J Colloid Interface Sci 2021;601:650-60. [PMID: 34091312 DOI: 10.1016/j.jcis.2021.05.126] [Reference Citation Analysis]
200 Sterner RC, Sterner RM. CAR-T cell therapy: current limitations and potential strategies. Blood Cancer J 2021;11:69. [PMID: 33824268 DOI: 10.1038/s41408-021-00459-7] [Cited by in Crossref: 12] [Cited by in F6Publishing: 9] [Article Influence: 12.0] [Reference Citation Analysis]
201 Vazakidou ME, Magkouta S, Moschos C, Psallidas I, Pappas A, Psarra K, Kalomenidis I. Temsirolimus targets multiple hallmarks of cancer to impede mesothelioma growth in vivo. Respirology 2015;20:1263-71. [PMID: 26245309 DOI: 10.1111/resp.12604] [Cited by in Crossref: 8] [Cited by in F6Publishing: 8] [Article Influence: 1.1] [Reference Citation Analysis]
202 Cantini L, Hassan R, Sterman DH, Aerts JGJV. Emerging Treatments for Malignant Pleural Mesothelioma: Where Are We Heading? Front Oncol 2020;10:343. [PMID: 32226777 DOI: 10.3389/fonc.2020.00343] [Cited by in Crossref: 18] [Cited by in F6Publishing: 18] [Article Influence: 9.0] [Reference Citation Analysis]
203 Chen Q, Feng L, Liu J, Zhu W, Dong Z, Wu Y, Liu Z. Intelligent Albumin-MnO 2 Nanoparticles as pH-/H 2 O 2 -Responsive Dissociable Nanocarriers to Modulate Tumor Hypoxia for Effective Combination Therapy. Adv Mater 2016;28:7129-36. [DOI: 10.1002/adma.201601902] [Cited by in Crossref: 584] [Cited by in F6Publishing: 554] [Article Influence: 97.3] [Reference Citation Analysis]
204 Li M, Xi N, Wang YC, Liu LQ. Atomic force microscopy for revealing micro/nanoscale mechanics in tumor metastasis: from single cells to microenvironmental cues. Acta Pharmacol Sin 2021;42:323-39. [PMID: 32807839 DOI: 10.1038/s41401-020-0494-3] [Cited by in Crossref: 5] [Cited by in F6Publishing: 4] [Article Influence: 2.5] [Reference Citation Analysis]
205 Bayat N, Izadpanah R, Ebrahimi-Barough S, Norouzi Javidan A, Ai A, Mokhtari Ardakan MM, Saberi H, Ai J. The Anti-Angiogenic Effect of Atorvastatin in Glioblastoma Spheroids Tumor Cultured in Fibrin Gel: in 3D in Vitro Model. Asian Pac J Cancer Prev 2018;19:2553-60. [PMID: 30256055 DOI: 10.22034/APJCP.2018.19.9.2553] [Cited by in F6Publishing: 4] [Reference Citation Analysis]
206 Wu J, Waxman DJ. Immunogenic chemotherapy: Dose and schedule dependence and combination with immunotherapy. Cancer Lett 2018;419:210-21. [PMID: 29414305 DOI: 10.1016/j.canlet.2018.01.050] [Cited by in Crossref: 98] [Cited by in F6Publishing: 93] [Article Influence: 32.7] [Reference Citation Analysis]
207 Penault-llorca F, Radosevic-robin N. Biomarkers of residual disease after neoadjuvant therapy for breast cancer. Nat Rev Clin Oncol 2016;13:487-503. [DOI: 10.1038/nrclinonc.2016.1] [Cited by in Crossref: 30] [Cited by in F6Publishing: 29] [Article Influence: 5.0] [Reference Citation Analysis]
208 Shi H, Ju Q, Mao Y, Wang Y, Ding J, Liu X, Tang X, Sun C. TAK1 Phosphorylates RASSF9 and Inhibits Esophageal Squamous Tumor Cell Proliferation by Targeting the RAS/MEK/ERK Axis. Adv Sci (Weinh) 2021;8:2001575. [PMID: 33717835 DOI: 10.1002/advs.202001575] [Cited by in Crossref: 2] [Cited by in F6Publishing: 2] [Article Influence: 2.0] [Reference Citation Analysis]
209 Miao YR, Xia M, Luo M, Luo T, Yang M, Guo AY. ImmuCellAI-mouse: a tool for comprehensive prediction of mouse immune cell abundance and immune microenvironment depiction. Bioinformatics 2021:btab711. [PMID: 34636837 DOI: 10.1093/bioinformatics/btab711] [Reference Citation Analysis]
210 Vedenko A, Panara K, Goldstein G, Ramasamy R, Arora H. Tumor Microenvironment and Nitric Oxide: Concepts and Mechanisms. Adv Exp Med Biol 2020;1277:143-58. [PMID: 33119871 DOI: 10.1007/978-3-030-50224-9_10] [Cited by in Crossref: 2] [Cited by in F6Publishing: 2] [Article Influence: 2.0] [Reference Citation Analysis]
211 Bingula R, Filaire E, Molnar I, Delmas E, Berthon JY, Vasson MP, Bernalier-Donadille A, Filaire M. Characterisation of microbiota in saliva, bronchoalveolar lavage fluid, non-malignant, peritumoural and tumour tissue in non-small cell lung cancer patients: a cross-sectional clinical trial. Respir Res 2020;21:129. [PMID: 32450847 DOI: 10.1186/s12931-020-01392-2] [Cited by in Crossref: 4] [Cited by in F6Publishing: 4] [Article Influence: 2.0] [Reference Citation Analysis]
212 Fiani ML, Barreca V, Sargiacomo M, Ferrantelli F, Manfredi F, Federico M. Exploiting Manipulated Small Extracellular Vesicles to Subvert Immunosuppression at the Tumor Microenvironment through Mannose Receptor/CD206 Targeting. Int J Mol Sci 2020;21:E6318. [PMID: 32878276 DOI: 10.3390/ijms21176318] [Cited by in Crossref: 3] [Cited by in F6Publishing: 3] [Article Influence: 1.5] [Reference Citation Analysis]
213 Zhu Y, Choi SH, Shah K. Multifunctional receptor-targeting antibodies for cancer therapy. The Lancet Oncology 2015;16:e543-54. [DOI: 10.1016/s1470-2045(15)00039-x] [Cited by in Crossref: 29] [Cited by in F6Publishing: 11] [Article Influence: 4.1] [Reference Citation Analysis]
214 Yoon AR, Stasinopoulos I, Kim JH, Yong HM, Kilic O, Wirtz D, Bhujwalla ZM, An SS. COX-2 dependent regulation of mechanotransduction in human breast cancer cells. Cancer Biol Ther 2015;16:430-7. [PMID: 25701047 DOI: 10.1080/15384047.2014.1003004] [Cited by in Crossref: 15] [Cited by in F6Publishing: 14] [Article Influence: 2.5] [Reference Citation Analysis]
215 Yang L, Peng X, Li Y, Zhang X, Ma Y, Wu C, Fan Q, Wei S, Li H, Liu J. Long non-coding RNA HOTAIR promotes exosome secretion by regulating RAB35 and SNAP23 in hepatocellular carcinoma. Mol Cancer 2019;18:78. [PMID: 30943982 DOI: 10.1186/s12943-019-0990-6] [Cited by in Crossref: 59] [Cited by in F6Publishing: 66] [Article Influence: 19.7] [Reference Citation Analysis]
216 Vigano S, Bobisse S, Coukos G, Perreau M, Harari A. Cancer and HIV-1 Infection: Patterns of Chronic Antigen Exposure. Front Immunol 2020;11:1350. [PMID: 32714330 DOI: 10.3389/fimmu.2020.01350] [Cited by in Crossref: 3] [Cited by in F6Publishing: 3] [Article Influence: 1.5] [Reference Citation Analysis]
217 Hyenne V, Lefebvre O, Goetz JG. Going live with tumor exosomes and microvesicles. Cell Adh Migr 2017;11:173-86. [PMID: 28135898 DOI: 10.1080/19336918.2016.1276694] [Cited by in Crossref: 24] [Cited by in F6Publishing: 21] [Article Influence: 4.8] [Reference Citation Analysis]
218 Liu Q, Hodge J, Wang J, Wang Y, Wang L, Singh U, Li Y, Yao Y, Wang D, Ai W, Nagarkatti P, Chen H, Xu P, Murphy EA, Fan D. Emodin reduces Breast Cancer Lung Metastasis by suppressing Macrophage-induced Breast Cancer Cell Epithelial-mesenchymal transition and Cancer Stem Cell formation. Theranostics 2020;10:8365-81. [PMID: 32724475 DOI: 10.7150/thno.45395] [Cited by in Crossref: 9] [Cited by in F6Publishing: 7] [Article Influence: 4.5] [Reference Citation Analysis]
219 Jones KM, Karanam B, Jones-Triche J, Sandey M, Henderson HJ, Samant RS, Temesgen S, Yates C, Bedi D. Phage Ligands for Identification of Mesenchymal-Like Breast Cancer Cells and Cancer-Associated Fibroblasts. Front Oncol 2018;8:625. [PMID: 30619759 DOI: 10.3389/fonc.2018.00625] [Reference Citation Analysis]
220 Mashouri L, Yousefi H, Aref AR, Ahadi AM, Molaei F, Alahari SK. Exosomes: composition, biogenesis, and mechanisms in cancer metastasis and drug resistance. Mol Cancer. 2019;18:75. [PMID: 30940145 DOI: 10.1186/s12943-019-0991-5] [Cited by in Crossref: 201] [Cited by in F6Publishing: 209] [Article Influence: 67.0] [Reference Citation Analysis]
221 Davies AE, Albeck JG. Microenvironmental Signals and Biochemical Information Processing: Cooperative Determinants of Intratumoral Plasticity and Heterogeneity. Front Cell Dev Biol 2018;6:44. [PMID: 29732370 DOI: 10.3389/fcell.2018.00044] [Cited by in Crossref: 17] [Cited by in F6Publishing: 16] [Article Influence: 4.3] [Reference Citation Analysis]
222 He B, Tan T, Wang H, Hu H, Wang Z, Wang J, Li J, Sun K, Zhang Z, Li Y. Rational Design of Tumor Microenvironment-Activated Micelles for Programed Targeting of Breast Cancer Metastasis. Adv Funct Mater 2018;28:1705622. [DOI: 10.1002/adfm.201705622] [Cited by in Crossref: 32] [Cited by in F6Publishing: 26] [Article Influence: 6.4] [Reference Citation Analysis]
223 Yu M, Guan R, Hong W, Zhou Y, Lin Y, Jin H, Hou B, Jian Z. Prognostic value of tumor-associated macrophages in pancreatic cancer: a meta-analysis. Cancer Manag Res 2019;11:4041-58. [PMID: 31118813 DOI: 10.2147/CMAR.S196951] [Cited by in Crossref: 17] [Cited by in F6Publishing: 10] [Article Influence: 5.7] [Reference Citation Analysis]
224 Schmitt M, Greten FR. The inflammatory pathogenesis of colorectal cancer. Nat Rev Immunol 2021. [PMID: 33911231 DOI: 10.1038/s41577-021-00534-x] [Cited by in Crossref: 4] [Cited by in F6Publishing: 4] [Article Influence: 4.0] [Reference Citation Analysis]
225 Henriet E, Sala M, Abou Hammoud A, Tuariihionoa A, Di Martino J, Ros M, Saltel F. Multitasking discoidin domain receptors are involved in several and specific hallmarks of cancer. Cell Adh Migr 2018;12:363-77. [PMID: 29701112 DOI: 10.1080/19336918.2018.1465156] [Cited by in Crossref: 12] [Cited by in F6Publishing: 20] [Article Influence: 3.0] [Reference Citation Analysis]
226 Al Jarroudi O, El Bairi K, Abda N, Zaimi A, Jaouani L, Chibani H, Afqir S. Neutrophil-to-lymphocyte and platelet-to-lymphocyte ratios as predictors of outcomes in inflammatory breast cancer. Biomark Med 2021;15:1289-98. [PMID: 34486882 DOI: 10.2217/bmm-2020-0717] [Reference Citation Analysis]
227 Zhao W, Jiang W, Wang H, He J, Su C, Yu Q. Impact of Smoking History on Response to Immunotherapy in Non-Small-Cell Lung Cancer: A Systematic Review and Meta-Analysis. Front Oncol 2021;11:703143. [PMID: 34497760 DOI: 10.3389/fonc.2021.703143] [Reference Citation Analysis]
228 Thomsen M, Kersten C, Sorbye H, Skovlund E, Glimelius B, Pfeiffer P, Johansen JS, Kure EH, Ikdahl T, Tveit KM, Christoffersen T, Guren TK. Interleukin-6 and C-reactive protein as prognostic biomarkers in metastatic colorectal cancer. Oncotarget 2016;7:75013-22. [PMID: 27738330 DOI: 10.18632/oncotarget.12601] [Cited by in Crossref: 38] [Cited by in F6Publishing: 36] [Article Influence: 9.5] [Reference Citation Analysis]
229 Ahmed M, Sottnik JL, Dancik GM, Sahu D, Hansel DE, Theodorescu D, Schwartz MA. An Osteopontin/CD44 Axis in RhoGDI2-Mediated Metastasis Suppression. Cancer Cell 2016;30:432-43. [PMID: 27593345 DOI: 10.1016/j.ccell.2016.08.002] [Cited by in Crossref: 29] [Cited by in F6Publishing: 29] [Article Influence: 4.8] [Reference Citation Analysis]
230 Scully T, Scott CD, Firth SM, Pintar JE, Twigg SM, Baxter RC. Contrasting effects of IGF binding protein-3 expression in mammary tumor cells and the tumor microenvironment. Exp Cell Res 2019;374:38-45. [PMID: 30419192 DOI: 10.1016/j.yexcr.2018.11.006] [Cited by in Crossref: 4] [Cited by in F6Publishing: 4] [Article Influence: 1.0] [Reference Citation Analysis]
231 Guo J, Cahill MR, McKenna SL, O'Driscoll CM. Biomimetic nanoparticles for siRNA delivery in the treatment of leukaemia. Biotechnol Adv 2014;32:1396-409. [PMID: 25218571 DOI: 10.1016/j.biotechadv.2014.08.007] [Cited by in Crossref: 26] [Cited by in F6Publishing: 24] [Article Influence: 3.3] [Reference Citation Analysis]
232 Wang T, Yu X, Han L, Liu T, Liu Y, Zhang N. Tumor microenvironment dual-responsive core-shell nanoparticles with hyaluronic acid-shield for efficient co-delivery of doxorubicin and plasmid DNA. Int J Nanomedicine 2017;12:4773-88. [PMID: 28740384 DOI: 10.2147/IJN.S134378] [Cited by in Crossref: 12] [Cited by in F6Publishing: 2] [Article Influence: 2.4] [Reference Citation Analysis]
233 Yaghoobi V, Moutafi M, Aung TN, Pelekanou V, Yaghoubi S, Blenman K, Ibrahim E, Vathiotis IA, Shafi S, Sharma A, O'Meara T, Fernandez AI, Pusztai L, Rimm DL. Quantitative assessment of the immune microenvironment in African American Triple Negative Breast Cancer: a case-control study. Breast Cancer Res 2021;23:113. [PMID: 34906209 DOI: 10.1186/s13058-021-01493-w] [Reference Citation Analysis]
234 Pan P, Yue Q, Li J, Gao M, Yang X, Ren Y, Cheng X, Cui P, Deng Y. Smart Cargo Delivery System based on Mesoporous Nanoparticles for Bone Disease Diagnosis and Treatment. Adv Sci (Weinh) 2021;8:e2004586. [PMID: 34165902 DOI: 10.1002/advs.202004586] [Reference Citation Analysis]
235 Jiang Y, Nakada D. Cell intrinsic and extrinsic regulation of leukemia cell metabolism. Int J Hematol 2016;103:607-16. [PMID: 26897135 DOI: 10.1007/s12185-016-1958-6] [Cited by in Crossref: 17] [Cited by in F6Publishing: 14] [Article Influence: 2.8] [Reference Citation Analysis]
236 Chang X, Ma Z, Zhu G, Lu Y, Yang J. New perspective into mesenchymal stem cells: Molecular mechanisms regulating osteosarcoma. J Bone Oncol 2021;29:100372. [PMID: 34258182 DOI: 10.1016/j.jbo.2021.100372] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 1.0] [Reference Citation Analysis]
237 He K, Liu P, Xu LX. The cryo-thermal therapy eradicated melanoma in mice by eliciting CD4+ T-cell-mediated antitumor memory immune response. Cell Death Dis 2017;8:e2703. [PMID: 28333145 DOI: 10.1038/cddis.2017.125] [Cited by in Crossref: 20] [Cited by in F6Publishing: 19] [Article Influence: 4.0] [Reference Citation Analysis]
238 Kon OL. An antiestrogen-binding protein in human tissues. J Biol Chem. 1983;258:3173-3177. [PMID: 6826555 DOI: 10.3390/cancers11101511] [Cited by in Crossref: 25] [Cited by in F6Publishing: 26] [Article Influence: 0.6] [Reference Citation Analysis]
239 Chattaragada MS, Riganti C, Sassoe M, Principe M, Santamorena MM, Roux C, Curcio C, Evangelista A, Allavena P, Salvia R, Rusev B, Scarpa A, Cappello P, Novelli F. FAM49B, a novel regulator of mitochondrial function and integrity that suppresses tumor metastasis. Oncogene 2018;37:697-709. [PMID: 29059164 DOI: 10.1038/onc.2017.358] [Cited by in Crossref: 24] [Cited by in F6Publishing: 21] [Article Influence: 4.8] [Reference Citation Analysis]
240 Li Z, Yu B, Qi F, Li F. KIF11 Serves as an Independent Prognostic Factor and Therapeutic Target for Patients With Lung Adenocarcinoma. Front Oncol 2021;11:670218. [PMID: 33968780 DOI: 10.3389/fonc.2021.670218] [Reference Citation Analysis]
241 Duan S, Wang S, Huang T, Wang J, Yuan X. circRNAs: Insight Into Their Role in Tumor-Associated Macrophages. Front Oncol 2021;11:780744. [DOI: 10.3389/fonc.2021.780744] [Cited by in Crossref: 1] [Article Influence: 1.0] [Reference Citation Analysis]
242 Liu Q, Duo Y, Fu J, Qiu M, Sun Z, Adah D, Kang J, Xie Z, Fan T, Bao S, Zhang H, Liu L, Cao Y. Nano-immunotherapy: Unique mechanisms of nanomaterials in synergizing cancer immunotherapy. Nano Today 2021;36:101023. [DOI: 10.1016/j.nantod.2020.101023] [Cited by in Crossref: 7] [Cited by in F6Publishing: 2] [Article Influence: 7.0] [Reference Citation Analysis]
243 Zhang L, Zhang X, Liu Y, Zhang T, Wang Z, Gu M, Li Y, Wang DD, Li W, Lin PP. PD-L1+ aneuploid circulating tumor endothelial cells (CTECs) exhibit resistance to the checkpoint blockade immunotherapy in advanced NSCLC patients. Cancer Letters 2020;469:355-66. [DOI: 10.1016/j.canlet.2019.10.041] [Cited by in Crossref: 20] [Cited by in F6Publishing: 20] [Article Influence: 10.0] [Reference Citation Analysis]
244 Xu P, Liang F. Nanomaterial-Based Tumor Photothermal Immunotherapy. Int J Nanomedicine 2020;15:9159-80. [PMID: 33244232 DOI: 10.2147/IJN.S249252] [Cited by in Crossref: 5] [Cited by in F6Publishing: 4] [Article Influence: 2.5] [Reference Citation Analysis]
245 Chen G, Zhang Y, Xue J, Zhu X, Liu C, Sun L, Gu X, Zhang H, Liu C. Surgical Outcomes of Implant-based Breast Reconstruction Using TiLoop Bra Mesh Combined With Pectoralis Major Disconnection. Ann Plast Surg 2019;83:396-400. [PMID: 31524731 DOI: 10.1097/SAP.0000000000001867] [Cited by in Crossref: 2] [Article Influence: 0.7] [Reference Citation Analysis]
246 Iurca I, Tirpe A, Zimta AA, Moldovan C, Gulei D, Slabý O, Condorelli G, Berindan-Neagoe I. Macrophages Interaction and MicroRNA Interplay in the Modulation of Cancer Development and Metastasis. Front Immunol 2020;11:870. [PMID: 32477352 DOI: 10.3389/fimmu.2020.00870] [Cited by in Crossref: 3] [Cited by in F6Publishing: 3] [Article Influence: 1.5] [Reference Citation Analysis]
247 Wang LT, Chiou SS, Chai CY, Hsi E, Chiang CM, Huang SK, Wang SN, Yokoyama KK, Hsu SH. Transcription factor SPZ1 promotes TWIST-mediated epithelial-mesenchymal transition and oncogenesis in human liver cancer. Oncogene 2017;36:4405-14. [PMID: 28368406 DOI: 10.1038/onc.2017.69] [Cited by in Crossref: 11] [Cited by in F6Publishing: 13] [Article Influence: 2.2] [Reference Citation Analysis]
248 Estaras M, Gonzalez-Portillo MR, Fernandez-Bermejo M, Mateos JM, Vara D, Blanco-Fernandez G, Lopez-Guerra D, Roncero V, Salido GM, González A. Melatonin Induces Apoptosis and Modulates Cyclin Expression and MAPK Phosphorylation in Pancreatic Stellate Cells Subjected to Hypoxia. Int J Mol Sci 2021;22:5555. [PMID: 34074034 DOI: 10.3390/ijms22115555] [Cited by in F6Publishing: 1] [Reference Citation Analysis]
249 Ma X, Gao Y, Chen Y, Liu J, Yang C, Bao C, Wang Y, Feng Y, Song X, Qiao S. M2-Type Macrophages Induce Tregs Generation by Activating the TGF-β/Smad Signalling Pathway to Promote Colorectal Cancer Development. Onco Targets Ther 2021;14:5391-402. [PMID: 34908844 DOI: 10.2147/OTT.S336548] [Reference Citation Analysis]
250 Best MG, Sol N, Kooi I, Tannous J, Westerman BA, Rustenburg F, Schellen P, Verschueren H, Post E, Koster J, Ylstra B, Ameziane N, Dorsman J, Smit EF, Verheul HM, Noske DP, Reijneveld JC, Nilsson RJA, Tannous BA, Wesseling P, Wurdinger T. RNA-Seq of Tumor-Educated Platelets Enables Blood-Based Pan-Cancer, Multiclass, and Molecular Pathway Cancer Diagnostics. Cancer Cell. 2015;28:666-676. [PMID: 26525104 DOI: 10.1016/j.ccell.2015.09.018] [Cited by in Crossref: 353] [Cited by in F6Publishing: 332] [Article Influence: 50.4] [Reference Citation Analysis]
251 Fang WY, Chen YW, Hsiao JR, Liu CS, Kuo YZ, Wang YC, Chang KC, Tsai ST, Chang MZ, Lin SH, Wu LW. Elevated S100A9 expression in tumor stroma functions as an early recurrence marker for early-stage oral cancer patients through increased tumor cell invasion, angiogenesis, macrophage recruitment and interleukin-6 production. Oncotarget 2015;6:28401-24. [PMID: 26315114 DOI: 10.18632/oncotarget.4951] [Cited by in Crossref: 14] [Cited by in F6Publishing: 15] [Article Influence: 2.3] [Reference Citation Analysis]
252 Jiang W, Chan CK, Weissman IL, Kim BYS, Hahn SM. Immune Priming of the Tumor Microenvironment by Radiation. Trends Cancer. 2016;2:638-645. [PMID: 28741502 DOI: 10.1016/j.trecan.2016.09.007] [Cited by in Crossref: 71] [Cited by in F6Publishing: 71] [Article Influence: 11.8] [Reference Citation Analysis]
253 Fan J, Slowikowski K, Zhang F. Single-cell transcriptomics in cancer: computational challenges and opportunities. Exp Mol Med 2020;52:1452-65. [PMID: 32929226 DOI: 10.1038/s12276-020-0422-0] [Cited by in Crossref: 27] [Cited by in F6Publishing: 17] [Article Influence: 13.5] [Reference Citation Analysis]
254 Maeda M, Takeshima H, Iida N, Hattori N, Yamashita S, Moro H, Yasukawa Y, Nishiyama K, Hashimoto T, Sekine S, Ishii G, Ochiai A, Fukagawa T, Katai H, Sakai Y, Ushijima T. Cancer cell niche factors secreted from cancer-associated fibroblast by loss of H3K27me3. Gut 2020;69:243-51. [DOI: 10.1136/gutjnl-2018-317645] [Cited by in Crossref: 28] [Cited by in F6Publishing: 26] [Article Influence: 9.3] [Reference Citation Analysis]
255 van der Weyden L, Arends MJ, Campbell AD, Bald T, Wardle-Jones H, Griggs N, Velasco-Herrera MD, Tüting T, Sansom OJ, Karp NA, Clare S, Gleeson D, Ryder E, Galli A, Tuck E, Cambridge EL, Voet T, Macaulay IC, Wong K, Spiegel S, Speak AO, Adams DJ; Sanger Mouse Genetics Project. Genome-wide in vivo screen identifies novel host regulators of metastatic colonization. Nature 2017;541:233-6. [PMID: 28052056 DOI: 10.1038/nature20792] [Cited by in Crossref: 131] [Cited by in F6Publishing: 123] [Article Influence: 26.2] [Reference Citation Analysis]
256 Mascheroni P, López Alfonso JC, Kalli M, Stylianopoulos T, Meyer-Hermann M, Hatzikirou H. On the Impact of Chemo-Mechanically Induced Phenotypic Transitions in Gliomas. Cancers (Basel) 2019;11:E716. [PMID: 31137643 DOI: 10.3390/cancers11050716] [Cited by in Crossref: 4] [Cited by in F6Publishing: 1] [Article Influence: 1.3] [Reference Citation Analysis]
257 Castro MG, Campos LE, Rodriguez YI, Alvarez SE. In Vitro Methods to Study the Modulation of Migration and Invasion by Sphingosine-1-Phosphate. Methods Mol Biol 2018;1697:117-31. [PMID: 28755279 DOI: 10.1007/7651_2017_51] [Cited by in Crossref: 4] [Cited by in F6Publishing: 5] [Article Influence: 1.0] [Reference Citation Analysis]
258 Rao J, Wu X, Zhou X, Deng R, Ma Y. TMEM205 Is an Independent Prognostic Factor and Is Associated With Immune Cell Infiltrates in Hepatocellular Carcinoma. Front Genet 2020;11:575776. [PMID: 33193690 DOI: 10.3389/fgene.2020.575776] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 0.5] [Reference Citation Analysis]
259 Kim MS, Ha SE, Wu M, Zogg H, Ronkon CF, Lee MY, Ro S. Extracellular Matrix Biomarkers in Colorectal Cancer. Int J Mol Sci 2021;22:9185. [PMID: 34502094 DOI: 10.3390/ijms22179185] [Reference Citation Analysis]
260 Tang S, Huang X, Jiang H, Qin S. Identification of a Five-Gene Prognostic Signature Related to B Cells Infiltration in Pancreatic Adenocarcinoma. Int J Gen Med 2021;14:5051-68. [PMID: 34511988 DOI: 10.2147/IJGM.S324432] [Reference Citation Analysis]
261 Gagliardi PA, Puliafito A, Primo L. PDK1: At the crossroad of cancer signaling pathways. Seminars in Cancer Biology 2018;48:27-35. [DOI: 10.1016/j.semcancer.2017.04.014] [Cited by in Crossref: 53] [Cited by in F6Publishing: 54] [Article Influence: 13.3] [Reference Citation Analysis]
262 Amreddy N, Babu A, Muralidharan R, Munshi A, Ramesh R. Polymeric Nanoparticle-Mediated Gene Delivery for Lung Cancer Treatment. Top Curr Chem (Cham) 2017;375:35. [PMID: 28290155 DOI: 10.1007/s41061-017-0128-5] [Cited by in Crossref: 25] [Cited by in F6Publishing: 16] [Article Influence: 5.0] [Reference Citation Analysis]
263 Landberg G, Fitzpatrick P, Isakson P, Jonasson E, Karlsson J, Larsson E, Svanström A, Rafnsdottir S, Persson E, Gustafsson A, Andersson D, Rosendahl J, Petronis S, Ranji P, Gregersson P, Magnusson Y, Håkansson J, Ståhlberg A. Patient-derived scaffolds uncover breast cancer promoting properties of the microenvironment. Biomaterials 2020;235:119705. [PMID: 31978840 DOI: 10.1016/j.biomaterials.2019.119705] [Cited by in Crossref: 17] [Cited by in F6Publishing: 17] [Article Influence: 5.7] [Reference Citation Analysis]
264 Cosentino G, Romero-Cordoba S, Plantamura I, Cataldo A, Iorio MV. miR-9-Mediated Inhibition of EFEMP1 Contributes to the Acquisition of Pro-Tumoral Properties in Normal Fibroblasts. Cells 2020;9:E2143. [PMID: 32972039 DOI: 10.3390/cells9092143] [Cited by in Crossref: 3] [Cited by in F6Publishing: 3] [Article Influence: 1.5] [Reference Citation Analysis]
265 Shakib H, Rajabi S, Dehghan MH, Mashayekhi FJ, Safari-Alighiarloo N, Hedayati M. Epithelial-to-mesenchymal transition in thyroid cancer: a comprehensive review. Endocrine 2019;66:435-55. [PMID: 31378850 DOI: 10.1007/s12020-019-02030-8] [Cited by in Crossref: 13] [Cited by in F6Publishing: 15] [Article Influence: 4.3] [Reference Citation Analysis]
266 Ye Y, Pei L, Ding J, Wu C, Sun C, Liu S. Effects of Platycodin D on S100A8/A9-induced inflammatory response in murine mammary carcinoma 4T1 cells. Int Immunopharmacol 2019;67:239-47. [PMID: 30562685 DOI: 10.1016/j.intimp.2018.12.008] [Cited by in Crossref: 9] [Cited by in F6Publishing: 9] [Article Influence: 2.3] [Reference Citation Analysis]
267 Ritter B, Greten FR. Modulating inflammation for cancer therapy. J Exp Med 2019;216:1234-43. [PMID: 31023715 DOI: 10.1084/jem.20181739] [Cited by in Crossref: 42] [Cited by in F6Publishing: 44] [Article Influence: 14.0] [Reference Citation Analysis]
268 Liu L, Liu L, Yao HH, Zhu ZQ, Ning ZL, Huang Q. Stromal Myofibroblasts Are Associated with Poor Prognosis in Solid Cancers: A Meta-Analysis of Published Studies. PLoS One 2016;11:e0159947. [PMID: 27459365 DOI: 10.1371/journal.pone.0159947] [Cited by in Crossref: 36] [Cited by in F6Publishing: 33] [Article Influence: 6.0] [Reference Citation Analysis]
269 Chu GC, Chung LWK, Gururajan M, Hsieh CL, Josson S, Nandana S, Sung SY, Wang R, Wu JB, Zhau HE. Regulatory signaling network in the tumor microenvironment of prostate cancer bone and visceral organ metastases and the development of novel therapeutics. Asian J Urol 2019;6:65-81. [PMID: 30775250 DOI: 10.1016/j.ajur.2018.11.003] [Cited by in Crossref: 3] [Cited by in F6Publishing: 2] [Article Influence: 0.8] [Reference Citation Analysis]
270 Hensel JA, Khattar V, Ashton R, Lee C, Siegal GP, Ponnazhagan S. Location of tumor affects local and distant immune cell type and number. Immun Inflamm Dis 2017;5:85-94. [PMID: 28250928 DOI: 10.1002/iid3.144] [Cited by in Crossref: 11] [Cited by in F6Publishing: 10] [Article Influence: 2.2] [Reference Citation Analysis]
271 Shibue T, Weinberg RA. EMT, CSCs, and drug resistance: the mechanistic link and clinical implications. Nat Rev Clin Oncol. 2017;14:611-629. [PMID: 28397828 DOI: 10.1038/nrclinonc.2017.44] [Cited by in Crossref: 886] [Cited by in F6Publishing: 886] [Article Influence: 177.2] [Reference Citation Analysis]
272 Credle JJ, Itoh CY, Yuan T, Sharma R, Scott ER, Workman RE, Fan Y, Housseau F, Llosa NJ, Bell WR, Miller H, Zhang SX, Timp W, Larman HB. Multiplexed analysis of fixed tissue RNA using Ligation in situ Hybridization. Nucleic Acids Res 2017;45:e128. [PMID: 28854731 DOI: 10.1093/nar/gkx471] [Cited by in Crossref: 5] [Cited by in F6Publishing: 4] [Article Influence: 1.0] [Reference Citation Analysis]
273 Kalpana G, Figy C, Yeung M, Yeung KC. Reduced RhoA expression enhances breast cancer metastasis with a concomitant increase in CCR5 and CXCR4 chemokines signaling. Sci Rep 2019;9:16351. [PMID: 31705019 DOI: 10.1038/s41598-019-52746-w] [Cited by in Crossref: 17] [Cited by in F6Publishing: 18] [Article Influence: 5.7] [Reference Citation Analysis]
274 Lorusso L, Cappagli V, Valerio L, Giani C, Viola D, Puleo L, Gambale C, Minaldi E, Campopiano MC, Matrone A, Bottici V, Agate L, Molinaro E, Elisei R. Thyroid Cancers: From Surgery to Current and Future Systemic Therapies through Their Molecular Identities. Int J Mol Sci 2021;22:3117. [PMID: 33803747 DOI: 10.3390/ijms22063117] [Cited by in Crossref: 4] [Cited by in F6Publishing: 3] [Article Influence: 4.0] [Reference Citation Analysis]
275 Fereres S, Hatori R, Hatori M, Kornberg TB. Cytoneme-mediated signaling essential for tumorigenesis. PLoS Genet 2019;15:e1008415. [PMID: 31568500 DOI: 10.1371/journal.pgen.1008415] [Cited by in Crossref: 25] [Cited by in F6Publishing: 19] [Article Influence: 8.3] [Reference Citation Analysis]
276 Batista A, Riedemann L, Vardam T, Jain RK. Targeting the Tumor Microenvironment to Enhance Pediatric Brain Cancer Treatment. The Cancer Journal 2015;21:307-13. [DOI: 10.1097/ppo.0000000000000125] [Cited by in Crossref: 7] [Cited by in F6Publishing: 3] [Article Influence: 1.0] [Reference Citation Analysis]
277 Deronic A, Tahvili S, Leanderson T, Ivars F. The anti-tumor effect of the quinoline-3-carboxamide tasquinimod: blockade of recruitment of CD11b(+) Ly6C(hi) cells to tumor tissue reduces tumor growth. BMC Cancer 2016;16:440. [PMID: 27400708 DOI: 10.1186/s12885-016-2481-0] [Cited by in Crossref: 7] [Cited by in F6Publishing: 8] [Article Influence: 1.2] [Reference Citation Analysis]
278 Feygenzon V, Loewenstein S, Lubezky N, Pasmanic-Chor M, Sher O, Klausner JM, Lahat G. Unique cellular interactions between pancreatic cancer cells and the omentum. PLoS One 2017;12:e0179862. [PMID: 28632775 DOI: 10.1371/journal.pone.0179862] [Cited by in Crossref: 11] [Cited by in F6Publishing: 11] [Article Influence: 2.2] [Reference Citation Analysis]
279 Jiang Y, Wang C, Zhou S. Targeting tumor microenvironment in ovarian cancer: Premise and promise. Biochim Biophys Acta Rev Cancer 2020;1873:188361. [PMID: 32234508 DOI: 10.1016/j.bbcan.2020.188361] [Cited by in Crossref: 18] [Cited by in F6Publishing: 18] [Article Influence: 9.0] [Reference Citation Analysis]
280 Luan H, Zhang C, Zhang T, He Y, Su Y, Zhou L. Identification of Key Prognostic Biomarker and Its Correlation with Immune Infiltrates in Pancreatic Ductal Adenocarcinoma. Dis Markers 2020;2020:8825997. [PMID: 32934754 DOI: 10.1155/2020/8825997] [Cited by in Crossref: 1] [Cited by in F6Publishing: 2] [Article Influence: 0.5] [Reference Citation Analysis]
281 Alves AM, Diel LF, Lamers ML. Macrophages and prognosis of oral squamous cell carcinoma: A systematic review. J Oral Pathol Med 2018;47:460-7. [PMID: 28940738 DOI: 10.1111/jop.12643] [Cited by in Crossref: 46] [Cited by in F6Publishing: 50] [Article Influence: 9.2] [Reference Citation Analysis]
282 Wong SL, Sukkar MB. The SPARC protein: an overview of its role in lung cancer and pulmonary fibrosis and its potential role in chronic airways disease. Br J Pharmacol. 2017;174:3-14. [PMID: 27759879 DOI: 10.1111/bph.13653] [Cited by in Crossref: 31] [Cited by in F6Publishing: 33] [Article Influence: 5.2] [Reference Citation Analysis]
283 Hill BS, Sarnella A, D'Avino G, Zannetti A. Recruitment of stromal cells into tumour microenvironment promote the metastatic spread of breast cancer. Semin Cancer Biol 2020;60:202-13. [PMID: 31377307 DOI: 10.1016/j.semcancer.2019.07.028] [Cited by in Crossref: 27] [Cited by in F6Publishing: 25] [Article Influence: 9.0] [Reference Citation Analysis]
284 Kemi N, Eskuri M, Herva A, Leppänen J, Huhta H, Helminen O, Saarnio J, Karttunen TJ, Kauppila JH. Tumour-stroma ratio and prognosis in gastric adenocarcinoma. Br J Cancer 2018;119:435-9. [PMID: 30057407 DOI: 10.1038/s41416-018-0202-y] [Cited by in Crossref: 31] [Cited by in F6Publishing: 32] [Article Influence: 7.8] [Reference Citation Analysis]
285 Yin SP, Gao Y, Xie XS, Xu DD, Riabov V, Du WD. Accumulation of stabilin-1 positive macrophages in the early stage of gastric cancer is associated with short cumulative survival. Oncol Lett 2020;19:2404-12. [PMID: 32194740 DOI: 10.3892/ol.2020.11310] [Reference Citation Analysis]
286 Wen Y, Lin A, Zhu W, Wei T, Luo P, Guo L, Zhang J. Catenin Alpha-2 Mutation Changes the Immune Microenvironment in Lung Adenocarcinoma Patients Receiving Immune Checkpoint Inhibitors. Front Pharmacol 2021;12:645862. [PMID: 34163353 DOI: 10.3389/fphar.2021.645862] [Reference Citation Analysis]
287 Deryugina EI, Quigley JP. Tumor angiogenesis: MMP-mediated induction of intravasation- and metastasis-sustaining neovasculature. Matrix Biol. 2015;44-46:94-112. [PMID: 25912949 DOI: 10.1016/j.matbio.2015.04.004] [Cited by in Crossref: 193] [Cited by in F6Publishing: 194] [Article Influence: 27.6] [Reference Citation Analysis]
288 Trivanović D, Krstić J, Djordjević IO, Mojsilović S, Santibanez JF, Bugarski D, Jauković A. The Roles of Mesenchymal Stromal/Stem Cells in Tumor Microenvironment Associated with Inflammation. Mediators Inflamm 2016;2016:7314016. [PMID: 27630452 DOI: 10.1155/2016/7314016] [Cited by in Crossref: 16] [Cited by in F6Publishing: 17] [Article Influence: 2.7] [Reference Citation Analysis]
289 Yang MH, Chung TW, Lu YS, Chen YL, Tsai WC, Jong SB, Yuan SS, Liao PC, Lin PC, Tyan YC. Activation of the ubiquitin proteasome pathway by silk fibroin modified chitosan nanoparticles in hepatic cancer cells. Int J Mol Sci 2015;16:1657-76. [PMID: 25588218 DOI: 10.3390/ijms16011657] [Cited by in Crossref: 7] [Cited by in F6Publishing: 6] [Article Influence: 1.0] [Reference Citation Analysis]
290 Zeng XY, Xie H, Yuan J, Jiang XY, Yong JH, Zeng D, Dou YY, Xiao SS. M2-like tumor-associated macrophages-secreted EGF promotes epithelial ovarian cancer metastasis via activating EGFR-ERK signaling and suppressing lncRNA LIMT expression. Cancer Biol Ther 2019;20:956-66. [PMID: 31062668 DOI: 10.1080/15384047.2018.1564567] [Cited by in Crossref: 29] [Cited by in F6Publishing: 32] [Article Influence: 9.7] [Reference Citation Analysis]
291 Liu Q, Liao Q, Zhao Y. Chemotherapy and tumor microenvironment of pancreatic cancer. Cancer Cell Int 2017;17:68. [PMID: 28694739 DOI: 10.1186/s12935-017-0437-3] [Cited by in Crossref: 44] [Cited by in F6Publishing: 44] [Article Influence: 8.8] [Reference Citation Analysis]
292 Li Y, Tao L, Cai W. Profiles of Immune Infiltration and Prognostic Immunoscore in Lung Adenocarcinoma. Biomed Res Int 2020;2020:5858092. [PMID: 32596334 DOI: 10.1155/2020/5858092] [Cited by in Crossref: 1] [Cited by in F6Publishing: 2] [Article Influence: 0.5] [Reference Citation Analysis]
293 Zhang J, Ji C, Li W, Mao Z, Shi Y, Shi H, Ji R, Qian H, Xu W, Zhang X. Tumor-Educated Neutrophils Activate Mesenchymal Stem Cells to Promote Gastric Cancer Growth and Metastasis. Front Cell Dev Biol 2020;8:788. [PMID: 32903528 DOI: 10.3389/fcell.2020.00788] [Cited by in Crossref: 7] [Cited by in F6Publishing: 6] [Article Influence: 3.5] [Reference Citation Analysis]
294 Yang Y, Li CW, Chan LC, Wei Y, Hsu JM, Xia W, Cha JH, Hou J, Hsu JL, Sun L, Hung MC. Exosomal PD-L1 harbors active defense function to suppress T cell killing of breast cancer cells and promote tumor growth. Cell Res. 2018;28:862-864. [PMID: 29959401 DOI: 10.1038/s41422-018-0060-4] [Cited by in Crossref: 117] [Cited by in F6Publishing: 122] [Article Influence: 29.3] [Reference Citation Analysis]
295 Chiavarina B, Ronca R, Otaka Y, Sutton RB, Rezzola S, Yokobori T, Chiodelli P, Souche R, Pourquier D, Maraver A, Faa G, Khellaf L, Turtoi E, Oyama T, Gofflot S, Bellahcène A, Detry O, Delvenne P, Castronovo V, Nishiyama M, Turtoi A. Fibroblast-derived prolargin is a tumor suppressor in hepatocellular carcinoma. Oncogene 2022. [PMID: 35031773 DOI: 10.1038/s41388-021-02171-z] [Reference Citation Analysis]
296 Garcia-Gomez A, Rodríguez-Ubreva J, Ballestar E. Epigenetic interplay between immune, stromal and cancer cells in the tumor microenvironment. Clin Immunol 2018;196:64-71. [PMID: 29501540 DOI: 10.1016/j.clim.2018.02.013] [Cited by in Crossref: 30] [Cited by in F6Publishing: 31] [Article Influence: 7.5] [Reference Citation Analysis]
297 Zlotogorski-hurvitz A, Dayan D, Chaushu G, Salo T, Vered M. Morphological and molecular features of oral fluid-derived exosomes: oral cancer patients versus healthy individuals. J Cancer Res Clin Oncol 2016;142:101-10. [DOI: 10.1007/s00432-015-2005-3] [Cited by in Crossref: 60] [Cited by in F6Publishing: 54] [Article Influence: 8.6] [Reference Citation Analysis]
298 Liu P, Weng Y, Sui Z, Wu Y, Meng X, Wu M, Jin H, Tan X, Zhang L, Zhang Y. Quantitative secretomic analysis of pancreatic cancer cells in serum-containing conditioned medium. Sci Rep 2016;6:37606. [PMID: 27869176 DOI: 10.1038/srep37606] [Cited by in Crossref: 22] [Cited by in F6Publishing: 21] [Article Influence: 3.7] [Reference Citation Analysis]
299 Zhang W, Torres-Rojas C, Yue J, Zhu BM. Adipose-derived stem cells in ovarian cancer progression, metastasis, and chemoresistance. Exp Biol Med (Maywood) 2021;246:1810-5. [PMID: 34229470 DOI: 10.1177/15353702211023846] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 1.0] [Reference Citation Analysis]
300 Falasca M, Maffucci T. Targeting p110gamma in gastrointestinal cancers: attack on multiple fronts. Front Physiol 2014;5:391. [PMID: 25360116 DOI: 10.3389/fphys.2014.00391] [Cited by in Crossref: 6] [Cited by in F6Publishing: 5] [Article Influence: 0.8] [Reference Citation Analysis]
301 Kai M, Ziemys A, Liu YT, Kojic M, Ferrari M, Yokoi K. Tumor Site-Dependent Transport Properties Determine Nanotherapeutics Delivery and Its Efficacy. Transl Oncol 2019;12:1196-205. [PMID: 31228770 DOI: 10.1016/j.tranon.2019.05.011] [Cited by in Crossref: 6] [Cited by in F6Publishing: 6] [Article Influence: 2.0] [Reference Citation Analysis]
302 Dong P, Xiong Y, Yue J, Hanley SJB, Watari H. B7H3 As a Promoter of Metastasis and Promising Therapeutic Target. Front Oncol. 2018;8:264. [PMID: 30035102 DOI: 10.3389/fonc.2018.00264] [Cited by in Crossref: 39] [Cited by in F6Publishing: 45] [Article Influence: 9.8] [Reference Citation Analysis]
303 Zhang CY, Gao J, Wang Z. Bioresponsive Nanoparticles Targeted to Infectious Microenvironments for Sepsis Management. Adv Mater 2018;30:e1803618. [PMID: 30203430 DOI: 10.1002/adma.201803618] [Cited by in Crossref: 53] [Cited by in F6Publishing: 57] [Article Influence: 13.3] [Reference Citation Analysis]
304 Li J, Li H, Zhang C, Zhang C, Wang H. Integrative analysis of genomic alteration, immune cells infiltration and prognosis of lung squamous cell carcinoma (LUSC) to identify smoking-related biomarkers. Int Immunopharmacol 2020;89:107053. [PMID: 33045568 DOI: 10.1016/j.intimp.2020.107053] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 0.5] [Reference Citation Analysis]
305 D'Almeida O, Mothar O, Bondzie EA, Lieumo Y, Tagne L, Gupta S, Volkert T, Levine S, Tagne JB. Encapsulated miR-200c and Nkx2.1 in a nuclear/mitochondria transcriptional regulatory network of non-metastatic and metastatic lung cancer cells. BMC Cancer 2019;19:136. [PMID: 30744585 DOI: 10.1186/s12885-019-5337-6] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 0.3] [Reference Citation Analysis]
306 Urbanski LM, Leclair N, Anczuków O. Alternative-splicing defects in cancer: Splicing regulators and their downstream targets, guiding the way to novel cancer therapeutics. Wiley Interdiscip Rev RNA 2018;9:e1476. [PMID: 29693319 DOI: 10.1002/wrna.1476] [Cited by in Crossref: 108] [Cited by in F6Publishing: 100] [Article Influence: 27.0] [Reference Citation Analysis]
307 He X, Cao H, Wang H, Tan T, Yu H, Zhang P, Yin Q, Zhang Z, Li Y. Inflammatory Monocytes Loading Protease-Sensitive Nanoparticles Enable Lung Metastasis Targeting and Intelligent Drug Release for Anti-Metastasis Therapy. Nano Lett 2017;17:5546-54. [DOI: 10.1021/acs.nanolett.7b02330] [Cited by in Crossref: 66] [Cited by in F6Publishing: 62] [Article Influence: 13.2] [Reference Citation Analysis]
308 Hawkins AG, Pedersen EA, Treichel S, Temprine K, Sperring C, Read JA, Magnuson B, Chugh R, Lawlor ER. Wnt/β-catenin-activated Ewing sarcoma cells promote the angiogenic switch. JCI Insight 2020;5:135188. [PMID: 32544094 DOI: 10.1172/jci.insight.135188] [Cited by in Crossref: 4] [Cited by in F6Publishing: 5] [Article Influence: 2.0] [Reference Citation Analysis]
309 Peng J, Yang Q, Li W, Tan L, Xiao Y, Chen L, Hao Y, Qian Z. Erythrocyte-Membrane-Coated Prussian Blue/Manganese Dioxide Nanoparticles as H2O2-Responsive Oxygen Generators To Enhance Cancer Chemotherapy/Photothermal Therapy. ACS Appl Mater Interfaces 2017;9:44410-22. [PMID: 29210279 DOI: 10.1021/acsami.7b17022] [Cited by in Crossref: 67] [Cited by in F6Publishing: 66] [Article Influence: 13.4] [Reference Citation Analysis]
310 Marino N, German R, Rao X, Simpson E, Liu S, Wan J, Liu Y, Sandusky G, Jacobsen M, Stoval M, Cao S, Storniolo AMV. Upregulation of lipid metabolism genes in the breast prior to cancer diagnosis. NPJ Breast Cancer 2020;6:50. [PMID: 33083529 DOI: 10.1038/s41523-020-00191-8] [Cited by in Crossref: 5] [Cited by in F6Publishing: 5] [Article Influence: 2.5] [Reference Citation Analysis]
311 Zhou H, Neelakantan D, Ford HL. Clonal cooperativity in heterogenous cancers. Semin Cell Dev Biol 2017;64:79-89. [PMID: 27582427 DOI: 10.1016/j.semcdb.2016.08.028] [Cited by in Crossref: 32] [Cited by in F6Publishing: 29] [Article Influence: 5.3] [Reference Citation Analysis]
312 Chen YT, Yang CC, Shao PL, Huang CR, Yip HK. Melatonin-mediated downregulation of ZNF746 suppresses bladder tumorigenesis mainly through inhibiting the AKT-MMP-9 signaling pathway. J Pineal Res 2019;66:e12536. [PMID: 30372570 DOI: 10.1111/jpi.12536] [Cited by in Crossref: 19] [Cited by in F6Publishing: 23] [Article Influence: 4.8] [Reference Citation Analysis]
313 Steponaitis G, Kazlauskas A, Skiriute D, Vaitkiene P, Skauminas K, Tamasauskas A. Significance of Amphiregulin (AREG) for the Outcome of Low and High Grade Astrocytoma Patients. J Cancer 2019;10:1479-88. [PMID: 31031857 DOI: 10.7150/jca.29282] [Cited by in Crossref: 8] [Cited by in F6Publishing: 10] [Article Influence: 2.7] [Reference Citation Analysis]
314 Sioud M, Pettersen S, Ailte I, Fløisand Y. Targeted Killing of Monocytes/Macrophages and Myeloid Leukemia Cells with Pro-Apoptotic Peptides. Cancers (Basel) 2019;11:E1088. [PMID: 31370273 DOI: 10.3390/cancers11081088] [Cited by in Crossref: 4] [Cited by in F6Publishing: 4] [Article Influence: 1.3] [Reference Citation Analysis]
315 Wang J, Han Q, Liu H, Luo H, Li L, Liu A, Jiang Y. Identification of Radiotherapy-Associated Genes in Lung Adenocarcinoma by an Integrated Bioinformatics Analysis Approach. Front Mol Biosci 2021;8:624575. [PMID: 34212001 DOI: 10.3389/fmolb.2021.624575] [Reference Citation Analysis]
316 Lim B, Woodward WA, Wang X, Reuben JM, Ueno NT. Inflammatory breast cancer biology: the tumour microenvironment is key. Nat Rev Cancer 2018;18:485-99. [PMID: 29703913 DOI: 10.1038/s41568-018-0010-y] [Cited by in Crossref: 102] [Cited by in F6Publishing: 95] [Article Influence: 34.0] [Reference Citation Analysis]
317 Xiao L, Yang S, Hao J, Yuan X, Luo W, Jiang L, Hu Y, Fu Z, Zhang Y, Zou C. Endostar attenuates melanoma tumor growth via its interruption of b-FGF mediated angiogenesis. Cancer Lett 2015;359:148-54. [PMID: 25597785 DOI: 10.1016/j.canlet.2015.01.012] [Cited by in Crossref: 21] [Cited by in F6Publishing: 20] [Article Influence: 3.0] [Reference Citation Analysis]
318 Desbois M, Béal C, Charrier M, Besse B, Meurice G, Cagnard N, Jacques Y, Béchard D, Cassard L, Chaput N. IL-15 superagonist RLI has potent immunostimulatory properties on NK cells: implications for antimetastatic treatment. J Immunother Cancer 2020;8:e000632. [PMID: 32532840 DOI: 10.1136/jitc-2020-000632] [Cited by in Crossref: 7] [Cited by in F6Publishing: 7] [Article Influence: 7.0] [Reference Citation Analysis]
319 Hou YC, Chao YJ, Hsieh MH, Tung HL, Wang HC, Shan YS. Low CD8⁺ T Cell Infiltration and High PD-L1 Expression Are Associated with Level of CD44⁺/CD133⁺ Cancer Stem Cells and Predict an Unfavorable Prognosis in Pancreatic Cancer. Cancers (Basel) 2019;11:E541. [PMID: 30991694 DOI: 10.3390/cancers11040541] [Cited by in Crossref: 41] [Cited by in F6Publishing: 41] [Article Influence: 13.7] [Reference Citation Analysis]
320 Zhao K, Li Z, Yao S, Wang Y, Wu X, Xu Z, Wu L, Huang Y, Liang C, Liu Z. Artificial intelligence quantified tumour-stroma ratio is an independent predictor for overall survival in resectable colorectal cancer. EBioMedicine. 2020;61:103054. [PMID: 33039706 DOI: 10.1016/j.ebiom.2020.103054] [Cited by in Crossref: 11] [Cited by in F6Publishing: 16] [Article Influence: 5.5] [Reference Citation Analysis]
321 Novizio N, Belvedere R, Pessolano E, Tosco A, Porta A, Perretti M, Campiglia P, Filippelli A, Petrella A. Annexin A1 Released in Extracellular Vesicles by Pancreatic Cancer Cells Activates Components of the Tumor Microenvironment, through Interaction with the Formyl-Peptide Receptors. Cells 2020;9:E2719. [PMID: 33353163 DOI: 10.3390/cells9122719] [Cited by in Crossref: 2] [Cited by in F6Publishing: 2] [Article Influence: 1.0] [Reference Citation Analysis]
322 Huang F, Chen WY, Ma J, He XL, Wang JW. Paradoxical role of interleukin-33/suppressor of tumorigenicity 2 in colorectal carcinogenesis: Progress and therapeutic potential. World J Clin Cases 2022; 10(1): 23-34 [DOI: 10.12998/wjcc.v10.i1.23] [Reference Citation Analysis]
323 Li X, Zhu H, Sun W, Yang X, Nie Q, Fang X. Role of glutamine and its metabolite ammonia in crosstalk of cancer-associated fibroblasts and cancer cells. Cancer Cell Int 2021;21:479. [PMID: 34503536 DOI: 10.1186/s12935-021-02121-5] [Reference Citation Analysis]
324 Rihawi K, Ricci AD, Rizzo A, Brocchi S, Marasco G, Pastore LV, Llimpe FLR, Golfieri R, Renzulli M. Tumor-Associated Macrophages and Inflammatory Microenvironment in Gastric Cancer: Novel Translational Implications. Int J Mol Sci 2021;22:3805. [PMID: 33916915 DOI: 10.3390/ijms22083805] [Cited by in Crossref: 1] [Cited by in F6Publishing: 2] [Article Influence: 1.0] [Reference Citation Analysis]
325 Kristensen LS, Ebbesen KK, Sokol M, Jakobsen T, Korsgaard U, Eriksen AC, Hansen TB, Kjems J, Hager H. Spatial expression analyses of the putative oncogene ciRS-7 in cancer reshape the microRNA sponge theory. Nat Commun 2020;11:4551. [PMID: 32917870 DOI: 10.1038/s41467-020-18355-2] [Cited by in Crossref: 22] [Cited by in F6Publishing: 26] [Article Influence: 11.0] [Reference Citation Analysis]
326 Janagama D, Hui SK. 3-D Cell Culture Systems in Bone Marrow Tissue and Organoid Engineering, and BM Phantoms as In Vitro Models of Hematological Cancer Therapeutics-A Review. Materials (Basel) 2020;13:E5609. [PMID: 33316977 DOI: 10.3390/ma13245609] [Reference Citation Analysis]
327 Atiya H, Frisbie L, Pressimone C, Coffman L. Mesenchymal Stem Cells in the Tumor Microenvironment. Adv Exp Med Biol 2020;1234:31-42. [PMID: 32040853 DOI: 10.1007/978-3-030-37184-5_3] [Cited by in Crossref: 26] [Cited by in F6Publishing: 26] [Article Influence: 13.0] [Reference Citation Analysis]
328 Lu P, Ma Y, Wei S, Liang X. The dual role of complement in cancers, from destroying tumors to promoting tumor development. Cytokine 2021;143:155522. [PMID: 33849765 DOI: 10.1016/j.cyto.2021.155522] [Reference Citation Analysis]
329 Dharmajaya R, Sari DK. Role and value of inflammatory markers in brain tumors: A case controlled study. Ann Med Surg (Lond) 2021;63:102107. [PMID: 33659053 DOI: 10.1016/j.amsu.2021.01.055] [Cited by in Crossref: 1] [Cited by in F6Publishing: 2] [Article Influence: 1.0] [Reference Citation Analysis]
330 Kuang C, Zhu Y, Guan Y, Xia J, Ouyang J, Liu G, Hao M, Liu J, Guo J, Zhang W, Feng X, Li X, Zhang J, Wu X, Xu H, Li G, Xie L, Fan S, Qiu L, Zhou W. COX2 confers bone marrow stromal cells to promoting TNFα/TNFR1β-mediated myeloma cell growth and adhesion. Cell Oncol (Dordr) 2021;44:643-59. [PMID: 33646559 DOI: 10.1007/s13402-021-00590-4] [Reference Citation Analysis]
331 Visciano C, Prevete N, Liotti F, Marone G. Tumor-Associated Mast Cells in Thyroid Cancer. Int J Endocrinol 2015;2015:705169. [PMID: 26379707 DOI: 10.1155/2015/705169] [Cited by in Crossref: 24] [Cited by in F6Publishing: 28] [Article Influence: 3.4] [Reference Citation Analysis]
332 Salvagno C, de Visser KE. Purification of Immune Cell Populations from Freshly Isolated Murine Tumors and Organs by Consecutive Magnetic Cell Sorting and Multi-parameter Flow Cytometry-Based Sorting. Methods Mol Biol 2016;1458:125-35. [PMID: 27581019 DOI: 10.1007/978-1-4939-3801-8_10] [Cited by in Crossref: 5] [Cited by in F6Publishing: 5] [Article Influence: 1.3] [Reference Citation Analysis]
333 Valdebenito S, D'amico D, Eugenin E. Novel approaches for glioblastoma treatment: Focus on tumor heterogeneity, treatment resistance, and computational tools. Cancer Reports 2019;2. [DOI: 10.1002/cnr2.1220] [Reference Citation Analysis]
334 Andl T, Zhou L, Yang K, Kadekaro AL, Zhang Y. YAP and WWTR1: New targets for skin cancer treatment. Cancer Lett 2017;396:30-41. [PMID: 28279717 DOI: 10.1016/j.canlet.2017.03.001] [Cited by in Crossref: 10] [Cited by in F6Publishing: 12] [Article Influence: 2.0] [Reference Citation Analysis]
335 Paul CD, Devine A, Bishop K, Xu Q, Wulftange WJ, Burr H, Daly KM, Lewis C, Green DS, Staunton JR, Choksi S, Liu ZG, Sood R, Tanner K. Human macrophages survive and adopt activated genotypes in living zebrafish. Sci Rep 2019;9:1759. [PMID: 30741975 DOI: 10.1038/s41598-018-38186-y] [Cited by in Crossref: 10] [Cited by in F6Publishing: 9] [Article Influence: 3.3] [Reference Citation Analysis]
336 Feng YX, Jin DX, Sokol ES, Reinhardt F, Miller DH, Gupta PB. Cancer-specific PERK signaling drives invasion and metastasis through CREB3L1. Nat Commun 2017;8:1079. [PMID: 29057869 DOI: 10.1038/s41467-017-01052-y] [Cited by in Crossref: 47] [Cited by in F6Publishing: 46] [Article Influence: 9.4] [Reference Citation Analysis]
337 Porcheri C, Mitsiadis TA. New Scenarios in Pharmacological Treatments of Head and Neck Squamous Cell Carcinomas. Cancers (Basel) 2021;13:5515. [PMID: 34771677 DOI: 10.3390/cancers13215515] [Reference Citation Analysis]
338 Merlino G, Miodini P, Paolini B, Carcangiu ML, Gennaro M, Dugo M, Daidone MG, Cappelletti V. Stromal Activation by Tumor Cells: An in Vitro Study in Breast Cancer. Microarrays (Basel) 2016;5:E10. [PMID: 27600076 DOI: 10.3390/microarrays5020010] [Cited by in Crossref: 5] [Cited by in F6Publishing: 5] [Article Influence: 0.8] [Reference Citation Analysis]
339 Li R, Serrano JC, Xing H, Lee TA, Azizgolshani H, Zaman M, Kamm RD. Interstitial flow promotes macrophage polarization toward an M2 phenotype. Mol Biol Cell 2018;29:1927-40. [PMID: 29995595 DOI: 10.1091/mbc.E18-03-0164] [Cited by in Crossref: 36] [Cited by in F6Publishing: 18] [Article Influence: 9.0] [Reference Citation Analysis]
340 Gaglio D, Valtorta S, Ripamonti M, Bonanomi M, Damiani C, Todde S, Negri AS, Sanvito F, Mastroianni F, Di Campli A, Turacchio G, Di Grigoli G, Belloli S, Luini A, Gilardi MC, Colangelo AM, Alberghina L, Moresco RM. Divergent in vitro/in vivo responses to drug treatments of highly aggressive NIH-Ras cancer cells: a PET imaging and metabolomics-mass-spectrometry study. Oncotarget 2016;7:52017-31. [PMID: 27409831 DOI: 10.18632/oncotarget.10470] [Cited by in Crossref: 7] [Cited by in F6Publishing: 7] [Article Influence: 1.8] [Reference Citation Analysis]
341 Li D, Yu H, Guo Z, Li S, Li Y, Guo Y, Zhong H, Xiong H, Liu Z. SERS analysis of carcinoma-associated fibroblasts in a tumor microenvironment based on targeted 2D nanosheets. Nanoscale 2020;12:2133-41. [PMID: 31913376 DOI: 10.1039/c9nr08754k] [Cited by in Crossref: 4] [Cited by in F6Publishing: 1] [Article Influence: 2.0] [Reference Citation Analysis]
342 Fernando K, Kwang LG, Lim JTC, Fong ELS. Hydrogels to engineer tumor microenvironments in vitro. Biomater Sci 2021;9:2362-83. [DOI: 10.1039/d0bm01943g] [Cited by in Crossref: 3] [Cited by in F6Publishing: 1] [Article Influence: 3.0] [Reference Citation Analysis]
343 Zhang X, Feng Y, Liu X, Ma J, Li Y, Wang T, Li X. Beyond a chemopreventive reagent, aspirin is a master regulator of the hallmarks of cancer. J Cancer Res Clin Oncol 2019;145:1387-403. [PMID: 31037399 DOI: 10.1007/s00432-019-02902-6] [Cited by in Crossref: 10] [Cited by in F6Publishing: 8] [Article Influence: 3.3] [Reference Citation Analysis]
344 Morisse MC, Jouannet S, Dominguez-Villar M, Sanson M, Idbaih A. Interactions between tumor-associated macrophages and tumor cells in glioblastoma: unraveling promising targeted therapies. Expert Rev Neurother 2018;18:729-37. [PMID: 30099909 DOI: 10.1080/14737175.2018.1510321] [Cited by in Crossref: 22] [Cited by in F6Publishing: 21] [Article Influence: 5.5] [Reference Citation Analysis]
345 Hajizadeh F, Moghadaszadeh Ardebili S, Baghi Moornani M, Masjedi A, Atyabi F, Kiani M, Namdar A, Karpisheh V, Izadi S, Baradaran B, Azizi G, Ghalamfarsa G, Sabz G, Yousefi M, Jadidi-Niaragh F. Silencing of HIF-1α/CD73 axis by siRNA-loaded TAT-chitosan-spion nanoparticles robustly blocks cancer cell progression. Eur J Pharmacol 2020;882:173235. [PMID: 32574672 DOI: 10.1016/j.ejphar.2020.173235] [Cited by in Crossref: 15] [Cited by in F6Publishing: 15] [Article Influence: 7.5] [Reference Citation Analysis]
346 Mascarella MA, Azzi JL, Silva SD, Mlynarek A, Forest V, Hier M, Richardson K, Sadeghi N. Postoperative infection predicts poor survival in locoregionally advanced oral cancer. Head & Neck 2019;41:3624-30. [DOI: 10.1002/hed.25885] [Cited by in Crossref: 2] [Cited by in F6Publishing: 1] [Article Influence: 0.7] [Reference Citation Analysis]
347 Liu J, Liu X, Qian J, Meng C, Zhu P, Hang J, Wang Y, Xiong B, Qiu X, Zhu W, Yang Y, Zhang Y, Ling Y. Development of pH/Glutathione-Responsive Theranostic Agents Activated by Glutathione S-Transferase π for Human Colon Cancer. J Med Chem 2020;63:9271-83. [PMID: 32787089 DOI: 10.1021/acs.jmedchem.0c00354] [Cited by in Crossref: 3] [Cited by in F6Publishing: 2] [Article Influence: 1.5] [Reference Citation Analysis]
348 Shin JM, Oh SJ, Kwon S, Deepagan VG, Lee M, Song SH, Lee HJ, Kim S, Song KH, Kim TW, Park JH. A PEGylated hyaluronic acid conjugate for targeted cancer immunotherapy. J Control Release 2017;267:181-90. [PMID: 28844759 DOI: 10.1016/j.jconrel.2017.08.032] [Cited by in Crossref: 26] [Cited by in F6Publishing: 22] [Article Influence: 5.2] [Reference Citation Analysis]
349 Gocheva V, Naba A, Bhutkar A, Guardia T, Miller KM, Li CM, Dayton TL, Sanchez-Rivera FJ, Kim-Kiselak C, Jailkhani N, Winslow MM, Del Rosario A, Hynes RO, Jacks T. Quantitative proteomics identify Tenascin-C as a promoter of lung cancer progression and contributor to a signature prognostic of patient survival. Proc Natl Acad Sci U S A 2017;114:E5625-34. [PMID: 28652369 DOI: 10.1073/pnas.1707054114] [Cited by in Crossref: 67] [Cited by in F6Publishing: 61] [Article Influence: 13.4] [Reference Citation Analysis]
350 Pang Z, Chen X, Wang Y, Wang Y, Yan T, Wan J, Wang K, Du J. Long non-coding RNA C5orf64 is a potential indicator for tumor microenvironment and mutation pattern remodeling in lung adenocarcinoma. Genomics 2021;113:291-304. [PMID: 33309768 DOI: 10.1016/j.ygeno.2020.12.010] [Cited by in Crossref: 2] [Cited by in F6Publishing: 4] [Article Influence: 1.0] [Reference Citation Analysis]
351 Ngambenjawong C, Pun SH. Multivalent polymers displaying M2 macrophage-targeting peptides improve target binding avidity and serum stability. ACS Biomater Sci Eng 2017;3:2050-3. [PMID: 29430522 DOI: 10.1021/acsbiomaterials.7b00332] [Cited by in Crossref: 7] [Cited by in F6Publishing: 8] [Article Influence: 1.4] [Reference Citation Analysis]
352 Chen C, Lin W, Huang Y, Chen X, Wang H, Teng L. The Essential Factors of Establishing Patient-derived Tumor Model. J Cancer 2021;12:28-37. [PMID: 33391400 DOI: 10.7150/jca.51749] [Cited by in Crossref: 3] [Cited by in F6Publishing: 3] [Article Influence: 3.0] [Reference Citation Analysis]
353 He Y, Chen Y, Tong Y, Long W, Liu Q. Identification of a circRNA-miRNA-mRNA regulatory network for exploring novel therapeutic options for glioma. PeerJ 2021;9:e11894. [PMID: 34434651 DOI: 10.7717/peerj.11894] [Reference Citation Analysis]
354 Zhang J, Yan Y, Yang Y, Wang L, Li M, Wang J, Liu X, Duan X, Wang J. High Infiltration of Tumor-Associated Macrophages Influences Poor Prognosis in Human Gastric Cancer Patients, Associates With the Phenomenon of EMT. Medicine (Baltimore). 2016;95:e2636. [PMID: 26871785 DOI: 10.1097/md.0000000000002636] [Cited by in Crossref: 46] [Cited by in F6Publishing: 30] [Article Influence: 7.7] [Reference Citation Analysis]
355 Landgraf M, McGovern JA, Friedl P, Hutmacher DW. Rational Design of Mouse Models for Cancer Research. Trends Biotechnol 2018;36:242-51. [PMID: 29310843 DOI: 10.1016/j.tibtech.2017.12.001] [Cited by in Crossref: 39] [Cited by in F6Publishing: 33] [Article Influence: 9.8] [Reference Citation Analysis]
356 Weddell JC, Chen S, Imoukhuede PI. VEGFR1 promotes cell migration and proliferation through PLCγ and PI3K pathways. NPJ Syst Biol Appl 2018;4:1. [PMID: 29263797 DOI: 10.1038/s41540-017-0037-9] [Cited by in Crossref: 26] [Cited by in F6Publishing: 19] [Article Influence: 5.2] [Reference Citation Analysis]
357 Capp JP, DeGregori J, Nedelcu AM, Dujon AM, Boutry J, Pujol P, Alix-Panabières C, Hamede R, Roche B, Ujvari B, Marusyk A, Gatenby R, Thomas F. Group phenotypic composition in cancer. Elife 2021;10:e63518. [PMID: 33784238 DOI: 10.7554/eLife.63518] [Cited by in Crossref: 2] [Cited by in F6Publishing: 1] [Article Influence: 2.0] [Reference Citation Analysis]
358 Mumtaz T, Qindeel M, Asim Ur Rehman, Tarhini M, Ahmed N, Elaissari A. Exploiting proteases for cancer theranostic through molecular imaging and drug delivery. Int J Pharm 2020;587:119712. [PMID: 32745499 DOI: 10.1016/j.ijpharm.2020.119712] [Cited by in Crossref: 4] [Cited by in F6Publishing: 2] [Article Influence: 2.0] [Reference Citation Analysis]
359 Pützer BM, Solanki M, Herchenröder O. Advances in cancer stem cell targeting: How to strike the evil at its root. Advanced Drug Delivery Reviews 2017;120:89-107. [DOI: 10.1016/j.addr.2017.07.013] [Cited by in Crossref: 33] [Cited by in F6Publishing: 33] [Article Influence: 6.6] [Reference Citation Analysis]
360 Chau LY. Heme oxygenase-1: emerging target of cancer therapy. J Biomed Sci 2015;22:22. [PMID: 25885228 DOI: 10.1186/s12929-015-0128-0] [Cited by in Crossref: 119] [Cited by in F6Publishing: 125] [Article Influence: 17.0] [Reference Citation Analysis]
361 Zimel MN, Horowitz CB, Rajasekhar VK, Christ AB, Wei X, Wu J, Wojnarowicz PM, Wang D, Goldring SR, Purdue PE, Healey JH. HPMA-Copolymer Nanocarrier Targets Tumor-Associated Macrophages in Primary and Metastatic Breast Cancer. Mol Cancer Ther 2017;16:2701-10. [PMID: 28830983 DOI: 10.1158/1535-7163.MCT-15-0995] [Cited by in Crossref: 14] [Cited by in F6Publishing: 4] [Article Influence: 2.8] [Reference Citation Analysis]
362 Gatto L, Franceschi E, Di Nunno V, Tosoni A, Lodi R, Brandes AA. Liquid Biopsy in Glioblastoma Management: From Current Research to Future Perspectives. Oncologist 2021. [PMID: 34105205 DOI: 10.1002/onco.13858] [Cited by in F6Publishing: 1] [Reference Citation Analysis]
363 Scioli MG, Terriaca S, Fiorelli E, Storti G, Fabbri G, Cervelli V, Orlandi A. Extracellular Vesicles and Cancer Stem Cells in Tumor Progression: New Therapeutic Perspectives. Int J Mol Sci 2021;22:10572. [PMID: 34638913 DOI: 10.3390/ijms221910572] [Cited by in Crossref: 1] [Article Influence: 1.0] [Reference Citation Analysis]
364 Li Y, Umbach DM, Bingham A, Li QJ, Zhuang Y, Li L. Putative biomarkers for predicting tumor sample purity based on gene expression data. BMC Genomics 2019;20:1021. [PMID: 31881847 DOI: 10.1186/s12864-019-6412-8] [Cited by in Crossref: 6] [Cited by in F6Publishing: 4] [Article Influence: 2.0] [Reference Citation Analysis]
365 Hu CT, Guo LL, Feng N, Zhang L, Zhou N, Ma LL, Shen L, Tong GH, Yan QW, Zhu SJ, Bian XW, Lai MD, Deng YJ, Ding YQ. MIF, secreted by human hepatic sinusoidal endothelial cells, promotes chemotaxis and outgrowth of colorectal cancer in liver prometastasis. Oncotarget. 2015;6:22410-22423. [PMID: 26087187 DOI: 10.18632/oncotarget.4198] [Cited by in Crossref: 31] [Cited by in F6Publishing: 32] [Article Influence: 5.2] [Reference Citation Analysis]
366 Xu SJ, Hu HT, Li HL, Chang S. The Role of miRNAs in Immune Cell Development, Immune Cell Activation, and Tumor Immunity: With a Focus on Macrophages and Natural Killer Cells. Cells 2019;8:E1140. [PMID: 31554344 DOI: 10.3390/cells8101140] [Cited by in Crossref: 24] [Cited by in F6Publishing: 25] [Article Influence: 8.0] [Reference Citation Analysis]
367 Sinha S, Singh SK, Jangde N, Ray R, Rai V. p32 promotes melanoma progression and metastasis by targeting EMT markers, Akt/PKB pathway, and tumor microenvironment. Cell Death Dis 2021;12:1012. [PMID: 34711805 DOI: 10.1038/s41419-021-04311-5] [Reference Citation Analysis]
368 Cuiffo BG, Campagne A, Bell GW, Lembo A, Orso F, Lien EC, Bhasin MK, Raimo M, Hanson SE, Marusyk A, El-Ashry D, Hematti P, Polyak K, Mechta-Grigoriou F, Mariani O, Volinia S, Vincent-Salomon A, Taverna D, Karnoub AE. MSC-regulated microRNAs converge on the transcription factor FOXP2 and promote breast cancer metastasis. Cell Stem Cell 2014;15:762-74. [PMID: 25515522 DOI: 10.1016/j.stem.2014.10.001] [Cited by in Crossref: 105] [Cited by in F6Publishing: 104] [Article Influence: 13.1] [Reference Citation Analysis]
369 Laplane L, Duluc D, Larmonier N, Pradeu T, Bikfalvi A. The Multiple Layers of the Tumor Environment. Trends Cancer 2018;4:802-9. [PMID: 30470302 DOI: 10.1016/j.trecan.2018.10.002] [Cited by in Crossref: 28] [Cited by in F6Publishing: 23] [Article Influence: 7.0] [Reference Citation Analysis]
370 Zheng HM, Chen C, Wu XH, Chen J, Sun S, Sun JZ, Wang MW, Sun SR. Quantum dot-based in situ simultaneous molecular imaging and quantitative analysis of EGFR and collagen IV and identification of their prognostic value in triple-negative breast cancer. Tumour Biol 2016;37:2509-18. [PMID: 26385773 DOI: 10.1007/s13277-015-4079-6] [Cited by in Crossref: 4] [Cited by in F6Publishing: 6] [Article Influence: 0.6] [Reference Citation Analysis]
371 Musa M. Single-cell analysis on stromal fibroblasts in the microenvironment of solid tumours. Adv Med Sci 2020;65:163-9. [PMID: 31972467 DOI: 10.1016/j.advms.2019.12.001] [Cited by in Crossref: 3] [Cited by in F6Publishing: 3] [Article Influence: 1.5] [Reference Citation Analysis]
372 Zhu Y, Liang J, Gao C, Wang A, Xia J, Hong C, Zhong Z, Zuo Z, Kim J, Ren H, Li S, Wang Q, Zhang F, Wang J. Multifunctional ginsenoside Rg3-based liposomes for glioma targeting therapy. Journal of Controlled Release 2021;330:641-57. [DOI: 10.1016/j.jconrel.2020.12.036] [Cited by in Crossref: 3] [Cited by in F6Publishing: 4] [Article Influence: 3.0] [Reference Citation Analysis]
373 Zhao X, Li L, Zhao Y, An H, Cai Q, Lang J, Han X, Peng B, Fei Y, Liu H, Qin H, Nie G, Wang H. In Situ Self‐Assembled Nanofibers Precisely Target Cancer‐Associated Fibroblasts for Improved Tumor Imaging. Angew Chem 2019;131:15431-8. [DOI: 10.1002/ange.201908185] [Cited by in Crossref: 12] [Cited by in F6Publishing: 7] [Article Influence: 4.0] [Reference Citation Analysis]
374 Yoon S, Kang BW, Park SY, Kim HJ, Park JS, Choi GS, Kim JG. Prognostic relevance of genetic variants involved in immune checkpoints in patients with colorectal cancer. J Cancer Res Clin Oncol 2016;142:1775-80. [PMID: 27339628 DOI: 10.1007/s00432-016-2196-2] [Cited by in Crossref: 9] [Cited by in F6Publishing: 9] [Article Influence: 1.5] [Reference Citation Analysis]
375 Yan D, Wang HW, Bowman RL, Joyce JA. STAT3 and STAT6 Signaling Pathways Synergize to Promote Cathepsin Secretion from Macrophages via IRE1α Activation. Cell Rep 2016;16:2914-27. [PMID: 27626662 DOI: 10.1016/j.celrep.2016.08.035] [Cited by in Crossref: 87] [Cited by in F6Publishing: 91] [Article Influence: 17.4] [Reference Citation Analysis]
376 Hashemzadeh N, Dolatkhah M, Adibkia K, Aghanejad A, Barzegar-Jalali M, Omidi Y, Barar J. Recent advances in breast cancer immunotherapy: The promising impact of nanomedicines. Life Sci 2021;271:119110. [PMID: 33513401 DOI: 10.1016/j.lfs.2021.119110] [Reference Citation Analysis]
377 Zins K, Abraham D. Cancer Immunotherapy: Targeting Tumor-Associated Macrophages by Gene Silencing. Methods Mol Biol 2020;2115:289-325. [PMID: 32006408 DOI: 10.1007/978-1-0716-0290-4_17] [Cited by in Crossref: 7] [Cited by in F6Publishing: 7] [Article Influence: 7.0] [Reference Citation Analysis]
378 Liu H, Amakye WK, Ren J. Codonopsis pilosula polysaccharide in synergy with dacarbazine inhibits mouse melanoma by repolarizing M2-like tumor-associated macrophages into M1-like tumor-associated macrophages. Biomed Pharmacother 2021;142:112016. [PMID: 34385100 DOI: 10.1016/j.biopha.2021.112016] [Cited by in Crossref: 1] [Article Influence: 1.0] [Reference Citation Analysis]
379 Graff RE, Judson G, Ahearn TU, Fiorentino M, Loda M, Giovannucci EL, Mucci LA, Pettersson A. Circulating Antioxidant Levels and Risk of Prostate Cancer by TMPRSS2:ERG. Prostate 2017;77:647-53. [PMID: 28102015 DOI: 10.1002/pros.23312] [Cited by in Crossref: 8] [Cited by in F6Publishing: 7] [Article Influence: 1.6] [Reference Citation Analysis]
380 A Razak SA, Mohd Gazzali A, Fisol FA, M Abdulbaqi I, Parumasivam T, Mohtar N, A Wahab H. Advances in Nanocarriers for Effective Delivery of Docetaxel in the Treatment of Lung Cancer: An Overview. Cancers (Basel) 2021;13:400. [PMID: 33499040 DOI: 10.3390/cancers13030400] [Cited by in Crossref: 6] [Cited by in F6Publishing: 5] [Article Influence: 6.0] [Reference Citation Analysis]
381 Koos B, Kamali-moghaddam M, David L, Sobrinho-simões M, Dimberg A, Nilsson M, Wählby C, Söderberg O. Next-Generation Pathology—Surveillance of Tumor Microecology. Journal of Molecular Biology 2015;427:2013-22. [DOI: 10.1016/j.jmb.2015.02.017] [Cited by in Crossref: 16] [Cited by in F6Publishing: 13] [Article Influence: 2.3] [Reference Citation Analysis]
382 Mao Y, Feng Q, Zheng P, Yang L, Zhu D, Chang W, Ji M, He G, Xu J. Low tumor infiltrating mast cell density confers prognostic benefit and reflects immunoactivation in colorectal cancer. Int J Cancer 2018;143:2271-80. [PMID: 29873076 DOI: 10.1002/ijc.31613] [Cited by in Crossref: 20] [Cited by in F6Publishing: 23] [Article Influence: 5.0] [Reference Citation Analysis]
383 Moussawi FA, Kumar A, Pasquereau S, Tripathy MK, Karam W, Diab-Assaf M, Herbein G. The transcriptome of human mammary epithelial cells infected with the HCMV-DB strain displays oncogenic traits. Sci Rep 2018;8:12574. [PMID: 30135434 DOI: 10.1038/s41598-018-30109-1] [Cited by in Crossref: 15] [Cited by in F6Publishing: 16] [Article Influence: 3.8] [Reference Citation Analysis]
384 Carvalho S, Troost EG, Bons J, Menheere P, Lambin P, Oberije C. Prognostic value of blood-biomarkers related to hypoxia, inflammation, immune response and tumour load in non-small cell lung cancer - A survival model with external validation. Radiother Oncol 2016;119:487-94. [PMID: 27139126 DOI: 10.1016/j.radonc.2016.04.024] [Cited by in Crossref: 21] [Cited by in F6Publishing: 20] [Article Influence: 3.5] [Reference Citation Analysis]
385 Wang G, Li H, Pan J, Yan T, Zhou H, Han X, Su L, Hou L, Xue X. Upregulated Expression of Cancer-Derived Immunoglobulin G Is Associated With Progression in Glioma. Front Oncol 2021;11:758856. [PMID: 34760705 DOI: 10.3389/fonc.2021.758856] [Reference Citation Analysis]
386 Cassetta L, Pollard JW. Targeting macrophages: therapeutic approaches in cancer. Nat Rev Drug Discov. 2018;17:887-904. [PMID: 30361552 DOI: 10.1038/nrd.2018.169] [Cited by in Crossref: 427] [Cited by in F6Publishing: 408] [Article Influence: 106.8] [Reference Citation Analysis]
387 Xuan W, Khan F, James CD, Heimberger AB, Lesniak MS, Chen P. Circadian regulation of cancer cell and tumor microenvironment crosstalk. Trends Cell Biol 2021:S0962-8924(21)00124-0. [PMID: 34272133 DOI: 10.1016/j.tcb.2021.06.008] [Reference Citation Analysis]
388 Yang M, Li X, Yoon J. Activatable supramolecular photosensitizers: advanced design strategies. Mater Chem Front 2021;5:1683-93. [DOI: 10.1039/d0qm00827c] [Cited by in Crossref: 2] [Article Influence: 2.0] [Reference Citation Analysis]
389 Fokkelman M, Balcıoğlu HE, Klip JE, Yan K, Verbeek FJ, Danen EH, van de Water B. Cellular adhesome screen identifies critical modulators of focal adhesion dynamics, cellular traction forces and cell migration behaviour. Sci Rep 2016;6:31707. [PMID: 27531518 DOI: 10.1038/srep31707] [Cited by in Crossref: 23] [Cited by in F6Publishing: 21] [Article Influence: 3.8] [Reference Citation Analysis]
390 Sakamoto T, Fukui Y, Kondoh Y, Honda K, Shimizu T, Hara T, Hayashi T, Saitoh Y, Murakami Y, Inoue JI, Kaneko S, Osada H, Seiki M. Pharmacological inhibition of Mint3 attenuates tumour growth, metastasis, and endotoxic shock. Commun Biol 2021;4:1165. [PMID: 34621018 DOI: 10.1038/s42003-021-02701-1] [Reference Citation Analysis]
391 Beaune G, Nagarajan U, Brochard-Wyart F, Winnik FM. Polymeric Nanoparticles Limit the Collective Migration of Cellular Aggregates. Langmuir 2019;35:7396-404. [PMID: 29975543 DOI: 10.1021/acs.langmuir.8b01736] [Cited by in Crossref: 4] [Cited by in F6Publishing: 3] [Article Influence: 1.0] [Reference Citation Analysis]
392 Zavidij O, Haradhvala NJ, Mouhieddine TH, Sklavenitis-Pistofidis R, Cai S, Reidy M, Rahmat M, Flaifel A, Ferland B, Su NK, Agius MP, Park J, Manier S, Bustoros M, Huynh D, Capelletti M, Berrios B, Liu CJ, He MX, Braggio E, Fonseca R, Maruvka Y, Guerriero JL, Goldman M, van Allen E, McCarroll SA, Azzi J, Getz G, Ghobrial IM. Single-cell RNA sequencing reveals compromised immune microenvironment in precursor stages of multiple myeloma. Nat Cancer 2020;1:493-506. [PMID: 33409501 DOI: 10.1038/s43018-020-0053-3] [Cited by in Crossref: 43] [Cited by in F6Publishing: 31] [Article Influence: 21.5] [Reference Citation Analysis]
393 Stella GM, Kolling S, Benvenuti S, Bortolotto C. Lung-Seeking Metastases. Cancers (Basel) 2019;11:E1010. [PMID: 31330946 DOI: 10.3390/cancers11071010] [Cited by in Crossref: 19] [Cited by in F6Publishing: 16] [Article Influence: 6.3] [Reference Citation Analysis]
394 Bannoud N, Dalotto-Moreno T, Kindgard L, García PA, Blidner AG, Mariño KV, Rabinovich GA, Croci DO. Hypoxia Supports Differentiation of Terminally Exhausted CD8 T Cells. Front Immunol 2021;12:660944. [PMID: 34025660 DOI: 10.3389/fimmu.2021.660944] [Cited by in Crossref: 1] [Cited by in F6Publishing: 2] [Article Influence: 1.0] [Reference Citation Analysis]
395 Ueno T, Utsumi J, Toi M, Shimizu K. Characteristic Gene Expression Profiles of Human Fibroblasts and Breast Cancer Cells in a Newly Developed Bilateral Coculture System. Biomed Res Int 2015;2015:960840. [PMID: 26171396 DOI: 10.1155/2015/960840] [Cited by in Crossref: 9] [Cited by in F6Publishing: 10] [Article Influence: 1.3] [Reference Citation Analysis]
396 Shen T, Li Y, Zhu S, Yu J, Zhang B, Chen X, Zhang Z, Ma Y, Niu Y, Shang Z. YAP1 plays a key role of the conversion of normal fibroblasts into cancer-associated fibroblasts that contribute to prostate cancer progression. J Exp Clin Cancer Res 2020;39:36. [PMID: 32066485 DOI: 10.1186/s13046-020-1542-z] [Cited by in Crossref: 8] [Cited by in F6Publishing: 10] [Article Influence: 4.0] [Reference Citation Analysis]
397 Franchi-Mendes T, Lopes N, Brito C. Heterotypic Tumor Spheroids in Agitation-Based Cultures: A Scaffold-Free Cell Model That Sustains Long-Term Survival of Endothelial Cells. Front Bioeng Biotechnol 2021;9:649949. [PMID: 34178955 DOI: 10.3389/fbioe.2021.649949] [Cited by in F6Publishing: 1] [Reference Citation Analysis]
398 Yao M, Ventura PB, Jiang Y, Rodriguez FJ, Wang L, Perry JSA, Yang Y, Wahl K, Crittenden RB, Bennett ML, Qi L, Gong CC, Li XN, Barres BA, Bender TP, Ravichandran KS, Janes KA, Eberhart CG, Zong H. Astrocytic trans-Differentiation Completes a Multicellular Paracrine Feedback Loop Required for Medulloblastoma Tumor Growth. Cell 2020;180:502-520.e19. [PMID: 31983537 DOI: 10.1016/j.cell.2019.12.024] [Cited by in Crossref: 28] [Cited by in F6Publishing: 23] [Article Influence: 14.0] [Reference Citation Analysis]
399 Hegmans JP, Aerts JG. Immunomodulation in cancer. Current Opinion in Pharmacology 2014;17:17-21. [DOI: 10.1016/j.coph.2014.06.007] [Cited by in Crossref: 23] [Cited by in F6Publishing: 22] [Article Influence: 2.9] [Reference Citation Analysis]
400 Liu X, Wang J, Xu W, Ding J, Shi B, Huang K, Zhuang X, Chen X. Glutathione-degradable drug-loaded nanogel effectively and securely suppresses hepatoma in mouse model. Int J Nanomedicine 2015;10:6587-602. [PMID: 26543363 DOI: 10.2147/IJN.S90000] [Cited by in Crossref: 5] [Cited by in F6Publishing: 7] [Article Influence: 0.7] [Reference Citation Analysis]
401 Meng MY, Li L, Wang WJ, Liu FF, Song J, Yang SL, Tan J, Gao H, Zhao YY, Tang WW, Han R, Zhu K, Liao LW, Hou ZL. Assessment of tumor promoting effects of amniotic and umbilical cord mesenchymal stem cells in vitro and in vivo. J Cancer Res Clin Oncol. 2019;145:1133-1146. [PMID: 30805774 DOI: 10.1007/s00432-019-02859-6] [Cited by in Crossref: 11] [Cited by in F6Publishing: 11] [Article Influence: 3.7] [Reference Citation Analysis]
402 Gu M, He T, Yuan Y, Duan S, Li X, Shen C. Single-Cell RNA Sequencing Reveals Multiple Pathways and the Tumor Microenvironment Could Lead to Chemotherapy Resistance in Cervical Cancer. Front Oncol 2021;11:753386. [PMID: 34900703 DOI: 10.3389/fonc.2021.753386] [Reference Citation Analysis]
403 Asare-Werehene M, Nakka K, Reunov A, Chiu CT, Lee WT, Abedini MR, Wang PW, Shieh DB, Dilworth FJ, Carmona E, Le T, Mes-Masson AM, Burger D, Tsang BK. The exosome-mediated autocrine and paracrine actions of plasma gelsolin in ovarian cancer chemoresistance. Oncogene 2020;39:1600-16. [PMID: 31700155 DOI: 10.1038/s41388-019-1087-9] [Cited by in Crossref: 23] [Cited by in F6Publishing: 20] [Article Influence: 7.7] [Reference Citation Analysis]
404 Lei Y, Hamada Y, Li J, Cong L, Wang N, Li Y, Zheng W, Jiang X. Targeted tumor delivery and controlled release of neuronal drugs with ferritin nanoparticles to regulate pancreatic cancer progression. J Control Release 2016;232:131-42. [PMID: 27046157 DOI: 10.1016/j.jconrel.2016.03.023] [Cited by in Crossref: 53] [Cited by in F6Publishing: 49] [Article Influence: 8.8] [Reference Citation Analysis]
405 Endo Y, Wu WJ. Tumor Extrinsic Factors Mediate Primary T-DM1 Resistance in HER2-Positive Breast Cancer Cells. Cancers (Basel) 2021;13:2331. [PMID: 34066157 DOI: 10.3390/cancers13102331] [Reference Citation Analysis]
406 Chen M, Yan C, Zhao X. Research Progress on Circular RNA in Glioma. Front Oncol 2021;11:705059. [PMID: 34745938 DOI: 10.3389/fonc.2021.705059] [Reference Citation Analysis]
407 Elahi M, Ali S, Tahir HM, Mushtaq R, Bhatti MF. Sericin and fibroin nanoparticles—natural product for cancer therapy: a comprehensive review. International Journal of Polymeric Materials and Polymeric Biomaterials 2021;70:256-69. [DOI: 10.1080/00914037.2019.1706515] [Cited by in Crossref: 6] [Cited by in F6Publishing: 2] [Article Influence: 3.0] [Reference Citation Analysis]
408 Firuzi O, Che PP, El Hassouni B, Buijs M, Coppola S, Löhr M, Funel N, Heuchel R, Carnevale I, Schmidt T, Mantini G, Avan A, Saso L, Peters GJ, Giovannetti E. Role of c-MET Inhibitors in Overcoming Drug Resistance in Spheroid Models of Primary Human Pancreatic Cancer and Stellate Cells. Cancers (Basel) 2019;11:E638. [PMID: 31072019 DOI: 10.3390/cancers11050638] [Cited by in Crossref: 20] [Cited by in F6Publishing: 21] [Article Influence: 6.7] [Reference Citation Analysis]
409 Iizuka S, Abdullah C, Buschman MD, Diaz B, Courtneidge SA. The role of Tks adaptor proteins in invadopodia formation, growth and metastasis of melanoma. Oncotarget 2016;7:78473-86. [PMID: 27802184 DOI: 10.18632/oncotarget.12954] [Cited by in Crossref: 25] [Cited by in F6Publishing: 23] [Article Influence: 6.3] [Reference Citation Analysis]
410 Hirakawa Y, Futaki S, Tanizaki H, Furukawa F, Maemura K, Kondo Y, Moriwaki S. Enhanced expression of nidogen 1 around the nest of basal cell carcinoma compared with that around squamous cell carcinoma. Med Mol Morphol 2019;52:99-105. [DOI: 10.1007/s00795-018-0207-x] [Cited by in Crossref: 3] [Cited by in F6Publishing: 3] [Article Influence: 0.8] [Reference Citation Analysis]
411 Umut Ö, Gottschlich A, Endres S, Kobold S. CAR T cell therapy in solid tumors: a short review. Memo 2021;14:143-9. [PMID: 34777609 DOI: 10.1007/s12254-021-00703-7] [Cited by in Crossref: 4] [Article Influence: 4.0] [Reference Citation Analysis]
412 McGovern JA, Shafiee A, Wagner F, Lahr CA, Landgraf M, Meinert C, Williams ED, Russell PJ, Clements JA, Loessner D, Holzapfel BM, Risbridger GP, Hutmacher DW. Humanization of the Prostate Microenvironment Reduces Homing of PC3 Prostate Cancer Cells to Human Tissue-Engineered Bone. Cancers (Basel) 2018;10:E438. [PMID: 30428629 DOI: 10.3390/cancers10110438] [Cited by in Crossref: 10] [Cited by in F6Publishing: 10] [Article Influence: 2.5] [Reference Citation Analysis]
413 Chen X, Shen R, Liu S, Xiao X, Yan J, Zhang Y, Jiang Z, Nie B, Liu J. The sensitive detection of single-cell secreted lactic acid for glycolytic inhibitor screening with a microdroplet biosensor. Anal Methods 2020;12:3250-9. [PMID: 32930188 DOI: 10.1039/d0ay00633e] [Cited by in Crossref: 2] [Article Influence: 1.0] [Reference Citation Analysis]
414 Wan L, Dong H, Xu H, Ma J, Zhu Y, Lu Y, Wang J, Zhang T, Li T, Xie J, Xu B, Xie F, Gao Y, Shao J, Tu X, Jia L. Aspirin, lysine, mifepristone and doxycycline combined can effectively and safely prevent and treat cancer metastasis: prevent seeds from gemmating on soil. Oncotarget 2015;6:35157-72. [PMID: 26459390 DOI: 10.18632/oncotarget.6038] [Cited by in Crossref: 30] [Cited by in F6Publishing: 28] [Article Influence: 5.0] [Reference Citation Analysis]
415 Shen M, Kang Y. pSTAT3+ Reactive Astrocytes Promote Brain Metastasis. Trends Mol Med 2018;24:733-5. [PMID: 30029985 DOI: 10.1016/j.molmed.2018.07.002] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 0.3] [Reference Citation Analysis]
416 Wang Y, Fu M, Liu J, Yang Y, Yu Y, Li J, Pan W, Fan L, Li G, Li X, Wang X. Inhibition of tumor metastasis by targeted daunorubicin and dioscin codelivery liposomes modified with PFV for the treatment of non-small-cell lung cancer. Int J Nanomedicine 2019;14:4071-90. [PMID: 31239668 DOI: 10.2147/IJN.S194304] [Cited by in Crossref: 18] [Cited by in F6Publishing: 14] [Article Influence: 6.0] [Reference Citation Analysis]
417 Falasca M, Casari I, Maffucci T. Cancer chemoprevention with nuts. J Natl Cancer Inst 2014;106:dju238. [PMID: 25210199 DOI: 10.1093/jnci/dju238] [Cited by in Crossref: 32] [Cited by in F6Publishing: 24] [Article Influence: 4.0] [Reference Citation Analysis]
418 Deng Z, Wu J, Xu S, Chen F, Zhang Z, Jin A, Wang J. Exosomes-microRNAs interacted with gastric cancer and its microenvironment: a mini literature review. Biomark Med 2020;14:141-50. [PMID: 32064893 DOI: 10.2217/bmm-2019-0387] [Cited by in Crossref: 1] [Cited by in F6Publishing: 3] [Article Influence: 0.5] [Reference Citation Analysis]
419 Cabanos HF, Hata AN. Emerging Insights into Targeted Therapy-Tolerant Persister Cells in Cancer. Cancers (Basel) 2021;13:2666. [PMID: 34071428 DOI: 10.3390/cancers13112666] [Reference Citation Analysis]
420 Fu Y, Liu S, Yin S, Niu W, Xiong W, Tan M, Li G, Zhou M. The reverse Warburg effect is likely to be an Achilles' heel of cancer that can be exploited for cancer therapy. Oncotarget 2017;8:57813-25. [PMID: 28915713 DOI: 10.18632/oncotarget.18175] [Cited by in Crossref: 105] [Cited by in F6Publishing: 100] [Article Influence: 21.0] [Reference Citation Analysis]
421 Bird RP. The Emerging Role of Vitamin B6 in Inflammation and Carcinogenesis. New Research and Developments of Water-Soluble Vitamins. Elsevier; 2018. pp. 151-94. [DOI: 10.1016/bs.afnr.2017.11.004] [Cited by in Crossref: 18] [Cited by in F6Publishing: 12] [Article Influence: 4.5] [Reference Citation Analysis]
422 Rambow F, Marine JC, Goding CR. Melanoma plasticity and phenotypic diversity: therapeutic barriers and opportunities. Genes Dev 2019;33:1295-318. [PMID: 31575676 DOI: 10.1101/gad.329771.119] [Cited by in Crossref: 68] [Cited by in F6Publishing: 56] [Article Influence: 22.7] [Reference Citation Analysis]
423 Maurya SK, Khan P, Rehman AU, Kanchan RK, Perumal N, Mahapatra S, Chand HS, Santamaria-Barria JA, Batra SK, Nasser MW. Rethinking the chemokine cascade in brain metastasis: Preventive and therapeutic implications. Semin Cancer Biol 2021:S1044-579X(21)00302-3. [PMID: 34968667 DOI: 10.1016/j.semcancer.2021.12.009] [Reference Citation Analysis]
424 Anfray C, Mainini F, Andón FT. Nanoparticles for immunotherapy. Colloids for Nanobiotechnology - Synthesis, Characterization and Potential Applications. Elsevier; 2020. pp. 265-306. [DOI: 10.1016/b978-0-08-102828-5.00011-5] [Cited by in Crossref: 3] [Article Influence: 1.5] [Reference Citation Analysis]
425 Guo J, Yan Y, Yan Y, Guo Q, Zhang M, Zhang J, Goltzman D. Tumor-associated macrophages induce the expression of FOXQ1 to promote epithelial-mesenchymal transition and metastasis in gastric cancer cells. Oncol Rep 2017;38:2003-10. [PMID: 28791370 DOI: 10.3892/or.2017.5877] [Cited by in Crossref: 9] [Cited by in F6Publishing: 12] [Article Influence: 1.8] [Reference Citation Analysis]
426 Yu J, Wang Q, Zhang X, Guo Z, Cui X. Mechanisms of Neoantigen-Targeted Induction of Pyroptosis and Ferroptosis: From Basic Research to Clinical Applications. Front Oncol 2021;11:685377. [PMID: 34123855 DOI: 10.3389/fonc.2021.685377] [Reference Citation Analysis]
427 Shrestha B, Wang L, Brey EM, Uribe GR, Tang L. Smart Nanoparticles for Chemo-Based Combinational Therapy. Pharmaceutics 2021;13:853. [PMID: 34201333 DOI: 10.3390/pharmaceutics13060853] [Reference Citation Analysis]
428 Piro G, Simionato F, Carbone C, Frizziero M, Malleo G, Zanini S, Casolino R, Santoro R, Mina MM, Zecchetto C, Merz V, Scarpa A, Bassi C, Tortora G, Melisi D. A circulating TH2 cytokines profile predicts survival in patients with resectable pancreatic adenocarcinoma. Oncoimmunology 2017;6:e1322242. [PMID: 28932629 DOI: 10.1080/2162402X.2017.1322242] [Cited by in Crossref: 20] [Cited by in F6Publishing: 15] [Article Influence: 4.0] [Reference Citation Analysis]
429 Meng L, Tian Z, Wang J, Liu X, Zhang W, Hu M, Wang M, Zhang Y. Effect of myeloid ecotropic viral integration site (MEIS) family genes on tumor microenvironment remodeling and its potential therapeutic effect. Transl Androl Urol 2021;10:594-608. [PMID: 33718062 DOI: 10.21037/tau-20-1163] [Reference Citation Analysis]
430 Wondimu A, Liu Y, Su Y, Bobb D, Ma JS, Chakrabarti L, Radoja S, Ladisch S. Gangliosides drive the tumor infiltration and function of myeloid-derived suppressor cells. Cancer Res 2014;74:5449-57. [PMID: 25115301 DOI: 10.1158/0008-5472.CAN-14-0927] [Cited by in Crossref: 25] [Cited by in F6Publishing: 9] [Article Influence: 3.1] [Reference Citation Analysis]
431 Harano K, Kogawa T, Wu J, Yuan Y, Cohen EN, Lim B, Reuben JM, Ueno NT. Thrombocytosis as a prognostic factor in inflammatory breast cancer. Breast Cancer Res Treat 2017;166:819-32. [PMID: 28831670 DOI: 10.1007/s10549-017-4463-6] [Cited by in Crossref: 6] [Cited by in F6Publishing: 8] [Article Influence: 1.2] [Reference Citation Analysis]
432 Kuwada K, Kagawa S, Yoshida R, Sakamoto S, Ito A, Watanabe M, Ieda T, Kuroda S, Kikuchi S, Tazawa H, Fujiwara T. The epithelial-to-mesenchymal transition induced by tumor-associated macrophages confers chemoresistance in peritoneally disseminated pancreatic cancer. J Exp Clin Cancer Res 2018;37:307. [PMID: 30537992 DOI: 10.1186/s13046-018-0981-2] [Cited by in Crossref: 39] [Cited by in F6Publishing: 38] [Article Influence: 9.8] [Reference Citation Analysis]
433 Sasaki S, Baba T, Nishimura T, Hayakawa Y, Hashimoto S, Gotoh N, Mukaida N. Essential roles of the interaction between cancer cell-derived chemokine, CCL4, and intra-bone CCR5-expressing fibroblasts in breast cancer bone metastasis. Cancer Lett 2016;378:23-32. [PMID: 27177471 DOI: 10.1016/j.canlet.2016.05.005] [Cited by in Crossref: 34] [Cited by in F6Publishing: 31] [Article Influence: 5.7] [Reference Citation Analysis]
434 Chen Y, Zeng C, Zhan Y, Wang H, Jiang X, Li W. Aberrant low expression of p85α in stromal fibroblasts promotes breast cancer cell metastasis through exosome-mediated paracrine Wnt10b. Oncogene 2017;36:4692-705. [PMID: 28394344 DOI: 10.1038/onc.2017.100] [Cited by in Crossref: 55] [Cited by in F6Publishing: 56] [Article Influence: 11.0] [Reference Citation Analysis]
435 García-Hevia L, Villegas JC, Fernández F, Casafont Í, González J, Valiente R, Fanarraga ML. Multiwalled Carbon Nanotubes Inhibit Tumor Progression in a Mouse Model. Adv Healthc Mater 2016;5:1080-7. [PMID: 26866927 DOI: 10.1002/adhm.201500753] [Cited by in Crossref: 21] [Cited by in F6Publishing: 22] [Article Influence: 3.5] [Reference Citation Analysis]
436 Ahn H, Kwon HJ, Park E, Kim H, Chung JH. Osteosarcomatous Differentiation in Rebiopsy Specimens of Pulmonary Adenocarcinoma with EGFR-TKI Resistance. J Pathol Transl Med 2018;52:130-2. [PMID: 28372343 DOI: 10.4132/jptm.2016.11.17] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 0.2] [Reference Citation Analysis]
437 Shamoun L, Landerholm K, Balboa Ramilo A, Andersson RE, Dimberg J, Wågsäter D. Association of gene and protein expression and genetic polymorphism of CC chemokine ligand 4 in colorectal cancer. World J Gastroenterol 2021; 27(30): 5076-5087 [PMID: 34497436 DOI: 10.3748/wjg.v27.i30.5076] [Reference Citation Analysis]
438 Aboushousha T, Hammam O, Safwat G, Eesa A, Ahmed S, Esmat ME, Helmy AH. Differential Expression of RAGE, EGFR and Ki-67 in Primary Tumors and Lymph Node Deposits of Breast Carcinoma. Asian Pac J Cancer Prev 2018;19:2269-77. [PMID: 30139236 DOI: 10.22034/APJCP.2018.19.8.2269] [Reference Citation Analysis]
439 Xiang Q, Dong S, Li XH. A Review of Phosphocreatine 3 Kinase δ Subtype (PI3Kδ) and Its Inhibitors in Malignancy. Med Sci Monit 2021;27:e932772. [PMID: 34625526 DOI: 10.12659/MSM.932772] [Reference Citation Analysis]
440 Kzhyshkowska J, Larionova I, Liu T. YKL-39 as a Potential New Target for Anti-Angiogenic Therapy in Cancer. Front Immunol 2019;10:2930. [PMID: 32038607 DOI: 10.3389/fimmu.2019.02930] [Cited by in Crossref: 6] [Cited by in F6Publishing: 6] [Article Influence: 3.0] [Reference Citation Analysis]
441 Kumamoto K, Tasaki T, Ohnishi K, Shibata M, Shimajiri S, Harada M, Komohara Y, Nakayama T. CD169 Expression on Lymph Node Macrophages Predicts in Patients With Gastric Cancer. Front Oncol 2021;11:636751. [PMID: 33816277 DOI: 10.3389/fonc.2021.636751] [Cited by in Crossref: 1] [Article Influence: 1.0] [Reference Citation Analysis]
442 Caron JM, Han X, Contois L, Vary CPH, Brooks PC. The HU177 Collagen Epitope Controls Melanoma Cell Migration and Experimental Metastasis by a CDK5/YAP-Dependent Mechanism. Am J Pathol 2018;188:2356-68. [PMID: 30118657 DOI: 10.1016/j.ajpath.2018.06.017] [Cited by in Crossref: 3] [Cited by in F6Publishing: 4] [Article Influence: 0.8] [Reference Citation Analysis]
443 Coughlin TR, Romero-Moreno R, Mason DE, Nystrom L, Boerckel JD, Niebur G, Littlepage LE. Bone: A Fertile Soil for Cancer Metastasis. Curr Drug Targets 2017;18:1281-95. [PMID: 28025941 DOI: 10.2174/1389450117666161226121650] [Cited by in Crossref: 11] [Cited by in F6Publishing: 15] [Article Influence: 2.8] [Reference Citation Analysis]
444 Xiang S, Li J, Shen J, Zhao Y, Wu X, Li M, Yang X, Kaboli PJ, Du F, Zheng Y, Wen Q, Cho CH, Yi T, Xiao Z. Identification of Prognostic Genes in the Tumor Microenvironment of Hepatocellular Carcinoma. Front Immunol 2021;12:653836. [PMID: 33897701 DOI: 10.3389/fimmu.2021.653836] [Cited by in F6Publishing: 1] [Reference Citation Analysis]
445 Luanpitpong S, Wang L, Castranova V, Dinu CZ, Issaragrisil S, Chen YC, Rojanasakul Y. Induction of cancer-associated fibroblast-like cells by carbon nanotubes dictates its tumorigenicity. Sci Rep 2016;6:39558. [PMID: 27996035 DOI: 10.1038/srep39558] [Cited by in Crossref: 9] [Cited by in F6Publishing: 9] [Article Influence: 1.5] [Reference Citation Analysis]
446 Lebdai S, Gigoux M, Alvim R, Somma A, Nagar K, Azzouzi AR, Cussenot O, Merghoub T, Wolchok JD, Scherz A, Kim K, Coleman J. Potentiating vascular-targeted photodynamic therapy through CSF-1R modulation of myeloid cells in a preclinical model of prostate cancer. Oncoimmunology 2019;8:e1581528. [PMID: 31069149 DOI: 10.1080/2162402X.2019.1581528] [Cited by in Crossref: 9] [Cited by in F6Publishing: 5] [Article Influence: 3.0] [Reference Citation Analysis]
447 Lei JJ, Peng RJ, Kuang BH, Yuan ZY, Qin T, Liu WS, Guo YM, Han HQ, Lian YF, Deng CC, Zhang HJ, Chen LZ, Feng QS, Xu M, Feng L, Bei JX, Zeng YX. NOP14 suppresses breast cancer progression by inhibiting NRIP1/Wnt/β-catenin pathway. Oncotarget 2015;6:25701-14. [PMID: 26213846 DOI: 10.18632/oncotarget.4573] [Cited by in Crossref: 15] [Cited by in F6Publishing: 15] [Article Influence: 2.5] [Reference Citation Analysis]
448 Qiu Q, Lin Y, Ma Y, Li X, Liang J, Chen Z, Liu K, Huang Y, Luo H, Huang R, Luo L. Exploring the Emerging Role of the Gut Microbiota and Tumor Microenvironment in Cancer Immunotherapy. Front Immunol 2020;11:612202. [PMID: 33488618 DOI: 10.3389/fimmu.2020.612202] [Cited by in Crossref: 8] [Cited by in F6Publishing: 8] [Article Influence: 8.0] [Reference Citation Analysis]
449 Rezaie J, Ahmadi M, Ravanbakhsh R, Mojarad B, Mahbubfam S, Shaban SA, Shadi K, Berenjabad NJ, Etemadi T. Tumor-derived extracellular vesicles: The metastatic organotropism drivers. Life Sci 2021;289:120216. [PMID: 34890589 DOI: 10.1016/j.lfs.2021.120216] [Reference Citation Analysis]
450 Wang Y, Wang J, Yang C, Wang Y, Liu J, Shi Z, Chen Y, Feng Y, Ma X, Qiao S. A study of the correlation between M2 macrophages and lymph node metastasis of colorectal carcinoma. World J Surg Oncol 2021;19:91. [PMID: 33781288 DOI: 10.1186/s12957-021-02195-5] [Reference Citation Analysis]
451 Messeha SS, Zarmouh NO, Soliman KFA. Polyphenols Modulating Effects of PD-L1/PD-1 Checkpoint and EMT-Mediated PD-L1 Overexpression in Breast Cancer. Nutrients 2021;13:1718. [PMID: 34069461 DOI: 10.3390/nu13051718] [Cited by in F6Publishing: 1] [Reference Citation Analysis]
452 Klymenko Y, Nephew KP. Epigenetic Crosstalk between the Tumor Microenvironment and Ovarian Cancer Cells: A Therapeutic Road Less Traveled. Cancers (Basel) 2018;10:E295. [PMID: 30200265 DOI: 10.3390/cancers10090295] [Cited by in Crossref: 24] [Cited by in F6Publishing: 22] [Article Influence: 6.0] [Reference Citation Analysis]
453 Bi J, Wu S, Zhang W, Mischel PS. Targeting cancer's metabolic co-dependencies: A landscape shaped by genotype and tissue context. Biochim Biophys Acta Rev Cancer 2018;1870:76-87. [PMID: 29775654 DOI: 10.1016/j.bbcan.2018.05.002] [Cited by in Crossref: 10] [Cited by in F6Publishing: 11] [Article Influence: 2.5] [Reference Citation Analysis]
454 Tang T, Zhu Q, Li X, Zhu G, Deng S, Wang Y, Ni L, Chen X, Zhang Y, Xia T, Zen K, Pan Y, Jin L. Protease Nexin I is a feedback regulator of EGF/PKC/MAPK/EGR1 signaling in breast cancer cells metastasis and stemness. Cell Death Dis 2019;10:649. [PMID: 31501409 DOI: 10.1038/s41419-019-1882-9] [Cited by in Crossref: 8] [Cited by in F6Publishing: 10] [Article Influence: 2.7] [Reference Citation Analysis]
455 Hayashi M, Yamamoto Y, Sueta A, Tomiguchi M, Yamamoto-Ibusuki M, Kawasoe T, Hamada A, Iwase H. Associations Between Elastography Findings and Clinicopathological Factors in Breast Cancer. Medicine (Baltimore) 2015;94:e2290. [PMID: 26683963 DOI: 10.1097/MD.0000000000002290] [Cited by in Crossref: 13] [Cited by in F6Publishing: 2] [Article Influence: 2.2] [Reference Citation Analysis]
456 Zhu J, Luo C, Zhao J, Zhu X, Lin K, Bu F, Yu Z, Zou F, Zhu Z. Expression of LOX Suggests Poor Prognosis in Gastric Cancer. Front Med (Lausanne) 2021;8:718986. [PMID: 34595188 DOI: 10.3389/fmed.2021.718986] [Reference Citation Analysis]
457 Zhang J, Jiang M, Qian L, Lin X, Song W, Gao Y, Zhou Y. The STAT3-miR-223-TGFBR3/HMGCS1 axis modulates the progression of cervical carcinoma. Mol Oncol 2020;14:2313-31. [PMID: 32491253 DOI: 10.1002/1878-0261.12737] [Cited by in Crossref: 5] [Cited by in F6Publishing: 6] [Article Influence: 2.5] [Reference Citation Analysis]
458 Cardin LT, Prates J, da Cunha BR, Tajara EH, Oliani SM, Rodrigues-Lisoni FC. Annexin A1 peptide and endothelial cell-conditioned medium modulate cervical tumorigenesis. FEBS Open Bio 2019;9:668-81. [PMID: 30984541 DOI: 10.1002/2211-5463.12603] [Cited by in Crossref: 3] [Cited by in F6Publishing: 3] [Article Influence: 1.0] [Reference Citation Analysis]
459 Chauhan A, Khan T, Omri A. Design and Encapsulation of Immunomodulators onto Gold Nanoparticles in Cancer Immunotherapy. Int J Mol Sci 2021;22:8037. [PMID: 34360803 DOI: 10.3390/ijms22158037] [Reference Citation Analysis]
460 Khalaf K, Hana D, Chou JT, Singh C, Mackiewicz A, Kaczmarek M. Aspects of the Tumor Microenvironment Involved in Immune Resistance and Drug Resistance. Front Immunol 2021;12:656364. [PMID: 34122412 DOI: 10.3389/fimmu.2021.656364] [Cited by in Crossref: 3] [Cited by in F6Publishing: 5] [Article Influence: 3.0] [Reference Citation Analysis]
461 Shi J, Kantoff PW, Wooster R, Farokhzad OC. Cancer nanomedicine: progress, challenges and opportunities. Nat Rev Cancer. 2017;17:20-37. [PMID: 27834398 DOI: 10.1038/nrc.2016.108] [Cited by in Crossref: 2374] [Cited by in F6Publishing: 2174] [Article Influence: 395.7] [Reference Citation Analysis]
462 Schulz M, Salamero-Boix A, Niesel K, Alekseeva T, Sevenich L. Microenvironmental Regulation of Tumor Progression and Therapeutic Response in Brain Metastasis. Front Immunol 2019;10:1713. [PMID: 31396225 DOI: 10.3389/fimmu.2019.01713] [Cited by in Crossref: 41] [Cited by in F6Publishing: 43] [Article Influence: 13.7] [Reference Citation Analysis]
463 Kim MJ, Sun HJ, Song YS, Yoo SK, Kim YA, Seo JS, Park YJ, Cho SW. CXCL16 positively correlated with M2-macrophage infiltration, enhanced angiogenesis, and poor prognosis in thyroid cancer. Sci Rep 2019;9:13288. [PMID: 31527616 DOI: 10.1038/s41598-019-49613-z] [Cited by in Crossref: 17] [Cited by in F6Publishing: 15] [Article Influence: 5.7] [Reference Citation Analysis]
464 Mao Y, Wang X, Huang P, Tian R. Spatial proteomics for understanding the tissue microenvironment. Analyst 2021;146:3777-98. [PMID: 34042124 DOI: 10.1039/d1an00472g] [Reference Citation Analysis]
465 Liu J, Wang Y, Qiu Z, Lv G, Huang X, Lin H, Lin Z, Qu P. Impact of TCM on Tumor-Infiltrating Myeloid Precursors in the Tumor Microenvironment. Front Cell Dev Biol 2021;9:635122. [PMID: 33748122 DOI: 10.3389/fcell.2021.635122] [Reference Citation Analysis]
466 Zhang P, Zhai Y, Cai Y, Zhao Y, Li Y. Nanomedicine-Based Immunotherapy for the Treatment of Cancer Metastasis. Adv Mater 2019;31:e1904156. [PMID: 31566275 DOI: 10.1002/adma.201904156] [Cited by in Crossref: 53] [Cited by in F6Publishing: 39] [Article Influence: 17.7] [Reference Citation Analysis]
467 Liu Y, Wu Y, Zhang P, Xu C, Liu Z, He C, Liu Y, Kang Z. CXCL12 and CD3E as Indicators for Tumor Microenvironment Modulation in Bladder Cancer and Their Correlations With Immune Infiltration and Molecular Subtypes. Front Oncol 2021;11:636870. [PMID: 33747959 DOI: 10.3389/fonc.2021.636870] [Cited by in Crossref: 2] [Cited by in F6Publishing: 3] [Article Influence: 2.0] [Reference Citation Analysis]
468 Boeri M, Milione M, Proto C, Signorelli D, Lo Russo G, Galeone C, Verri C, Mensah M, Centonze G, Martinetti A, Sottotetti E, Pastorino U, Garassino MC, Sozzi G. Circulating miRNAs and PD-L1 Tumor Expression Are Associated with Survival in Advanced NSCLC Patients Treated with Immunotherapy: a Prospective Study. Clin Cancer Res 2019;25:2166-73. [PMID: 30617131 DOI: 10.1158/1078-0432.CCR-18-1981] [Cited by in Crossref: 31] [Cited by in F6Publishing: 20] [Article Influence: 10.3] [Reference Citation Analysis]
469 Lambert AW, Pattabiraman DR, Weinberg RA. Emerging Biological Principles of Metastasis. Cell. 2017;168:670-691. [PMID: 28187288 DOI: 10.1016/j.cell.2016.11.037] [Cited by in Crossref: 1131] [Cited by in F6Publishing: 1055] [Article Influence: 226.2] [Reference Citation Analysis]
470 Laubach JP, Liu CJ, Raje NS, Yee AJ, Armand P, Schlossman RL, Rosenblatt J, Hedlund J, Martin M, Reynolds C, Shain KH, Zackon I, Stampleman L, Henrick P, Rivotto B, Hornburg KTV, Dumke HJ, Chuma S, Savell A, Handisides DR, Kroll S, Anderson KC, Richardson PG, Ghobrial IM. A Phase I/II Study of Evofosfamide, A Hypoxia-activated Prodrug with or without Bortezomib in Subjects with Relapsed/Refractory Multiple Myeloma. Clin Cancer Res 2019;25:478-86. [PMID: 30279233 DOI: 10.1158/1078-0432.CCR-18-1325] [Cited by in Crossref: 19] [Cited by in F6Publishing: 10] [Article Influence: 4.8] [Reference Citation Analysis]
471 Liu S, Sun X, Li K, Zha R, Feng Y, Sano T, Dong C, Liu Y, Aryal UK, Sudo A, Li BY, Yokota H. Generation of the tumor-suppressive secretome from tumor cells. Theranostics 2021;11:8517-34. [PMID: 34373756 DOI: 10.7150/thno.61006] [Reference Citation Analysis]
472 Barbarisi M, Iaffaioli RV, Armenia E, Schiavo L, De Sena G, Tafuto S, Barbarisi A, Quagliariello V. Novel nanohydrogel of hyaluronic acid loaded with quercetin alone and in combination with temozolomide as new therapeutic tool, CD44 targeted based, of glioblastoma multiforme. J Cell Physiol 2018;233:6550-64. [PMID: 29030990 DOI: 10.1002/jcp.26238] [Cited by in Crossref: 18] [Cited by in F6Publishing: 18] [Article Influence: 4.5] [Reference Citation Analysis]
473 Armstrong D, Chang CY, Lazarus DR, Corry D, Kheradmand F. Lung Cancer Heterogeneity in Modulation of Th17/IL17A Responses. Front Oncol 2019;9:1384. [PMID: 31921642 DOI: 10.3389/fonc.2019.01384] [Cited by in Crossref: 3] [Cited by in F6Publishing: 4] [Article Influence: 1.0] [Reference Citation Analysis]
474 Vaisitti T, Arruga F, Deaglio S. Targeting the Adenosinergic Axis in Chronic Lymphocytic Leukemia: A Way to Disrupt the Tumor Niche? Int J Mol Sci 2018;19:E1167. [PMID: 29649100 DOI: 10.3390/ijms19041167] [Cited by in Crossref: 2] [Cited by in F6Publishing: 2] [Article Influence: 0.5] [Reference Citation Analysis]
475 Vizovisek M, Ristanovic D, Menghini S, Christiansen MG, Schuerle S. The Tumor Proteolytic Landscape: A Challenging Frontier in Cancer Diagnosis and Therapy. Int J Mol Sci 2021;22:2514. [PMID: 33802262 DOI: 10.3390/ijms22052514] [Cited by in Crossref: 2] [Cited by in F6Publishing: 2] [Article Influence: 2.0] [Reference Citation Analysis]
476 Ben Baruch B, Blacher E, Mantsur E, Schwartz H, Vaknine H, Erez N, Stein R. Stromal CD38 regulates outgrowth of primary melanoma and generation of spontaneous metastasis. Oncotarget 2018;9:31797-811. [PMID: 30159123 DOI: 10.18632/oncotarget.25737] [Cited by in Crossref: 7] [Cited by in F6Publishing: 8] [Article Influence: 1.8] [Reference Citation Analysis]
477 Soukup K, Halfmann A, Dillinger B, Poyer F, Martin K, Blauensteiner B, Kauer M, Kuttke M, Schabbauer G, Dohnal AM. Loss of MAPK-activated protein kinase 2 enables potent dendritic cell-driven anti-tumour T cell response. Sci Rep 2017;7:11746. [PMID: 28924177 DOI: 10.1038/s41598-017-12208-7] [Cited by in Crossref: 5] [Cited by in F6Publishing: 5] [Article Influence: 1.0] [Reference Citation Analysis]
478 Du XX, He C, Lu X, Guo YL, Chen ZH, Cai LJ. YAP/STAT3 promotes the immune escape of larynx carcinoma by activating VEGFR1-TGFβ signaling to facilitate PD-L1 expression in M2-like TAMs. Exp Cell Res 2021;405:112655. [PMID: 34044017 DOI: 10.1016/j.yexcr.2021.112655] [Reference Citation Analysis]
479 Yang Z, Zhang M, Peng R, Liu J, Wang F, Li Y, Zhao Q, Liu J. The prognostic and clinicopathological value of tumor-associated macrophages in patients with colorectal cancer: a systematic review and meta-analysis. Int J Colorectal Dis 2020;35:1651-61. [PMID: 32666290 DOI: 10.1007/s00384-020-03686-9] [Cited by in Crossref: 5] [Cited by in F6Publishing: 7] [Article Influence: 2.5] [Reference Citation Analysis]
480 Vivacqua A, Muoio MG, Miglietta AM, Maggiolini M. Differential MicroRNA Landscape Triggered by Estrogens in Cancer Associated Fibroblasts (CAFs) of Primary and Metastatic Breast Tumors. Cancers (Basel) 2019;11:E412. [PMID: 30909585 DOI: 10.3390/cancers11030412] [Cited by in Crossref: 10] [Cited by in F6Publishing: 9] [Article Influence: 3.3] [Reference Citation Analysis]
481 Ngambenjawong C, Gustafson HH, Pun SH. Progress in tumor-associated macrophage (TAM)-targeted therapeutics. Adv Drug Deliv Rev 2017;114:206-21. [PMID: 28449873 DOI: 10.1016/j.addr.2017.04.010] [Cited by in Crossref: 168] [Cited by in F6Publishing: 177] [Article Influence: 33.6] [Reference Citation Analysis]
482 Byrne NM, Tambe P, Coulter JA. Radiation Response in the Tumour Microenvironment: Predictive Biomarkers and Future Perspectives. J Pers Med 2021;11:53. [PMID: 33467153 DOI: 10.3390/jpm11010053] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 1.0] [Reference Citation Analysis]
483 Smith BN, Bhowmick NA. Role of EMT in Metastasis and Therapy Resistance. J Clin Med 2016;5:E17. [PMID: 26828526 DOI: 10.3390/jcm5020017] [Cited by in Crossref: 227] [Cited by in F6Publishing: 226] [Article Influence: 37.8] [Reference Citation Analysis]
484 Zhu X, Zhong J, Zhao Z, Sheng J, Wang J, Liu J, Cui K, Chang J, Zhao H, Wong S. Epithelial derived CTGF promotes breast tumor progression via inducing EMT and collagen I fibers deposition. Oncotarget 2015;6:25320-38. [PMID: 26318291 DOI: 10.18632/oncotarget.4659] [Cited by in Crossref: 22] [Cited by in F6Publishing: 21] [Article Influence: 3.7] [Reference Citation Analysis]
485 Parayath N, Padmakumar S, Nair SV, Menon D, Amiji MM. Strategies for Targeting Cancer Immunotherapy Through Modulation of the Tumor Microenvironment. Regen Eng Transl Med 2020;6:29-49. [DOI: 10.1007/s40883-019-00113-6] [Cited by in Crossref: 6] [Cited by in F6Publishing: 2] [Article Influence: 2.0] [Reference Citation Analysis]
486 Ma A, Fan D, Yan F. A study of the application of TAP combined with transvaginal ultrasound in the diagnosis of early-stage endometrial cancer. Oncol Lett 2018;16:5186-90. [PMID: 30250586 DOI: 10.3892/ol.2018.9250] [Cited by in Crossref: 2] [Cited by in F6Publishing: 3] [Article Influence: 0.5] [Reference Citation Analysis]
487 Dean KM, Palmer AE. Advances in fluorescence labeling strategies for dynamic cellular imaging. Nat Chem Biol 2014;10:512-23. [PMID: 24937069 DOI: 10.1038/nchembio.1556] [Cited by in Crossref: 295] [Cited by in F6Publishing: 262] [Article Influence: 36.9] [Reference Citation Analysis]
488 Reznik E, Luna A, Aksoy BA, Liu EM, La K, Ostrovnaya I, Creighton CJ, Hakimi AA, Sander C. A Landscape of Metabolic Variation across Tumor Types. Cell Syst 2018;6:301-313.e3. [PMID: 29396322 DOI: 10.1016/j.cels.2017.12.014] [Cited by in Crossref: 52] [Cited by in F6Publishing: 54] [Article Influence: 13.0] [Reference Citation Analysis]
489 Benito-Martin A, Di Giannatale A, Ceder S, Peinado H. The new deal: a potential role for secreted vesicles in innate immunity and tumor progression. Front Immunol 2015;6:66. [PMID: 25759690 DOI: 10.3389/fimmu.2015.00066] [Cited by in Crossref: 64] [Cited by in F6Publishing: 66] [Article Influence: 9.1] [Reference Citation Analysis]
490 Wu H, Liu L, Song L, Ma M, Gu N, Zhang Y. Enhanced Tumor Synergistic Therapy by Injectable Magnetic Hydrogel Mediated Generation of Hyperthermia and Highly Toxic Reactive Oxygen Species. ACS Nano 2019;13:14013-23. [DOI: 10.1021/acsnano.9b06134] [Cited by in Crossref: 51] [Cited by in F6Publishing: 31] [Article Influence: 17.0] [Reference Citation Analysis]
491 Gong F, Yang N, Wang X, Zhao Q, Chen Q, Liu Z, Cheng L. Tumor microenvironment-responsive intelligent nanoplatforms for cancer theranostics. Nano Today 2020;32:100851. [DOI: 10.1016/j.nantod.2020.100851] [Cited by in Crossref: 68] [Cited by in F6Publishing: 38] [Article Influence: 34.0] [Reference Citation Analysis]
492 Okano M, Oshi M, Butash A, Okano I, Saito K, Kawaguchi T, Nagahashi M, Kono K, Ohtake T, Takabe K. Orthotopic Implantation Achieves Better Engraftment and Faster Growth Than Subcutaneous Implantation in Breast Cancer Patient-Derived Xenografts. J Mammary Gland Biol Neoplasia 2020;25:27-36. [PMID: 32109311 DOI: 10.1007/s10911-020-09442-7] [Cited by in Crossref: 5] [Cited by in F6Publishing: 5] [Article Influence: 2.5] [Reference Citation Analysis]
493 Peng L, Hayatullah G, Zhou H, Chang S, Liu L, Qiu H, Duan X, Han L. Tumor microenvironment characterization in cervical cancer identifies prognostic relevant gene signatures. PLoS One 2021;16:e0249374. [PMID: 33901225 DOI: 10.1371/journal.pone.0249374] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 1.0] [Reference Citation Analysis]
494 Bergström SH, Rudolfsson SH, Bergh A. Rat Prostate Tumor Cells Progress in the Bone Microenvironment to a Highly Aggressive Phenotype. Neoplasia 2016;18:152-61. [PMID: 26992916 DOI: 10.1016/j.neo.2016.01.007] [Cited by in Crossref: 3] [Cited by in F6Publishing: 3] [Article Influence: 0.5] [Reference Citation Analysis]
495 Parascandolo A, Bonavita R, Astaburuaga R, Sciuto A, Reggio S, Barra E, Corcione F, Salvatore M, Mazzoccoli G, Relógio A, Laukkanen MO. Effect of naive and cancer-educated fibroblasts on colon cancer cell circadian growth rhythm. Cell Death Dis 2020;11:289. [PMID: 32341349 DOI: 10.1038/s41419-020-2468-2] [Cited by in Crossref: 2] [Cited by in F6Publishing: 1] [Article Influence: 1.0] [Reference Citation Analysis]
496 Høye AM, Erler JT. Structural ECM components in the premetastatic and metastatic niche. Am J Physiol Cell Physiol 2016;310:C955-67. [PMID: 27053524 DOI: 10.1152/ajpcell.00326.2015] [Cited by in Crossref: 50] [Cited by in F6Publishing: 48] [Article Influence: 8.3] [Reference Citation Analysis]
497 Gao D, Cazares LH, Fish EN. CCL5-CCR5 interactions modulate metabolic events during tumor onset to promote tumorigenesis. BMC Cancer 2017;17:834. [PMID: 29216863 DOI: 10.1186/s12885-017-3817-0] [Cited by in Crossref: 26] [Cited by in F6Publishing: 26] [Article Influence: 5.2] [Reference Citation Analysis]
498 Wang L, Kang FB, Sun N, Wang J, Chen W, Li D, Shan BE. The tumor suppressor miR-124 inhibits cell proliferation and invasion by targeting B7-H3 in osteosarcoma. Tumour Biol 2016;37:14939-47. [PMID: 27644254 DOI: 10.1007/s13277-016-5386-2] [Cited by in Crossref: 30] [Cited by in F6Publishing: 31] [Article Influence: 5.0] [Reference Citation Analysis]
499 Suzuki HI, Katsura A, Matsuyama H, Miyazono K. MicroRNA regulons in tumor microenvironment. Oncogene 2015;34:3085-94. [PMID: 25132266 DOI: 10.1038/onc.2014.254] [Cited by in Crossref: 111] [Cited by in F6Publishing: 113] [Article Influence: 13.9] [Reference Citation Analysis]
500 Fares J, Ulasov I, Timashev P, Lesniak MS. Emerging principles of brain immunology and immune checkpoint blockade in brain metastases. Brain 2021;144:1046-66. [PMID: 33893488 DOI: 10.1093/brain/awab012] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 1.0] [Reference Citation Analysis]
501 Nguyen PM, Abdirahman SM, Putoczki TL. Emerging roles for Interleukin-11 in disease. Growth Factors 2019;37:1-11. [PMID: 31161823 DOI: 10.1080/08977194.2019.1620227] [Cited by in Crossref: 10] [Cited by in F6Publishing: 11] [Article Influence: 3.3] [Reference Citation Analysis]
502 Erejuwa OO, Sulaiman SA, Wahab MS. Effects of honey and its mechanisms of action on the development and progression of cancer. Molecules. 2014;19:2497-2522. [PMID: 24566317 DOI: 10.3390/molecules19022497] [Cited by in Crossref: 94] [Cited by in F6Publishing: 70] [Article Influence: 11.8] [Reference Citation Analysis]
503 Alpha KM, Xu W, Turner CE. Paxillin family of focal adhesion adaptor proteins and regulation of cancer cell invasion. Int Rev Cell Mol Biol 2020;355:1-52. [PMID: 32859368 DOI: 10.1016/bs.ircmb.2020.05.003] [Cited by in Crossref: 3] [Cited by in F6Publishing: 2] [Article Influence: 1.5] [Reference Citation Analysis]
504 Cacciola NA, Sgadari M, Sepe F, Petillo O, Margarucci S, Martano M, Maiolino P, Restucci B. Metabolic Flexibility in Canine Mammary Tumors: Implications of the Carnitine System. Animals (Basel) 2021;11:2969. [PMID: 34679988 DOI: 10.3390/ani11102969] [Reference Citation Analysis]
505 Yue GG, Gao S, Lee JK, Chan YY, Wong EC, Zheng T, Li XX, Shaw PC, Simmonds MSJ, Lau CB. A Natural Flavone Tricin from Grains Can Alleviate Tumor Growth and Lung Metastasis in Colorectal Tumor Mice. Molecules 2020;25:E3730. [PMID: 32824166 DOI: 10.3390/molecules25163730] [Cited by in Crossref: 3] [Cited by in F6Publishing: 3] [Article Influence: 1.5] [Reference Citation Analysis]
506 Seip K, Jørgensen K, Haselager MV, Albrecht M, Haugen MH, Egeland EV, Lucarelli P, Engebraaten O, Sauter T, Mælandsmo GM, Prasmickaite L. Stroma-induced phenotypic plasticity offers phenotype-specific targeting to improve melanoma treatment. Cancer Letters 2018;439:1-13. [DOI: 10.1016/j.canlet.2018.09.023] [Cited by in Crossref: 3] [Cited by in F6Publishing: 3] [Article Influence: 0.8] [Reference Citation Analysis]
507 Yang Q, Guo N, Zhou Y, Chen J, Wei Q, Han M. The role of tumor-associated macrophages (TAMs) in tumor progression and relevant advance in targeted therapy. Acta Pharm Sin B 2020;10:2156-70. [PMID: 33304783 DOI: 10.1016/j.apsb.2020.04.004] [Cited by in Crossref: 26] [Cited by in F6Publishing: 20] [Article Influence: 13.0] [Reference Citation Analysis]
508 Wang X, Zhong L, Zhao Y. Oncolytic adenovirus: A tool for reversing the tumor microenvironment and promoting cancer treatment (Review). Oncol Rep 2021;45:49. [PMID: 33760203 DOI: 10.3892/or.2021.8000] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 1.0] [Reference Citation Analysis]
509 Li F, Deng Q, Pang X, Huang S, Zhang J, Zhu X, Chen H, Liu X. m5C Regulator-Mediated Methylation Modification Patterns and Tumor Microenvironment Infiltration Characterization in Papillary Thyroid Carcinoma. Front Oncol 2021;11:729887. [PMID: 34804923 DOI: 10.3389/fonc.2021.729887] [Reference Citation Analysis]
510 Park TM, Kang D, Jang I, Yun WS, Shim JH, Jeong YH, Kwak JY, Yoon S, Jin S. Fabrication of In Vitro Cancer Microtissue Array on Fibroblast-Layered Nanofibrous Membrane by Inkjet Printing. Int J Mol Sci 2017;18:E2348. [PMID: 29112150 DOI: 10.3390/ijms18112348] [Cited by in Crossref: 14] [Cited by in F6Publishing: 13] [Article Influence: 2.8] [Reference Citation Analysis]
511 Xiao A, Gibbons AE, Luker KE, Luker GD. Fluorescence Lifetime Imaging of Apoptosis. Tomography 2015;1:115-24. [PMID: 26771007 DOI: 10.18383/j.tom.2015.00163] [Cited by in Crossref: 12] [Cited by in F6Publishing: 11] [Article Influence: 1.7] [Reference Citation Analysis]
512 Shi Y, Jiang J, Cui Y, Chen Y, Dong T, An H, Liu P. MSH6 Aggravates the Hypoxic Microenvironment via Regulating HIF1A to Promote the Metastasis of Glioblastoma Multiforme. DNA Cell Biol 2021;40:93-100. [PMID: 33181035 DOI: 10.1089/dna.2020.5442] [Reference Citation Analysis]
513 Wang J, Kato F, Oyama-Manabe N, Li R, Cui Y, Tha KK, Yamashita H, Kudo K, Shirato H. Identifying Triple-Negative Breast Cancer Using Background Parenchymal Enhancement Heterogeneity on Dynamic Contrast-Enhanced MRI: A Pilot Radiomics Study. PLoS One. 2015;10:e0143308. [PMID: 26600392 DOI: 10.1371/journal.pone.0143308] [Cited by in Crossref: 75] [Cited by in F6Publishing: 73] [Article Influence: 10.7] [Reference Citation Analysis]
514 Nam J, Son S, Park KS, Moon JJ. Photothermal therapy combined with neoantigen cancer vaccination for effective immunotherapy against large established tumors and distant metastasis. Adv Ther (Weinh) 2021;4:2100093. [PMID: 34485685 DOI: 10.1002/adtp.202100093] [Reference Citation Analysis]
515 Meng M, Wang W, Yan J, Tan J, Liao L, Shi J, Wei C, Xie Y, Jin X, Yang L, Jin Q, Zhu H, Tan W, Yang F, Hou Z. Immunization of stromal cell targeting fibroblast activation protein providing immunotherapy to breast cancer mouse model. Tumour Biol 2016;37:10317-27. [PMID: 26842926 DOI: 10.1007/s13277-016-4825-4] [Cited by in Crossref: 12] [Cited by in F6Publishing: 10] [Article Influence: 2.0] [Reference Citation Analysis]
516 Qu H, Jin Q, Quan C. CLDN6: From Traditional Barrier Function to Emerging Roles in Cancers. Int J Mol Sci 2021;22:13416. [PMID: 34948213 DOI: 10.3390/ijms222413416] [Reference Citation Analysis]
517 Hima S, Sreeja S. Modulatory role of 17 β -estradiol in the tumor microenvironment of thyroid cancer: ROLE OF 17β-ESTRADIOL IN THE TME OF THYROID CANCER. IUBMB Life 2016;68:85-96. [DOI: 10.1002/iub.1462] [Cited by in Crossref: 11] [Cited by in F6Publishing: 11] [Article Influence: 1.6] [Reference Citation Analysis]
518 Takahashi H, Kikuchi Y. 3D in vitro co-culture disc for spatiotemporal image analysis of cancer-stromal cell interaction. Biomater Sci 2021;9:4448-58. [PMID: 33997871 DOI: 10.1039/d1bm00629k] [Reference Citation Analysis]
519 Bellazzo A, Collavin L. A mechanism for cell non-autonomous inactivation of the tumor suppressor DAB2IP. Oncoscience 2018;5:177-8. [PMID: 30035183 DOI: 10.18632/oncoscience.441] [Reference Citation Analysis]
520 Ngo S, Liang J, Su YH, O'Brien LE. Disruption of EGF Feedback by Intestinal Tumors and Neighboring Cells in Drosophila. Curr Biol 2020;30:1537-1546.e3. [PMID: 32243854 DOI: 10.1016/j.cub.2020.01.082] [Cited by in Crossref: 8] [Cited by in F6Publishing: 5] [Article Influence: 4.0] [Reference Citation Analysis]
521 Braicu C, Buse M, Busuioc C, Drula R, Gulei D, Raduly L, Rusu A, Irimie A, Atanasov AG, Slaby O, Ionescu C, Berindan-Neagoe I. A Comprehensive Review on MAPK: A Promising Therapeutic Target in Cancer. Cancers (Basel) 2019;11:E1618. [PMID: 31652660 DOI: 10.3390/cancers11101618] [Cited by in Crossref: 134] [Cited by in F6Publishing: 125] [Article Influence: 44.7] [Reference Citation Analysis]
522 Lim J, Kim MJ, Park Y, Ahn JW, Hwang SJ, Moon JS, Cho KG, Kwack K. Upregulation of the NLRC4 inflammasome contributes to poor prognosis in glioma patients. Sci Rep 2019;9:7895. [PMID: 31133717 DOI: 10.1038/s41598-019-44261-9] [Cited by in Crossref: 4] [Cited by in F6Publishing: 7] [Article Influence: 1.3] [Reference Citation Analysis]
523 Zhao H, Gao Y, Chen Q, Li J, Ren M, Zhao X, Yue W. RAD51AP1 promotes progression of ovarian cancer via TGF-β/Smad signalling pathway. J Cell Mol Med 2021;25:1927-38. [PMID: 33314567 DOI: 10.1111/jcmm.15877] [Cited by in Crossref: 1] [Cited by in F6Publishing: 2] [Article Influence: 0.5] [Reference Citation Analysis]
524 Zhang Y, Tu L, Zhou X, Li B. Curcumin-Mediated Induction of Apoptosis in Human Glioma CHME Cells. Med Sci Monit Basic Res 2018;24:216-24. [PMID: 30531680 DOI: 10.12659/MSMBR.912313] [Cited by in Crossref: 2] [Cited by in F6Publishing: 3] [Article Influence: 0.5] [Reference Citation Analysis]
525 Moccia C, Haase K. Engineering Breast Cancer On-chip-Moving Toward Subtype Specific Models. Front Bioeng Biotechnol 2021;9:694218. [PMID: 34249889 DOI: 10.3389/fbioe.2021.694218] [Reference Citation Analysis]
526 Zhou Z, Wang P, Sun R, Li J, Hu Z, Xin H, Luo C, Zhou J, Fan J, Zhou S. Tumor-associated neutrophils and macrophages interaction contributes to intrahepatic cholangiocarcinoma progression by activating STAT3. J Immunother Cancer 2021;9:e001946. [PMID: 33692217 DOI: 10.1136/jitc-2020-001946] [Cited by in Crossref: 1] [Cited by in F6Publishing: 2] [Article Influence: 1.0] [Reference Citation Analysis]
527 Gu JJ, Hoj J, Rouse C, Pendergast AM. Mesenchymal stem cells promote metastasis through activation of an ABL-MMP9 signaling axis in lung cancer cells. PLoS One 2020;15:e0241423. [PMID: 33119681 DOI: 10.1371/journal.pone.0241423] [Cited by in Crossref: 1] [Cited by in F6Publishing: 3] [Article Influence: 0.5] [Reference Citation Analysis]
528 Li J, Zhang Z, Deng H, Zheng Z. Cinobufagin-Loaded and Folic Acid-Modified Polydopamine Nanomedicine Combined With Photothermal Therapy for the Treatment of Lung Cancer. Front Chem 2021;9:637754. [PMID: 33855009 DOI: 10.3389/fchem.2021.637754] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 1.0] [Reference Citation Analysis]
529 Sun D, Shen W, Zhang F, Fan H, Xu C, Li L, Tan J, Miao Y, Zhang H, Yang Y, Cheng H. α-Hederin inhibits interleukin 6-induced epithelial-to-mesenchymal transition associated with disruption of JAK2/STAT3 signaling in colon cancer cells. Biomed Pharmacother 2018;101:107-14. [PMID: 29477470 DOI: 10.1016/j.biopha.2018.02.062] [Cited by in Crossref: 18] [Cited by in F6Publishing: 15] [Article Influence: 4.5] [Reference Citation Analysis]
530 Moore GY, Pidgeon GP. Cross-Talk between Cancer Cells and the Tumour Microenvironment: The Role of the 5-Lipoxygenase Pathway. Int J Mol Sci 2017;18:E236. [PMID: 28125014 DOI: 10.3390/ijms18020236] [Cited by in Crossref: 44] [Cited by in F6Publishing: 43] [Article Influence: 8.8] [Reference Citation Analysis]
531 Poh AR, Ernst M. Tumor-Associated Macrophages in Pancreatic Ductal Adenocarcinoma: Therapeutic Opportunities and Clinical Challenges. Cancers (Basel) 2021;13:2860. [PMID: 34201127 DOI: 10.3390/cancers13122860] [Reference Citation Analysis]
532 Gyori D, Lim EL, Grant FM, Spensberger D, Roychoudhuri R, Shuttleworth SJ, Okkenhaug K, Stephens LR, Hawkins PT. Compensation between CSF1R+ macrophages and Foxp3+ Treg cells drives resistance to tumor immunotherapy. JCI Insight 2018;3:120631. [PMID: 29875321 DOI: 10.1172/jci.insight.120631] [Cited by in Crossref: 35] [Cited by in F6Publishing: 32] [Article Influence: 8.8] [Reference Citation Analysis]
533 Yang Y, Jin G, Liu H, Liu K, Zhao J, Chen X, Wang D, Bai R, Li X, Jang Y, Lu J, Xing Y, Dong Z. Metformin inhibits esophageal squamous cell carcinoma-induced angiogenesis by suppressing JAK/STAT3 signaling pathway. Oncotarget 2017;8:74673-87. [PMID: 29088816 DOI: 10.18632/oncotarget.20341] [Cited by in Crossref: 17] [Cited by in F6Publishing: 16] [Article Influence: 3.4] [Reference Citation Analysis]
534 Desa DE, Strawderman RL, Wu W, Hill RL, Smid M, Martens JWM, Turner BM, Brown EB. Intratumoral heterogeneity of second-harmonic generation scattering from tumor collagen and its effects on metastatic risk prediction. BMC Cancer 2020;20:1217. [PMID: 33302909 DOI: 10.1186/s12885-020-07713-4] [Cited by in Crossref: 3] [Cited by in F6Publishing: 1] [Article Influence: 1.5] [Reference Citation Analysis]
535 Chen Y, McAndrews KM, Kalluri R. Clinical and therapeutic relevance of cancer-associated fibroblasts. Nat Rev Clin Oncol 2021. [PMID: 34489603 DOI: 10.1038/s41571-021-00546-5] [Cited by in Crossref: 1] [Article Influence: 1.0] [Reference Citation Analysis]
536 Marofi F, Motavalli R, Safonov VA, Thangavelu L, Yumashev AV, Alexander M, Shomali N, Chartrand MS, Pathak Y, Jarahian M, Izadi S, Hassanzadeh A, Shirafkan N, Tahmasebi S, Khiavi FM. CAR T cells in solid tumors: challenges and opportunities. Stem Cell Res Ther 2021;12:81. [PMID: 33494834 DOI: 10.1186/s13287-020-02128-1] [Cited by in Crossref: 20] [Cited by in F6Publishing: 19] [Article Influence: 20.0] [Reference Citation Analysis]
537 Harrer DC, Dörrie J, Schaft N. Chimeric Antigen Receptors in Different Cell Types: New Vehicles Join the Race. Hum Gene Ther 2018;29:547-58. [PMID: 29320890 DOI: 10.1089/hum.2017.236] [Cited by in Crossref: 20] [Cited by in F6Publishing: 20] [Article Influence: 5.0] [Reference Citation Analysis]
538 Ngan E, Kiepas A, Brown CM, Siegel PM. Emerging roles for LPP in metastatic cancer progression. J Cell Commun Signal 2018;12:143-56. [PMID: 29027626 DOI: 10.1007/s12079-017-0415-5] [Cited by in Crossref: 10] [Cited by in F6Publishing: 9] [Article Influence: 2.0] [Reference Citation Analysis]
539 Lian S, Meng L, Xing X, Yang Y, Qu L, Shou C. PRL-3 promotes cell adhesion by interacting with JAM2 in colon cancer. Oncol Lett 2016;12:1661-6. [PMID: 27588115 DOI: 10.3892/ol.2016.4836] [Cited by in Crossref: 6] [Cited by in F6Publishing: 8] [Article Influence: 1.0] [Reference Citation Analysis]
540 Xue B, Chuang CH, Prosser HM, Fuziwara CS, Chan C, Sahasrabudhe N, Kühn M, Wu Y, Chen J, Biton A, Chen C, Wilkinson JE, McManus MT, Bradley A, Winslow MM, Su B, He L. miR-200 deficiency promotes lung cancer metastasis by activating Notch signaling in cancer-associated fibroblasts. Genes Dev 2021;35:1109-22. [PMID: 34301766 DOI: 10.1101/gad.347344.120] [Reference Citation Analysis]
541 Liao ZQ, Ye M, Yu PG, Xiao C, Lin FY. Glioma-Associated Oncogene Homolog1 (Gli1)-Aquaporin1 pathway promotes glioma cell metastasis. BMB Rep 2016;49:394-9. [PMID: 27157540 DOI: 10.5483/bmbrep.2016.49.7.011] [Cited by in Crossref: 6] [Cited by in F6Publishing: 6] [Article Influence: 1.2] [Reference Citation Analysis]
542 Masjedi A, Hassannia H, Atyabi F, Rastegari A, Hojjat-Farsangi M, Namdar A, Soleimanpour H, Azizi G, Nikkhoo A, Ghalamfarsa G, Mirshafiey A, Jadidi-Niaragh F. Downregulation of A2AR by siRNA loaded PEG-chitosan-lactate nanoparticles restores the T cell mediated anti-tumor responses through blockage of PKA/CREB signaling pathway. Int J Biol Macromol 2019;133:436-45. [PMID: 30936011 DOI: 10.1016/j.ijbiomac.2019.03.223] [Cited by in Crossref: 40] [Cited by in F6Publishing: 40] [Article Influence: 13.3] [Reference Citation Analysis]
543 Zhu R, He H, Liu Y, Cao D, Yan J, Duan S, Chen Y, Yin L. Cancer-Selective Bioreductive Chemotherapy Mediated by Dual Hypoxia-Responsive Nanomedicine upon Photodynamic Therapy-Induced Hypoxia Aggravation. Biomacromolecules 2019;20:2649-56. [DOI: 10.1021/acs.biomac.9b00428] [Cited by in Crossref: 24] [Cited by in F6Publishing: 23] [Article Influence: 8.0] [Reference Citation Analysis]
544 Lee SS, Bindokas VP, Kron SJ. Multiplex three-dimensional optical mapping of tumor immune microenvironment. Sci Rep 2017;7:17031. [PMID: 29208908 DOI: 10.1038/s41598-017-16987-x] [Cited by in Crossref: 21] [Cited by in F6Publishing: 18] [Article Influence: 4.2] [Reference Citation Analysis]
545 Saby C, Buache E, Brassart-Pasco S, El Btaouri H, Courageot MP, Van Gulick L, Garnotel R, Jeannesson P, Morjani H. Type I collagen aging impairs discoidin domain receptor 2-mediated tumor cell growth suppression. Oncotarget 2016;7:24908-27. [PMID: 27121132 DOI: 10.18632/oncotarget.8795] [Cited by in Crossref: 17] [Cited by in F6Publishing: 16] [Article Influence: 4.3] [Reference Citation Analysis]
546 Zhou YF, Song SS, Tian MX, Tang Z, Wang H, Fang Y, Qu WF, Jiang XF, Tao CY, Huang R, Zhou PY, Zhu SG, Zhou J, Fan J, Liu WR, Shi YH. Cystathionine β-synthase mediated PRRX2/IL-6/STAT3 inactivation suppresses Tregs infiltration and induces apoptosis to inhibit HCC carcinogenesis. J Immunother Cancer 2021;9:e003031. [PMID: 34413167 DOI: 10.1136/jitc-2021-003031] [Reference Citation Analysis]
547 Zhang J, Song C, Tian Y, Yang X. Single-Cell RNA Sequencing in Lung Cancer: Revealing Phenotype Shaping of Stromal Cells in the Microenvironment. Front Immunol 2022;12:802080. [DOI: 10.3389/fimmu.2021.802080] [Reference Citation Analysis]
548 Maimon A, Levi-Yahid V, Ben-Meir K, Halpern A, Talmi Z, Priya S, Mizraji G, Mistriel-Zerbib S, Berger M, Baniyash M, Loges S, Burstyn-Cohen T. Myeloid cell-derived PROS1 inhibits tumor metastasis by regulating inflammatory and immune responses via IL-10. J Clin Invest 2021;131:126089. [PMID: 33848267 DOI: 10.1172/JCI126089] [Cited by in Crossref: 2] [Cited by in F6Publishing: 1] [Article Influence: 2.0] [Reference Citation Analysis]
549 Albritton JL, Miller JS. 3D bioprinting: improving in vitro models of metastasis with heterogeneous tumor microenvironments. Dis Model Mech 2017;10:3-14. [PMID: 28067628 DOI: 10.1242/dmm.025049] [Cited by in Crossref: 84] [Cited by in F6Publishing: 69] [Article Influence: 16.8] [Reference Citation Analysis]
550 Sun W, Fu S. Role of cancer-associated fibroblasts in tumor structure, composition and the microenvironment in ovarian cancer. Oncol Lett 2019;18:2173-8. [PMID: 31452720 DOI: 10.3892/ol.2019.10587] [Cited by in Crossref: 5] [Cited by in F6Publishing: 9] [Article Influence: 1.7] [Reference Citation Analysis]
551 Santos NL, Bustos SO, Bhatt D, Chammas R, Andrade LNS. Tumor-Derived Extracellular Vesicles: Modulation of Cellular Functional Dynamics in Tumor Microenvironment and Its Clinical Implications. Front Cell Dev Biol 2021;9:737449. [PMID: 34532325 DOI: 10.3389/fcell.2021.737449] [Cited by in Crossref: 1] [Article Influence: 1.0] [Reference Citation Analysis]
552 Akoto T, Saini S. Role of Exosomes in Prostate Cancer Metastasis. Int J Mol Sci 2021;22:3528. [PMID: 33805398 DOI: 10.3390/ijms22073528] [Cited by in Crossref: 2] [Cited by in F6Publishing: 2] [Article Influence: 2.0] [Reference Citation Analysis]
553 Pedersen SF, Novak I, Alves F, Schwab A, Pardo LA. Alternating pH landscapes shape epithelial cancer initiation and progression: Focus on pancreatic cancer. BioEssays 2017;39:1600253. [DOI: 10.1002/bies.201600253] [Cited by in Crossref: 30] [Cited by in F6Publishing: 26] [Article Influence: 6.0] [Reference Citation Analysis]
554 Tao Y, Shen H, Liu Y, Li G, Huang Z, Liu Y. IL-23R in laryngeal cancer: a cancer immunoediting process that facilitates tumor cell proliferation and results in cisplatin resistance. Carcinogenesis 2021;42:118-26. [PMID: 32526010 DOI: 10.1093/carcin/bgaa058] [Cited by in Crossref: 3] [Cited by in F6Publishing: 3] [Article Influence: 3.0] [Reference Citation Analysis]
555 Han S, Lee SY, Wang WW, Tan YB, Sim RHZ, Cheong R, Tan C, Hopkins R, Connolly J, Shuen WH, Toh HC. A Perspective on Cell Therapy and Cancer Vaccine in Biliary Tract Cancers (BTCs). Cancers (Basel) 2020;12:E3404. [PMID: 33212880 DOI: 10.3390/cancers12113404] [Cited by in Crossref: 4] [Cited by in F6Publishing: 4] [Article Influence: 2.0] [Reference Citation Analysis]
556 Ciszewski WM, Sobierajska K, Wawro ME, Klopocka W, Chefczyńska N, Muzyczuk A, Siekacz K, Wujkowska A, Niewiarowska J. The ILK-MMP9-MRTF axis is crucial for EndMT differentiation of endothelial cells in a tumor microenvironment. Biochim Biophys Acta Mol Cell Res 2017;1864:2283-96. [PMID: 28893556 DOI: 10.1016/j.bbamcr.2017.09.004] [Cited by in Crossref: 15] [Cited by in F6Publishing: 17] [Article Influence: 3.0] [Reference Citation Analysis]
557 Seol MA, Kim JH, Oh K, Kim G, Seo MW, Shin YK, Sim JH, Shin HM, Seo BY, Lee DS, Ku JL, Han I, Kang I, Park SI, Kim HR. Interleukin-7 Contributes to the Invasiveness of Prostate Cancer Cells by Promoting Epithelial-Mesenchymal Transition. Sci Rep 2019;9:6917. [PMID: 31061414 DOI: 10.1038/s41598-019-43294-4] [Cited by in Crossref: 11] [Cited by in F6Publishing: 11] [Article Influence: 3.7] [Reference Citation Analysis]
558 Andersen S, Solstad Ø, Moi L, Donnem T, Eilertsen M, Nordby Y, Ness N, Richardsen E, Busund LT, Bremnes RM. Organized metabolic crime in prostate cancer: The coexpression of MCT1 in tumor and MCT4 in stroma is an independent prognosticator for biochemical failure. Urol Oncol 2015;33:338.e9-17. [PMID: 26066969 DOI: 10.1016/j.urolonc.2015.05.013] [Cited by in Crossref: 9] [Cited by in F6Publishing: 13] [Article Influence: 1.3] [Reference Citation Analysis]
559 Di Conza G, Ho PC. Metabolic adaptation of macrophages in chronic diseases. Cancer Lett 2018;414:250-6. [PMID: 29175462 DOI: 10.1016/j.canlet.2017.11.023] [Cited by in Crossref: 2] [Cited by in F6Publishing: 2] [Article Influence: 0.4] [Reference Citation Analysis]
560 Carnielli CM, Macedo CCS, De Rossi T, Granato DC, Rivera C, Domingues RR, Pauletti BA, Yokoo S, Heberle H, Busso-Lopes AF, Cervigne NK, Sawazaki-Calone I, Meirelles GV, Marchi FA, Telles GP, Minghim R, Ribeiro ACP, Brandão TB, de Castro G Jr, González-Arriagada WA, Gomes A, Penteado F, Santos-Silva AR, Lopes MA, Rodrigues PC, Sundquist E, Salo T, da Silva SD, Alaoui-Jamali MA, Graner E, Fox JW, Coletta RD, Paes Leme AF. Combining discovery and targeted proteomics reveals a prognostic signature in oral cancer. Nat Commun 2018;9:3598. [PMID: 30185791 DOI: 10.1038/s41467-018-05696-2] [Cited by in Crossref: 53] [Cited by in F6Publishing: 48] [Article Influence: 13.3] [Reference Citation Analysis]
561 Zhang M, Gao S, Yang D, Fang Y, Lin X, Jin X, Liu Y, Liu X, Su K, Shi K. Influencing factors and strategies of enhancing nanoparticles into tumors in vivo. Acta Pharm Sin B 2021;11:2265-85. [PMID: 34522587 DOI: 10.1016/j.apsb.2021.03.033] [Cited by in Crossref: 5] [Article Influence: 5.0] [Reference Citation Analysis]
562 Taki S, Matsuoka K, Nishinaga Y, Takahashi K, Yasui H, Koike C, Shimizu M, Sato M, Sato K. Spatiotemporal depletion of tumor-associated immune checkpoint PD-L1 with near-infrared photoimmunotherapy promotes antitumor immunity. J Immunother Cancer 2021;9:e003036. [PMID: 34725216 DOI: 10.1136/jitc-2021-003036] [Reference Citation Analysis]
563 Nakamura K, Sawada K, Kobayashi M, Miyamoto M, Shimizu A, Yamamoto M, Kinose Y, Kimura T. Role of the Exosome in Ovarian Cancer Progression and Its Potential as a Therapeutic Target. Cancers (Basel) 2019;11:E1147. [PMID: 31405096 DOI: 10.3390/cancers11081147] [Cited by in Crossref: 24] [Cited by in F6Publishing: 21] [Article Influence: 8.0] [Reference Citation Analysis]
564 Thakur N, Thakur S, Chatterjee S, Das J, Sil PC. Nanoparticles as Smart Carriers for Enhanced Cancer Immunotherapy. Front Chem 2020;8:597806. [PMID: 33409265 DOI: 10.3389/fchem.2020.597806] [Cited by in Crossref: 4] [Cited by in F6Publishing: 2] [Article Influence: 4.0] [Reference Citation Analysis]
565 Kumar S, Han J, Michael IJ, Ki D, Sunkara V, Park J, Gautam S, Ha HK, Zhang L, Cho Y. Human Platelet Membrane Functionalized Microchips with Plasmonic Codes for Cancer Detection. Adv Funct Mater 2019;29:1902669. [DOI: 10.1002/adfm.201902669] [Cited by in Crossref: 12] [Cited by in F6Publishing: 8] [Article Influence: 4.0] [Reference Citation Analysis]
566 Lim SY, Yuzhalin AE, Gordon-Weeks AN, Muschel RJ. Targeting the CCL2-CCR2 signaling axis in cancer metastasis. Oncotarget 2016;7:28697-710. [PMID: 26885690 DOI: 10.18632/oncotarget.7376] [Cited by in Crossref: 213] [Cited by in F6Publishing: 220] [Article Influence: 42.6] [Reference Citation Analysis]
567 Qin H, Chen Y. Lipid Metabolism and Tumor Antigen Presentation. Adv Exp Med Biol 2021;1316:169-89. [PMID: 33740250 DOI: 10.1007/978-981-33-6785-2_11] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 1.0] [Reference Citation Analysis]
568 Kumar P, Sebastian A, Verma K, Dixit R, Kumari S, Singh J, Tiwary SK, Narayan G. mRNA Expression Analysis of E-Cadherin, VEGF, and MMPs in Gastric Cancer: a Pilot Study. Indian J Surg Oncol 2021;12:85-92. [PMID: 33994733 DOI: 10.1007/s13193-020-01096-5] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 0.5] [Reference Citation Analysis]
569 Rebelo SP, Pinto C, Martins TR, Harrer N, Estrada MF, Loza-Alvarez P, Cabeçadas J, Alves PM, Gualda EJ, Sommergruber W, Brito C. 3D-3-culture: A tool to unveil macrophage plasticity in the tumour microenvironment. Biomaterials 2018;163:185-97. [PMID: 29477032 DOI: 10.1016/j.biomaterials.2018.02.030] [Cited by in Crossref: 73] [Cited by in F6Publishing: 71] [Article Influence: 18.3] [Reference Citation Analysis]
570 Fu F, Nowak MA, Bonhoeffer S. Spatial heterogeneity in drug concentrations can facilitate the emergence of resistance to cancer therapy. PLoS Comput Biol 2015;11:e1004142. [PMID: 25789469 DOI: 10.1371/journal.pcbi.1004142] [Cited by in Crossref: 72] [Cited by in F6Publishing: 58] [Article Influence: 10.3] [Reference Citation Analysis]
571 Gener Lahav T, Adler O, Zait Y, Shani O, Amer M, Doron H, Abramovitz L, Yofe I, Cohen N, Erez N. Melanoma‐derived extracellular vesicles instigate proinflammatory signaling in the metastatic microenvironment. Int J Cancer 2019;145:2521-34. [DOI: 10.1002/ijc.32521] [Cited by in Crossref: 23] [Cited by in F6Publishing: 20] [Article Influence: 7.7] [Reference Citation Analysis]
572 Katlinski KV, Gui J, Katlinskaya YV, Ortiz A, Chakraborty R, Bhattacharya S, Carbone CJ, Beiting DP, Girondo MA, Peck AR, Puré E, Chatterji P, Rustgi AK, Diehl JA, Koumenis C, Rui H, Fuchs SY. Inactivation of Interferon Receptor Promotes the Establishment of Immune Privileged Tumor Microenvironment. Cancer Cell 2017;31:194-207. [PMID: 28196594 DOI: 10.1016/j.ccell.2017.01.004] [Cited by in Crossref: 106] [Cited by in F6Publishing: 103] [Article Influence: 21.2] [Reference Citation Analysis]
573 Zhao WJ, Ou GY, Lin WW. Integrative Analysis of Neuregulin Family Members-Related Tumor Microenvironment for Predicting the Prognosis in Gliomas. Front Immunol 2021;12:682415. [PMID: 34054873 DOI: 10.3389/fimmu.2021.682415] [Cited by in Crossref: 1] [Cited by in F6Publishing: 2] [Article Influence: 1.0] [Reference Citation Analysis]
574 Sevenich L, Joyce JA. Pericellular proteolysis in cancer. Genes Dev. 2014;28:2331-2347. [PMID: 25367033 DOI: 10.1101/gad.250647.114] [Cited by in Crossref: 110] [Cited by in F6Publishing: 96] [Article Influence: 13.8] [Reference Citation Analysis]
575 Kasashima H, Duran A, Martinez-Ordoñez A, Nakanishi Y, Kinoshita H, Linares JF, Reina-Campos M, Kudo Y, L'Hermitte A, Yashiro M, Ohira M, Bao F, Tauriello DVF, Batlle E, Diaz-Meco MT, Moscat J. Stromal SOX2 Upregulation Promotes Tumorigenesis through the Generation of a SFRP1/2-Expressing Cancer-Associated Fibroblast Population. Dev Cell 2021;56:95-110.e10. [PMID: 33207226 DOI: 10.1016/j.devcel.2020.10.014] [Cited by in Crossref: 5] [Cited by in F6Publishing: 8] [Article Influence: 2.5] [Reference Citation Analysis]
576 Gu Q, He Y, Ji J, Yao Y, Shen W, Luo J, Zhu W, Cao H, Geng Y, Xu J, Zhang S, Cao J, Ding WQ. Hypoxia-inducible factor 1α (HIF-1α) and reactive oxygen species (ROS) mediates radiation-induced invasiveness through the SDF-1α/CXCR4 pathway in non-small cell lung carcinoma cells. Oncotarget 2015;6:10893-907. [PMID: 25843954 DOI: 10.18632/oncotarget.3535] [Cited by in Crossref: 41] [Cited by in F6Publishing: 41] [Article Influence: 6.8] [Reference Citation Analysis]
577 Pawar VK, Singh Y, Sharma K, Shrivastav A, Sharma A, Singh A, Meher JG, Singh P, Raval K, Bora HK, Datta D, Lal J, Chourasia MK. Doxorubicin Hydrochloride Loaded Zymosan-Polyethylenimine Biopolymeric Nanoparticles for Dual 'Chemoimmunotherapeutic' Intervention in Breast Cancer. Pharm Res 2017;34:1857-71. [PMID: 28608139 DOI: 10.1007/s11095-017-2195-2] [Cited by in Crossref: 8] [Cited by in F6Publishing: 7] [Article Influence: 1.6] [Reference Citation Analysis]
578 Yang Z, Chen Q, Chen J, Dong Z, Zhang R, Liu J, Liu Z. Tumor-pH-Responsive Dissociable Albumin-Tamoxifen Nanocomplexes Enabling Efficient Tumor Penetration and Hypoxia Relief for Enhanced Cancer Photodynamic Therapy. Small 2018;14:e1803262. [PMID: 30307701 DOI: 10.1002/smll.201803262] [Cited by in Crossref: 54] [Cited by in F6Publishing: 53] [Article Influence: 13.5] [Reference Citation Analysis]
579 Balhouse BN, Patterson L, Schmelz EM, Slade DJ, Verbridge SS. N-(3-oxododecanoyl)-L-homoserine lactone interactions in the breast tumor microenvironment: Implications for breast cancer viability and proliferation in vitro. PLoS One 2017;12:e0180372. [PMID: 28692660 DOI: 10.1371/journal.pone.0180372] [Cited by in Crossref: 8] [Cited by in F6Publishing: 6] [Article Influence: 1.6] [Reference Citation Analysis]
580 Shen S, Chen L, Liu J, Yang L, Zhang M, Wang L, Zhang R, Uemura Y, Wu Q, Yu X, Liu T. Current state and future of co-inhibitory immune checkpoints for the treatment of glioblastoma. Cancer Biol Med 2020;17:555-68. [PMID: 32944390 DOI: 10.20892/j.issn.2095-3941.2020.0027] [Cited by in Crossref: 2] [Cited by in F6Publishing: 3] [Article Influence: 1.0] [Reference Citation Analysis]
581 Unterleuthner D, Neuhold P, Schwarz K, Janker L, Neuditschko B, Nivarthi H, Crncec I, Kramer N, Unger C, Hengstschläger M, Eferl R, Moriggl R, Sommergruber W, Gerner C, Dolznig H. Cancer-associated fibroblast-derived WNT2 increases tumor angiogenesis in colon cancer. Angiogenesis 2020;23:159-77. [PMID: 31667643 DOI: 10.1007/s10456-019-09688-8] [Cited by in Crossref: 32] [Cited by in F6Publishing: 38] [Article Influence: 10.7] [Reference Citation Analysis]
582 Tiwari S, Triulzi T, Holton S, Regondi V, Paolini B, Tagliabue E, Bhargava R. Infrared Spectroscopic Imaging Visualizes a Prognostic Extracellular Matrix-Related Signature in Breast Cancer. Sci Rep 2020;10:5442. [PMID: 32214177 DOI: 10.1038/s41598-020-62403-2] [Cited by in Crossref: 3] [Cited by in F6Publishing: 2] [Article Influence: 1.5] [Reference Citation Analysis]
583 Asada K, Takasawa K, Machino H, Takahashi S, Shinkai N, Bolatkan A, Kobayashi K, Komatsu M, Kaneko S, Okamoto K, Hamamoto R. Single-Cell Analysis Using Machine Learning Techniques and Its Application to Medical Research. Biomedicines 2021;9:1513. [PMID: 34829742 DOI: 10.3390/biomedicines9111513] [Reference Citation Analysis]
584 Copeland BT, Shallal H, Shen C, Pienta KJ, Foss CA, Pomper MG. Imaging and Characterization of Macrophage Distribution in Mouse Models of Human Prostate Cancer. Mol Imaging Biol 2019;21:1054-63. [PMID: 30805886 DOI: 10.1007/s11307-019-01318-5] [Cited by in Crossref: 6] [Cited by in F6Publishing: 4] [Article Influence: 3.0] [Reference Citation Analysis]
585 Yu B, Luo F, Sun B, Liu W, Shi Q, Cheng SY, Chen C, Chen G, Li Y, Feng H. KAT6A Acetylation of SMAD3 Regulates Myeloid-Derived Suppressor Cell Recruitment, Metastasis, and Immunotherapy in Triple-Negative Breast Cancer. Adv Sci (Weinh) 2021;:e2100014. [PMID: 34392614 DOI: 10.1002/advs.202100014] [Reference Citation Analysis]
586 Wong SW, Lenzini S, Shin JW. Perspective: Biophysical regulation of cancerous and normal blood cell lineages in hematopoietic malignancies. APL Bioeng 2018;2:031802. [PMID: 31069313 DOI: 10.1063/1.5025689] [Cited by in Crossref: 4] [Cited by in F6Publishing: 3] [Article Influence: 1.0] [Reference Citation Analysis]
587 Ganesh K, Massagué J. Targeting metastatic cancer. Nat Med 2021;27:34-44. [PMID: 33442008 DOI: 10.1038/s41591-020-01195-4] [Cited by in Crossref: 18] [Cited by in F6Publishing: 25] [Article Influence: 18.0] [Reference Citation Analysis]
588 Si C, Chen C, Guo Y, Kang Q, Sun Z. Effect, Mechanism, and Applications of Coding/Non-coding RNA m6A Modification in Tumor Microenvironment. Front Cell Dev Biol 2021;9:711815. [PMID: 34660577 DOI: 10.3389/fcell.2021.711815] [Reference Citation Analysis]
589 Tauriello DVF. From poor prognosis to promising treatment. Science 2019;363:1051. [PMID: 30846592 DOI: 10.1126/science.aaw3609] [Cited by in Crossref: 2] [Cited by in F6Publishing: 1] [Article Influence: 0.7] [Reference Citation Analysis]
590 Liu J, Pradhan P, Roy K. Synthetic Polymeric Nanoparticles for Immunomodulation. In: Lu Z, Sakuma S, editors. Nanomaterials in Pharmacology. New York: Springer; 2016. pp. 413-38. [DOI: 10.1007/978-1-4939-3121-7_21] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 0.2] [Reference Citation Analysis]
591 Saxena S, Singh RK. Chemokines orchestrate tumor cells and the microenvironment to achieve metastatic heterogeneity. Cancer Metastasis Rev 2021;40:447-76. [PMID: 33959849 DOI: 10.1007/s10555-021-09970-6] [Reference Citation Analysis]
592 Zhou X, Liu X, Huang L. Macrophage-Mediated Tumor Cell Phagocytosis: Opportunity for Nanomedicine Intervention. Adv Funct Mater 2021;31:2006220. [PMID: 33692665 DOI: 10.1002/adfm.202006220] [Cited by in Crossref: 8] [Cited by in F6Publishing: 4] [Article Influence: 4.0] [Reference Citation Analysis]
593 Hu ZQ, Zhou ZJ, Luo CB, Xin HY, Li J, Yu SY, Zhou SL. Peritumoral plasmacytoid dendritic cells predict a poor prognosis for intrahepatic cholangiocarcinoma after curative resection. Cancer Cell Int 2020;20:582. [PMID: 33292317 DOI: 10.1186/s12935-020-01676-z] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 0.5] [Reference Citation Analysis]
594 Casadei C, Dizman N, Schepisi G, Cursano MC, Basso U, Santini D, Pal SK, De Giorgi U. Targeted therapies for advanced bladder cancer: new strategies with FGFR inhibitors. Ther Adv Med Oncol 2019;11:1758835919890285. [PMID: 31803255 DOI: 10.1177/1758835919890285] [Cited by in Crossref: 34] [Cited by in F6Publishing: 31] [Article Influence: 11.3] [Reference Citation Analysis]
595 Shi X, Li R, Dong X, Chen AM, Liu X, Lu D, Feng S, Wang H, Cai K. IRGS: an immune-related gene classifier for lung adenocarcinoma prognosis. J Transl Med 2020;18:55. [PMID: 32019546 DOI: 10.1186/s12967-020-02233-y] [Cited by in Crossref: 10] [Cited by in F6Publishing: 13] [Article Influence: 5.0] [Reference Citation Analysis]
596 Burlaka AP, Ganusevich II, Vovk AV, Burlaka AA, Gafurov MR, Lukin SN. Redox state of adipose tissue for patients with gastric cancer and its connection with the body mass index and distance from the tumor. Obes Res Clin Pract 2020;14:34-8. [PMID: 31711773 DOI: 10.1016/j.orcp.2019.10.003] [Reference Citation Analysis]
597 Li B, He Y, Li P, Chen X. Leptin Receptor Overlapping Transcript (LEPROT) Is Associated with the Tumor Microenvironment and a Prognostic Predictor in Pan-Cancer. Front Genet 2021;12:749435. [PMID: 34804118 DOI: 10.3389/fgene.2021.749435] [Reference Citation Analysis]
598 Kfoury Y, Scadden DT. Cellular thrust and parry in the leukemic niche. Blood 2014;124:2760-1. [DOI: 10.1182/blood-2014-09-597716] [Cited by in Crossref: 4] [Cited by in F6Publishing: 4] [Article Influence: 0.5] [Reference Citation Analysis]
599 Asselin-labat M. Cells tagged near an early spread of cancer. Nature 2019;572:589-90. [DOI: 10.1038/d41586-019-02399-6] [Cited by in Crossref: 2] [Cited by in F6Publishing: 2] [Article Influence: 0.7] [Reference Citation Analysis]
600 Hameed S, Bhattarai P, Dai Z. Nanotherapeutic approaches targeting angiogenesis and immune dysfunction in tumor microenvironment. Sci China Life Sci 2018;61:380-91. [PMID: 29607461 DOI: 10.1007/s11427-017-9256-1] [Cited by in Crossref: 11] [Cited by in F6Publishing: 10] [Article Influence: 2.8] [Reference Citation Analysis]
601 Gonzalez H, Hagerling C, Werb Z. Roles of the immune system in cancer: from tumor initiation to metastatic progression. Genes Dev. 2018;32:1267-1284. [PMID: 30275043 DOI: 10.1101/gad.314617.118] [Cited by in Crossref: 419] [Cited by in F6Publishing: 401] [Article Influence: 104.8] [Reference Citation Analysis]
602 Woo Y, Kim H, Kim KC, Han JA, Jung YJ. Tumor-secreted factors induce IL-1β maturation via the glucose-mediated synergistic axis of mTOR and NF-κB pathways in mouse macrophages. PLoS One 2018;13:e0209653. [PMID: 30586442 DOI: 10.1371/journal.pone.0209653] [Cited by in Crossref: 4] [Cited by in F6Publishing: 5] [Article Influence: 1.0] [Reference Citation Analysis]
603 Lin L, Kuhn C, Ditsch N, Kolben T, Czogalla B, Beyer S, Trillsch F, Schmoeckel E, Mayr D, Mahner S, Jeschke U, Hester A. Breast adipose tissue macrophages (BATMs) have a stronger correlation with breast cancer survival than breast tumor stroma macrophages (BTSMs). Breast Cancer Res 2021;23:45. [PMID: 33849622 DOI: 10.1186/s13058-021-01422-x] [Reference Citation Analysis]
604 Chen J, Chen Q, Liang C, Yang Z, Zhang L, Yi X, Dong Z, Chao Y, Chen Y, Liu Z. Albumin-templated biomineralizing growth of composite nanoparticles as smart nano-theranostics for enhanced radiotherapy of tumors. Nanoscale 2017;9:14826-35. [PMID: 28972612 DOI: 10.1039/c7nr05316a] [Cited by in Crossref: 49] [Cited by in F6Publishing: 8] [Article Influence: 12.3] [Reference Citation Analysis]
605 Huai Y, Hossen MN, Wilhelm S, Bhattacharya R, Mukherjee P. Nanoparticle Interactions with the Tumor Microenvironment. Bioconjug Chem 2019;30:2247-63. [PMID: 31408324 DOI: 10.1021/acs.bioconjchem.9b00448] [Cited by in Crossref: 25] [Cited by in F6Publishing: 23] [Article Influence: 8.3] [Reference Citation Analysis]
606 Kievit FM, Wang K, Erickson AE, Lan Levengood SK, Ellenbogen RG, Zhang M. Modeling the tumor microenvironment using chitosan-alginate scaffolds to control the stem-like state of glioblastoma cells. Biomater Sci 2016;4:610-3. [PMID: 26688867 DOI: 10.1039/c5bm00514k] [Cited by in Crossref: 20] [Cited by in F6Publishing: 5] [Article Influence: 2.9] [Reference Citation Analysis]
607 Kotlan B, Plotar V, Eles K, Horvath S, Balatoni T, Csuka O, Újhelyi M, Sávolt Á, Szollar A, Vamosi-Nagy I, Toth L, Farkas E, Toth J, Kasler M, Liszkay G. Challenging tumour immunological techniques that help to track cancer stem cells in malignant melanomas and other solid tumours. Contemp Oncol (Pozn) 2018;22:41-7. [PMID: 29628793 DOI: 10.5114/wo.2018.73884] [Reference Citation Analysis]
608 Zhao M, Liu Q, Gong Y, Xu X, Zhang C, Liu X, Zhang C, Guo H, Zhang X, Gong Y, Shao C. GSH-dependent antioxidant defense contributes to the acclimation of colon cancer cells to acidic microenvironment. Cell Cycle 2016;15:1125-33. [PMID: 26950675 DOI: 10.1080/15384101.2016.1158374] [Cited by in Crossref: 16] [Cited by in F6Publishing: 20] [Article Influence: 3.2] [Reference Citation Analysis]
609 Wan D, Yang Y, Liu Y, Cun X, Li M, Xu S, Zhao W, Xiang Y, Qiu Y, Yu Q, Tang X, Zhang Z, He Q. Sequential depletion of myeloid-derived suppressor cells and tumor cells with a dual-pH-sensitive conjugated micelle system for cancer chemoimmunotherapy. J Control Release 2020;317:43-56. [PMID: 31758970 DOI: 10.1016/j.jconrel.2019.11.011] [Cited by in Crossref: 9] [Cited by in F6Publishing: 8] [Article Influence: 3.0] [Reference Citation Analysis]
610 He R, Lao Y, Yu W, Zhang X, Jiang M, Zhu C. Progress in the Application of Immune Checkpoint Inhibitor-Based Immunotherapy for Targeting Different Types of Colorectal Cancer. Front Oncol 2021;11:764618. [PMID: 34888243 DOI: 10.3389/fonc.2021.764618] [Reference Citation Analysis]
611 Pascual-García M, Bonfill-Teixidor E, Planas-Rigol E, Rubio-Perez C, Iurlaro R, Arias A, Cuartas I, Sala-Hojman A, Escudero L, Martínez-Ricarte F, Huber-Ruano I, Nuciforo P, Pedrosa L, Marques C, Braña I, Garralda E, Vieito M, Squatrito M, Pineda E, Graus F, Espejo C, Sahuquillo J, Tabernero J, Seoane J. LIF regulates CXCL9 in tumor-associated macrophages and prevents CD8+ T cell tumor-infiltration impairing anti-PD1 therapy. Nat Commun 2019;10:2416. [PMID: 31186412 DOI: 10.1038/s41467-019-10369-9] [Cited by in Crossref: 49] [Cited by in F6Publishing: 44] [Article Influence: 16.3] [Reference Citation Analysis]
612 Regier MC, Alarid ET, Beebe DJ. Progress towards understanding heterotypic interactions in multi-culture models of breast cancer. Integr Biol (Camb) 2016;8:684-92. [PMID: 27097801 DOI: 10.1039/c6ib00001k] [Cited by in Crossref: 11] [Cited by in F6Publishing: 5] [Article Influence: 1.8] [Reference Citation Analysis]
613 Mukhopadhyay S, Bhutia SK. Trends in CRISPR-Cas9 technology application in cancer. Prog Mol Biol Transl Sci 2021;178:175-92. [PMID: 33685596 DOI: 10.1016/bs.pmbts.2020.12.004] [Reference Citation Analysis]
614 Wang J, Lee JS, Kim D, Zhu L. Exploration of Zinc Oxide Nanoparticles as a Multitarget and Multifunctional Anticancer Nanomedicine. ACS Appl Mater Interfaces 2017;9:39971-84. [DOI: 10.1021/acsami.7b11219] [Cited by in Crossref: 63] [Cited by in F6Publishing: 53] [Article Influence: 12.6] [Reference Citation Analysis]
615 Xu WW, Li B, Guan XY, Chung SK, Wang Y, Yip YL, Law SYK, Chan KT, Lee NPY, Chan KW, Xu LY, Li EM, Tsao SW, He Q, Cheung ALM. Cancer cell-secreted IGF2 instigates fibroblasts and bone marrow-derived vascular progenitor cells to promote cancer progression. Nat Commun 2017;8. [DOI: 10.1038/ncomms14399] [Reference Citation Analysis]
616 Zanconato F, Cordenonsi M, Piccolo S. YAP and TAZ: a signalling hub of the tumour microenvironment. Nat Rev Cancer 2019;19:454-64. [PMID: 31270418 DOI: 10.1038/s41568-019-0168-y] [Cited by in Crossref: 110] [Cited by in F6Publishing: 100] [Article Influence: 36.7] [Reference Citation Analysis]
617 Guo M, Kolberg KL, Smith EC, Smith BW, Yousif JE, Kessler JL, Linzey JR, Calinescu A, Clines GA, Spratt DE, Szerlip NJ. Predominance of Spinal Metastases Involving the Posterior Vertebral Body. World Neurosurgery 2018;119:e991-6. [DOI: 10.1016/j.wneu.2018.08.029] [Cited by in Crossref: 5] [Cited by in F6Publishing: 4] [Article Influence: 1.3] [Reference Citation Analysis]
618 Ghahremanifard P, Chanda A, Bonni S, Bose P. TGF-β Mediated Immune Evasion in Cancer-Spotlight on Cancer-Associated Fibroblasts. Cancers (Basel) 2020;12:E3650. [PMID: 33291370 DOI: 10.3390/cancers12123650] [Cited by in Crossref: 7] [Cited by in F6Publishing: 8] [Article Influence: 3.5] [Reference Citation Analysis]
619 Naves MA, Graminha AE, Vegas LC, Luna-dulcey L, Honorato J, Menezes ACS, Batista AA, Cominetti MR. Transport of the Ruthenium Complex [Ru(GA)(dppe) 2 ]PF 6 into Triple-Negative Breast Cancer Cells Is Facilitated by Transferrin Receptors. Mol Pharmaceutics 2019;16:1167-83. [DOI: 10.1021/acs.molpharmaceut.8b01154] [Cited by in Crossref: 18] [Cited by in F6Publishing: 13] [Article Influence: 6.0] [Reference Citation Analysis]
620 Wu T, Dai Y. Tumor microenvironment and therapeutic response. Cancer Lett. 2017;387:61-68. [PMID: 26845449 DOI: 10.1016/j.canlet.2016.01.043] [Cited by in Crossref: 348] [Cited by in F6Publishing: 372] [Article Influence: 58.0] [Reference Citation Analysis]
621 Tang PC, Chung JY, Xue VW, Xiao J, Meng XM, Huang XR, Zhou S, Chan AS, Tsang AC, Cheng AS, Lee TL, Leung KT, Lam EW, To KF, Tang PM, Lan HY. Smad3 Promotes Cancer-Associated Fibroblasts Generation via Macrophage-Myofibroblast Transition. Adv Sci (Weinh) 2021;:e2101235. [PMID: 34791825 DOI: 10.1002/advs.202101235] [Reference Citation Analysis]
622 Park H, Lee Y, Lee H, Kim JW, Hwang JH, Kim J, Yoon YS, Han HS, Kim H. The prognostic significance of cancer-associated fibroblasts in pancreatic ductal adenocarcinoma. Tumour Biol 2017;39:1010428317718403. [PMID: 29025374 DOI: 10.1177/1010428317718403] [Cited by in Crossref: 15] [Cited by in F6Publishing: 16] [Article Influence: 3.0] [Reference Citation Analysis]
623 Chatterjee S, Bhat V, Berdnikov A, Liu J, Zhang G, Buchel E, Safneck J, Marshall AJ, Murphy LC, Postovit LM, Raouf A. Paracrine Crosstalk between Fibroblasts and ER+ Breast Cancer Cells Creates an IL1β-Enriched Niche that Promotes Tumor Growth. iScience 2019;19:388-401. [PMID: 31419632 DOI: 10.1016/j.isci.2019.07.034] [Cited by in Crossref: 17] [Cited by in F6Publishing: 14] [Article Influence: 5.7] [Reference Citation Analysis]
624 Kelbauskas L, Ashili SP, Lee KB, Zhu H, Tian Y, Meldrum DR. Simultaneous Multiparameter Cellular Energy Metabolism Profiling of Small Populations of Cells. Sci Rep 2018;8:4359. [PMID: 29531352 DOI: 10.1038/s41598-018-22599-w] [Cited by in Crossref: 2] [Cited by in F6Publishing: 2] [Article Influence: 0.5] [Reference Citation Analysis]
625 Lorenzo-Sanz L, Muñoz P. Tumor-Infiltrating Immunosuppressive Cells in Cancer-Cell Plasticity, Tumor Progression and Therapy Response. Cancer Microenviron 2019;12:119-32. [PMID: 31583529 DOI: 10.1007/s12307-019-00232-2] [Cited by in Crossref: 14] [Cited by in F6Publishing: 14] [Article Influence: 4.7] [Reference Citation Analysis]
626 Shen H, Yu X, Yang F, Zhang Z, Shen J, Sun J, Choksi S, Jitkaew S, Shu Y. Reprogramming of Normal Fibroblasts into Cancer-Associated Fibroblasts by miRNAs-Mediated CCL2/VEGFA Signaling. PLoS Genet 2016;12:e1006244. [PMID: 27541266 DOI: 10.1371/journal.pgen.1006244] [Cited by in Crossref: 42] [Cited by in F6Publishing: 40] [Article Influence: 7.0] [Reference Citation Analysis]
627 Bae SJ, Cha YJ, Yoon C, Kim D, Lee J, Park S, Cha C, Kim JY, Ahn SG, Park HS, Park S, Kim SI, Jeong J. Prognostic value of neutrophil-to-lymphocyte ratio in human epidermal growth factor receptor 2-negative breast cancer patients who received neoadjuvant chemotherapy. Sci Rep 2020;10:13078. [PMID: 32753659 DOI: 10.1038/s41598-020-69965-1] [Cited by in Crossref: 3] [Cited by in F6Publishing: 4] [Article Influence: 1.5] [Reference Citation Analysis]
628 Greco L, Rubbino F, Morelli A, Gaiani F, Grizzi F, de'Angelis GL, Malesci A, Laghi L. Epithelial to Mesenchymal Transition: A Challenging Playground for Translational Research. Current Models and Focus on TWIST1 Relevance and Gastrointestinal Cancers. Int J Mol Sci 2021;22:11469. [PMID: 34768901 DOI: 10.3390/ijms222111469] [Reference Citation Analysis]
629 Gu Y, Liu Y, Cao X. Genome-wide in vivo screen identifies host molecule in promoting cancer metastasis. Protein Cell 2017;8:398-400. [PMID: 28290052 DOI: 10.1007/s13238-017-0391-9] [Reference Citation Analysis]
630 Gampa G, Vaidhyanathan S, Resman BW, Parrish KE, Markovic SN, Sarkaria JN, Elmquist WF. Challenges in the delivery of therapies to melanoma brain metastases. Curr Pharmacol Rep 2016;2:309-25. [PMID: 28546917 DOI: 10.1007/s40495-016-0072-z] [Cited by in Crossref: 7] [Cited by in F6Publishing: 7] [Article Influence: 1.2] [Reference Citation Analysis]
631 Pelagalli A, Nardelli A, Fontanella R, Zannetti A. Inhibition of AQP1 Hampers Osteosarcoma and Hepatocellular Carcinoma Progression Mediated by Bone Marrow-Derived Mesenchymal Stem Cells. Int J Mol Sci 2016;17:E1102. [PMID: 27409610 DOI: 10.3390/ijms17071102] [Cited by in Crossref: 22] [Cited by in F6Publishing: 24] [Article Influence: 3.7] [Reference Citation Analysis]
632 Huang MY, Jiang XM, Wang BL, Sun Y, Lu JJ. Combination therapy with PD-1/PD-L1 blockade in non-small cell lung cancer: strategies and mechanisms. Pharmacol Ther 2021;219:107694. [PMID: 32980443 DOI: 10.1016/j.pharmthera.2020.107694] [Cited by in Crossref: 5] [Cited by in F6Publishing: 5] [Article Influence: 2.5] [Reference Citation Analysis]
633 Li M, Feng W, Zhao M, Dai P, Zhou Y, Wang J, Lv W, Liu S, Zhao Q. Overcoming Tumor Hypoxia through Multiple Pathways Using an All-in-One Polymeric Therapeutic Agent to Enhance Synergistic Cancer Photo/Chemotherapy Effects. Bioconjug Chem 2021. [PMID: 34236842 DOI: 10.1021/acs.bioconjchem.1c00307] [Reference Citation Analysis]
634 Lee SY, Jeon HM, Ju MK, Jeong EK, Kim CH, Park HG, Han SI, Kang HS. Dlx-2 and glutaminase upregulate epithelial-mesenchymal transition and glycolytic switch. Oncotarget 2016;7:7925-39. [PMID: 26771232 DOI: 10.18632/oncotarget.6879] [Cited by in Crossref: 37] [Cited by in F6Publishing: 38] [Article Influence: 6.2] [Reference Citation Analysis]
635 Espinoza-Sánchez NA, Enciso J, Pelayo R, Fuentes-Pananá EM. An NFκB-dependent mechanism of tumor cell plasticity and lateral transmission of aggressive features. Oncotarget 2018;9:26679-700. [PMID: 29928478 DOI: 10.18632/oncotarget.25465] [Cited by in Crossref: 4] [Cited by in F6Publishing: 5] [Article Influence: 1.0] [Reference Citation Analysis]
636 Aoyama N, Miyoshi H, Miyachi H, Sonoshita M, Okabe M, Taketo MM. Transgenic mice that accept Luciferase- or GFP-expressing syngeneic tumor cells at high efficiencies. Genes Cells 2018;23:580-9. [PMID: 29749672 DOI: 10.1111/gtc.12592] [Cited by in Crossref: 6] [Cited by in F6Publishing: 4] [Article Influence: 1.5] [Reference Citation Analysis]
637 Sisakhtnezhad S, Khosravi L. Emerging physiological and pathological implications of tunneling nanotubes formation between cells. Eur J Cell Biol 2015;94:429-43. [PMID: 26164368 DOI: 10.1016/j.ejcb.2015.06.010] [Cited by in Crossref: 57] [Cited by in F6Publishing: 58] [Article Influence: 8.1] [Reference Citation Analysis]
638 Dittmer J, Leyh B. The impact of tumor stroma on drug response in breast cancer. Semin Cancer Biol. 2015;31:3-15. [PMID: 24912116 DOI: 10.1016/j.semcancer.2014.05.006] [Cited by in Crossref: 59] [Cited by in F6Publishing: 61] [Article Influence: 7.4] [Reference Citation Analysis]
639 Miro C, Nappi A, Cicatiello AG, Di Cicco E, Sagliocchi S, Murolo M, Belli V, Troiani T, Albanese S, Amiranda S, Zavacki AM, Stornaiuolo M, Mancini M, Salvatore D, Dentice M. Thyroid Hormone Enhances Angiogenesis and the Warburg Effect in Squamous Cell Carcinomas. Cancers (Basel) 2021;13:2743. [PMID: 34205977 DOI: 10.3390/cancers13112743] [Reference Citation Analysis]
640 Lyu J, Yang EJ, Head SA, Ai N, Zhang B, Wu C, Li RJ, Liu Y, Yang C, Dang Y, Kwon HJ, Ge W, Liu JO, Shim JS. Pharmacological blockade of cholesterol trafficking by cepharanthine in endothelial cells suppresses angiogenesis and tumor growth. Cancer Lett 2017;409:91-103. [PMID: 28923401 DOI: 10.1016/j.canlet.2017.09.009] [Cited by in Crossref: 29] [Cited by in F6Publishing: 28] [Article Influence: 5.8] [Reference Citation Analysis]
641 Jo Y, Choi N, Kim K, Koo HJ, Choi J, Kim HN. Chemoresistance of Cancer Cells: Requirements of Tumor Microenvironment-mimicking In Vitro Models in Anti-Cancer Drug Development. Theranostics 2018;8:5259-75. [PMID: 30555545 DOI: 10.7150/thno.29098] [Cited by in Crossref: 53] [Cited by in F6Publishing: 57] [Article Influence: 13.3] [Reference Citation Analysis]
642 Zhou Y, Zhang G, Zhang W, Wei X, Hou J, Huang Y. B7-H3 Promotes Prostate Cancer Progression in Mice by Antagonizing Myeloid-Derived Suppressor Cell Apoptosis. Technol Cancer Res Treat 2020;19:1533033820971649. [PMID: 33280506 DOI: 10.1177/1533033820971649] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 0.5] [Reference Citation Analysis]
643 Lai H, Fu X, Sang C, Hou L, Feng P, Li X, Chen T. Selenadiazole Derivatives Inhibit Angiogenesis-Mediated Human Breast Tumor Growth by Suppressing the VEGFR2-Mediated ERK and AKT Signaling Pathways. Chem Asian J 2018;13:1447-57. [DOI: 10.1002/asia.201800110] [Cited by in Crossref: 13] [Cited by in F6Publishing: 12] [Article Influence: 3.3] [Reference Citation Analysis]
644 Boire A, Zou Y, Shieh J, Macalinao DG, Pentsova E, Massagué J. Complement Component 3 Adapts the Cerebrospinal Fluid for Leptomeningeal Metastasis. Cell 2017;168:1101-1113.e13. [PMID: 28283064 DOI: 10.1016/j.cell.2017.02.025] [Cited by in Crossref: 114] [Cited by in F6Publishing: 101] [Article Influence: 22.8] [Reference Citation Analysis]
645 Qin X, Denton WD, Huiting LN, Smith KS, Feng H. Unraveling the regulatory role of endoplasmic-reticulum-associated degradation in tumor immunity. Crit Rev Biochem Mol Biol 2020;55:322-53. [PMID: 32633575 DOI: 10.1080/10409238.2020.1784085] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 0.5] [Reference Citation Analysis]
646 Suda K. Tumor-associated macrophages-additional effectors at anti-PD-1/PD-L1 therapy? J Thorac Dis 2017;9:4197-200. [PMID: 29268470 DOI: 10.21037/jtd.2017.10.15] [Cited by in Crossref: 2] [Cited by in F6Publishing: 3] [Article Influence: 0.4] [Reference Citation Analysis]
647 Blando J, Sharma A, Higa MG, Zhao H, Vence L, Yadav SS, Kim J, Sepulveda AM, Sharp M, Maitra A, Wargo J, Tetzlaff M, Broaddus R, Katz MHG, Varadhachary GR, Overman M, Wang H, Yee C, Bernatchez C, Iacobuzio-Donahue C, Basu S, Allison JP, Sharma P. Comparison of immune infiltrates in melanoma and pancreatic cancer highlights VISTA as a potential target in pancreatic cancer. Proc Natl Acad Sci U S A 2019;116:1692-7. [PMID: 30635425 DOI: 10.1073/pnas.1811067116] [Cited by in Crossref: 104] [Cited by in F6Publishing: 101] [Article Influence: 34.7] [Reference Citation Analysis]
648 Niu B, Zeng X, Phan TA, Szulzewsky F, Holte S, Holland EC, Tian JP. Mathematical modeling of PDGF-driven glioma reveals the dynamics of immune cells infiltrating into tumors. Neoplasia 2020;22:323-32. [PMID: 32585427 DOI: 10.1016/j.neo.2020.05.005] [Cited by in Crossref: 3] [Cited by in F6Publishing: 3] [Article Influence: 1.5] [Reference Citation Analysis]
649 Schadendorf D, Fisher DE, Garbe C, Gershenwald JE, Grob JJ, Halpern A, Herlyn M, Marchetti MA, McArthur G, Ribas A, Roesch A, Hauschild A. Melanoma. Nat Rev Dis Primers 2015;1:15003. [PMID: 27188223 DOI: 10.1038/nrdp.2015.3] [Cited by in Crossref: 212] [Cited by in F6Publishing: 203] [Article Influence: 30.3] [Reference Citation Analysis]
650 Tung JC, Barnes JM, Desai SR, Sistrunk C, Conklin MW, Schedin P, Eliceiri KW, Keely PJ, Seewaldt VL, Weaver VM. Tumor mechanics and metabolic dysfunction. Free Radic Biol Med 2015;79:269-80. [PMID: 25532934 DOI: 10.1016/j.freeradbiomed.2014.11.020] [Cited by in Crossref: 69] [Cited by in F6Publishing: 62] [Article Influence: 8.6] [Reference Citation Analysis]
651 Janssen E, Subtil B, de la Jara Ortiz F, Verheul HMW, Tauriello DVF. Combinatorial Immunotherapies for Metastatic Colorectal Cancer. Cancers (Basel) 2020;12:E1875. [PMID: 32664619 DOI: 10.3390/cancers12071875] [Cited by in Crossref: 5] [Cited by in F6Publishing: 1] [Article Influence: 2.5] [Reference Citation Analysis]
652 Wu P, Gao W, Su M, Nice EC, Zhang W, Lin J, Xie N. Adaptive Mechanisms of Tumor Therapy Resistance Driven by Tumor Microenvironment. Front Cell Dev Biol 2021;9:641469. [PMID: 33732706 DOI: 10.3389/fcell.2021.641469] [Cited by in Crossref: 14] [Cited by in F6Publishing: 12] [Article Influence: 14.0] [Reference Citation Analysis]
653 Halder D, Mallick D, Chatterjee A, Jana SS. Nonmuscle Myosin II in cancer cell migration and mechanotransduction. Int J Biochem Cell Biol 2021;139:106058. [PMID: 34400319 DOI: 10.1016/j.biocel.2021.106058] [Reference Citation Analysis]
654 Brescacin L, Masi A, Sava G, Bergamo A. Effects of the ruthenium-based drug NAMI-A on the roles played by TGF-β1 in the metastatic process. J Biol Inorg Chem 2015;20:1163-73. [DOI: 10.1007/s00775-015-1297-8] [Cited by in Crossref: 17] [Cited by in F6Publishing: 16] [Article Influence: 2.4] [Reference Citation Analysis]
655 Li X, Wang M, Gong T, Lei X, Hu T, Tian M, Ding F, Ma F, Chen H, Liu Z. A S100A14-CCL2/CXCL5 signaling axis drives breast cancer metastasis. Theranostics 2020;10:5687-703. [PMID: 32483412 DOI: 10.7150/thno.42087] [Cited by in Crossref: 5] [Cited by in F6Publishing: 7] [Article Influence: 2.5] [Reference Citation Analysis]
656 Wada Y, Tokuda K, Morine Y, Okikawa S, Yamashita S, Ikemoto T, Imura S, Saito Y, Yamada S, Shimada M. The inhibitory effect of TU-100 on hepatic stellate cell activation in the tumor microenvironment. Oncotarget 2020;11:4593-604. [PMID: 33346211 DOI: 10.18632/oncotarget.27835] [Reference Citation Analysis]
657 Sun Z, Wang CY, Lawson DA, Kwek S, Velozo HG, Owyong M, Lai MD, Fong L, Wilson M, Su H, Werb Z, Cooke DL. Single-cell RNA sequencing reveals gene expression signatures of breast cancer-associated endothelial cells. Oncotarget. 2017;9:10945-10961. [PMID: 29541388 DOI: 10.18632/oncotarget.23760] [Cited by in Crossref: 23] [Cited by in F6Publishing: 24] [Article Influence: 4.6] [Reference Citation Analysis]
658 Lisovska N, Shanazarov N. Tumor progression mechanisms: Insights from the central immune regulation of tissue homeostasis. Oncol Lett 2019;17:5311-8. [PMID: 31186747 DOI: 10.3892/ol.2019.10218] [Reference Citation Analysis]
659 Balani S, Nguyen LV, Eaves CJ. Modeling the process of human tumorigenesis. Nat Commun 2017;8:15422. [PMID: 28541307 DOI: 10.1038/ncomms15422] [Cited by in Crossref: 25] [Cited by in F6Publishing: 23] [Article Influence: 5.0] [Reference Citation Analysis]
660 Liu Y, Cao X. Immunosuppressive cells in tumor immune escape and metastasis. J Mol Med (Berl) 2016;94:509-22. [PMID: 26689709 DOI: 10.1007/s00109-015-1376-x] [Cited by in Crossref: 123] [Cited by in F6Publishing: 120] [Article Influence: 17.6] [Reference Citation Analysis]
661 Ge P, Wang W, Li L, Zhang G, Gao Z, Tang Z, Dang X, Wu Y. Profiles of immune cell infiltration and immune-related genes in the tumor microenvironment of colorectal cancer. Biomed Pharmacother 2019;118:109228. [PMID: 31351430 DOI: 10.1016/j.biopha.2019.109228] [Cited by in Crossref: 58] [Cited by in F6Publishing: 64] [Article Influence: 19.3] [Reference Citation Analysis]
662 Zhu L, Xi PW, Li XX, Sun X, Zhou WB, Xia TS, Shi L, Hu Y, Ding Q, Wei JF. The RNA binding protein RBMS3 inhibits the metastasis of breast cancer by regulating Twist1 expression. J Exp Clin Cancer Res 2019;38:105. [PMID: 30819235 DOI: 10.1186/s13046-019-1111-5] [Cited by in Crossref: 11] [Cited by in F6Publishing: 12] [Article Influence: 3.7] [Reference Citation Analysis]
663 Na K, Cho Y, Choi DH, Park MJ, Yang JH, Chung S. Gamma irradiation exposure for collapsed cell junctions and reduced angiogenesis of 3-D in vitro blood vessels. Sci Rep 2021;11:18230. [PMID: 34521931 DOI: 10.1038/s41598-021-97692-8] [Reference Citation Analysis]
664 Yang K, Zhang J, Bao C. Exosomal circEIF3K from cancer-associated fibroblast promotes colorectal cancer (CRC) progression via miR-214/PD-L1 axis. BMC Cancer 2021;21:933. [PMID: 34412616 DOI: 10.1186/s12885-021-08669-9] [Reference Citation Analysis]
665 Chen D, Qu X, Shao J, Wang W, Dong X. Anti-vascular nano agents: a promising approach for cancer treatment. J Mater Chem B 2020;8:2990-3004. [PMID: 32211649 DOI: 10.1039/c9tb02957e] [Cited by in Crossref: 13] [Article Influence: 6.5] [Reference Citation Analysis]
666 Clere N, Renault S, Corre I. Endothelial-to-Mesenchymal Transition in Cancer. Front Cell Dev Biol 2020;8:747. [PMID: 32923440 DOI: 10.3389/fcell.2020.00747] [Cited by in Crossref: 13] [Cited by in F6Publishing: 11] [Article Influence: 6.5] [Reference Citation Analysis]
667 Lawson DA, Kessenbrock K, Davis RT, Pervolarakis N, Werb Z. Tumour heterogeneity and metastasis at single-cell resolution. Nat Cell Biol 2018;20:1349-60. [PMID: 30482943 DOI: 10.1038/s41556-018-0236-7] [Cited by in Crossref: 191] [Cited by in F6Publishing: 149] [Article Influence: 47.8] [Reference Citation Analysis]
668 Liang Y, Chen X, Wu Y, Li J, Zhang S, Wang K, Guan X, Yang K, Bai Y. LncRNA CASC9 promotes esophageal squamous cell carcinoma metastasis through upregulating LAMC2 expression by interacting with the CREB-binding protein. Cell Death Differ 2018;25:1980-95. [PMID: 29511340 DOI: 10.1038/s41418-018-0084-9] [Cited by in Crossref: 84] [Cited by in F6Publishing: 98] [Article Influence: 21.0] [Reference Citation Analysis]
669 Almendros I, Khalyfa A, Trzepizur W, Gileles-Hillel A, Huang L, Akbarpour M, Andrade J, Farré R, Gozal D. Tumor Cell Malignant Properties Are Enhanced by Circulating Exosomes in Sleep Apnea. Chest 2016;150:1030-41. [PMID: 27568581 DOI: 10.1016/j.chest.2016.08.1438] [Cited by in Crossref: 29] [Cited by in F6Publishing: 24] [Article Influence: 4.8] [Reference Citation Analysis]
670 Hiroshima Y, Kasajima R, Kimura Y, Komura D, Ishikawa S, Ichikawa Y, Bouvet M, Yamamoto N, Oshima T, Morinaga S, Singh SR, Hoffman RM, Endo I, Miyagi Y. Novel targets identified by integrated cancer-stromal interactome analysis of pancreatic adenocarcinoma. Cancer Letters 2020;469:217-27. [DOI: 10.1016/j.canlet.2019.10.031] [Cited by in Crossref: 5] [Cited by in F6Publishing: 5] [Article Influence: 2.5] [Reference Citation Analysis]
671 Huang X, Tang T, Zhang G, Hong Z, Xu J, Yadav DK, Bai X, Liang T. Genomic investigation of co-targeting tumor immune microenvironment and immune checkpoints in pan-cancer immunotherapy. NPJ Precis Oncol 2020;4:29. [PMID: 33299118 DOI: 10.1038/s41698-020-00136-1] [Cited by in Crossref: 3] [Cited by in F6Publishing: 3] [Article Influence: 1.5] [Reference Citation Analysis]
672 Bagheri AR, Li C, Zhang X, Zhou X, Aramesh N, Zhou H, Jia J. Recent advances in covalent organic frameworks for cancer diagnosis and therapy. Biomater Sci 2021;9:5745-61. [PMID: 34318797 DOI: 10.1039/d1bm00960e] [Cited by in Crossref: 2] [Article Influence: 2.0] [Reference Citation Analysis]
673 Jayakumar A, Bothwell ALM. Functional Diversity of Myeloid-Derived Suppressor Cells: The Multitasking Hydra of Cancer. J Immunol 2019;203:1095-103. [PMID: 31427398 DOI: 10.4049/jimmunol.1900500] [Cited by in Crossref: 9] [Cited by in F6Publishing: 9] [Article Influence: 4.5] [Reference Citation Analysis]
674 Pavesi A, Tan AT, Koh S, Chia A, Colombo M, Antonecchia E, Miccolis C, Ceccarello E, Adriani G, Raimondi MT, Kamm RD, Bertoletti A. A 3D microfluidic model for preclinical evaluation of TCR-engineered T cells against solid tumors. JCI Insight 2017;2:89762. [PMID: 28614795 DOI: 10.1172/jci.insight.89762] [Cited by in Crossref: 93] [Cited by in F6Publishing: 83] [Article Influence: 18.6] [Reference Citation Analysis]
675 Foglietta F, Serpe L, Canaparo R. The Effective Combination between 3D Cancer Models and Stimuli-Responsive Nanoscale Drug Delivery Systems. Cells 2021;10:3295. [PMID: 34943803 DOI: 10.3390/cells10123295] [Cited by in Crossref: 1] [Article Influence: 1.0] [Reference Citation Analysis]
676 Ding X, Zhang J, Shi M, Liu D, Zhang L, Zhang R, Su B, Ai K. High expression level of interleukin-1β is correlated with poor prognosis and PD-1 expression in patients with lung adenocarcinoma. Clin Transl Oncol 2021;23:35-42. [PMID: 32472456 DOI: 10.1007/s12094-020-02392-w] [Cited by in Crossref: 1] [Article Influence: 0.5] [Reference Citation Analysis]
677 Comen EA, Bowman RL, Kleppe M. Underlying Causes and Therapeutic Targeting of the Inflammatory Tumor Microenvironment. Front Cell Dev Biol 2018;6:56. [PMID: 29946544 DOI: 10.3389/fcell.2018.00056] [Cited by in Crossref: 24] [Cited by in F6Publishing: 26] [Article Influence: 6.0] [Reference Citation Analysis]
678 Guan X, Lu Y, Zhu H, Yu S, Zhao W, Chi X, Xie C, Yin Z. The Crosstalk Between Cancer Cells and Neutrophils Enhances Hepatocellular Carcinoma Metastasis via Neutrophil Extracellular Traps-Associated Cathepsin G Component: A Potential Therapeutic Target. J Hepatocell Carcinoma 2021;8:451-65. [PMID: 34046369 DOI: 10.2147/JHC.S303588] [Cited by in F6Publishing: 1] [Reference Citation Analysis]
679 Lin A, Wei T, Meng H, Luo P, Zhang J. Role of the dynamic tumor microenvironment in controversies regarding immune checkpoint inhibitors for the treatment of non-small cell lung cancer (NSCLC) with EGFR mutations. Mol Cancer 2019;18:139. [PMID: 31526368 DOI: 10.1186/s12943-019-1062-7] [Cited by in Crossref: 44] [Cited by in F6Publishing: 43] [Article Influence: 14.7] [Reference Citation Analysis]
680 Chen YL, Lin HW, Chien CL, Lai YL, Sun WZ, Chen CA, Cheng WF. BTLA blockade enhances Cancer therapy by inhibiting IL-6/IL-10-induced CD19high B lymphocytes. J Immunother Cancer 2019;7:313. [PMID: 31753019 DOI: 10.1186/s40425-019-0744-4] [Cited by in Crossref: 24] [Cited by in F6Publishing: 22] [Article Influence: 8.0] [Reference Citation Analysis]
681 Kong X, Zhu M, Wang Z, Xu Z, Shao J. Characteristics and clinical significance of CD163+/CD206+M2 mono-macrophage in the bladder cancer microenvironment. Turk J Biol 2021;45:624-32. [PMID: 34803459 DOI: 10.3906/biy-2104-17] [Reference Citation Analysis]
682 Gao J, Wang S, Dong X, Wang Z. RGD-expressed bacterial membrane-derived nanovesicles enhance cancer therapy via multiple tumorous targeting. Theranostics 2021;11:3301-16. [PMID: 33537088 DOI: 10.7150/thno.51988] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 1.0] [Reference Citation Analysis]
683 Okamoto A, Sakakura K, Takahashi H, Motegi SI, Kaira K, Yokobori-Kuwabara Y, Ishikawa O, Chikamatsu K. Immunological and Clinicopathological Significance of MFG-E8 Expression in Patients with Oral Squamous Cell Carcinoma. Pathol Oncol Res 2020;26:1263-8. [PMID: 31256324 DOI: 10.1007/s12253-019-00692-3] [Reference Citation Analysis]
684 Ricci C, Mota C, Moscato S, D'Alessandro D, Ugel S, Sartoris S, Bronte V, Boggi U, Campani D, Funel N, Moroni L, Danti S. Interfacing polymeric scaffolds with primary pancreatic ductal adenocarcinoma cells to develop 3D cancer models. Biomatter 2014;4:e955386. [PMID: 25482337 DOI: 10.4161/21592527.2014.955386] [Cited by in Crossref: 25] [Cited by in F6Publishing: 26] [Article Influence: 3.6] [Reference Citation Analysis]
685 Ponert JM, Gockel LM, Henze S, Schlesinger M. Unfractionated and Low Molecular Weight Heparin Reduce Platelet Induced Epithelial-Mesenchymal Transition in Pancreatic and Prostate Cancer Cells. Molecules 2018;23:E2690. [PMID: 30347648 DOI: 10.3390/molecules23102690] [Cited by in Crossref: 4] [Cited by in F6Publishing: 4] [Article Influence: 1.0] [Reference Citation Analysis]
686 Gong Z, Chen M, Ren Q, Yue X, Dai Z. Fibronectin-targeted dual-acting micelles for combination therapy of metastatic breast cancer. Signal Transduct Target Ther 2020;5:12. [PMID: 32296050 DOI: 10.1038/s41392-019-0104-3] [Cited by in Crossref: 9] [Cited by in F6Publishing: 9] [Article Influence: 4.5] [Reference Citation Analysis]
687 Nasrollahzadeh E, Razi S, Keshavarz-Fathi M, Mazzone M, Rezaei N. Pro-tumorigenic functions of macrophages at the primary, invasive and metastatic tumor site. Cancer Immunol Immunother 2020;69:1673-97. [PMID: 32500231 DOI: 10.1007/s00262-020-02616-6] [Cited by in Crossref: 11] [Cited by in F6Publishing: 12] [Article Influence: 5.5] [Reference Citation Analysis]
688 Tang H, Chu Y, Huang Z, Cai J, Wang Z. The metastatic phenotype shift toward myofibroblast of adipose-derived mesenchymal stem cells promotes ovarian cancer progression. Carcinogenesis 2020;41:182-93. [PMID: 31046126 DOI: 10.1093/carcin/bgz083] [Cited by in Crossref: 11] [Cited by in F6Publishing: 11] [Article Influence: 5.5] [Reference Citation Analysis]
689 Rodenhizer D, Dean T, Xu B, Cojocari D, Mcguigan AP. A three-dimensional engineered heterogeneous tumor model for assessing cellular environment and response. Nat Protoc 2018;13:1917-57. [DOI: 10.1038/s41596-018-0022-9] [Cited by in Crossref: 10] [Cited by in F6Publishing: 6] [Article Influence: 2.5] [Reference Citation Analysis]
690 Zhang Q, Lou Y, Bai XL, Liang TB. Immunometabolism: A novel perspective of liver cancer microenvironment and its influence on tumor progression. World J Gastroenterol 2018; 24(31): 3500-3512 [PMID: 30131656 DOI: 10.3748/wjg.v24.i31.3500] [Cited by in CrossRef: 26] [Cited by in F6Publishing: 22] [Article Influence: 6.5] [Reference Citation Analysis]
691 Zhang W, Xing J, Liu T, Zhang J, Dai Z, Zhang H, Wang D, Tang D. Small extracellular vesicles: from mediating cancer cell metastasis to therapeutic value in pancreatic cancer. Cell Commun Signal 2022;20:1. [PMID: 34980146 DOI: 10.1186/s12964-021-00806-y] [Cited by in Crossref: 1] [Article Influence: 1.0] [Reference Citation Analysis]
692 Karakas D, Ozpolat B. Eukaryotic elongation factor-2 kinase (eEF2K) signaling in tumor and microenvironment as a novel molecular target. J Mol Med (Berl) 2020;98:775-87. [PMID: 32377852 DOI: 10.1007/s00109-020-01917-8] [Cited by in Crossref: 7] [Cited by in F6Publishing: 6] [Article Influence: 3.5] [Reference Citation Analysis]
693 Yang B, Chen Q. Cross-Talk between Oxidative Stress and m6A RNA Methylation in Cancer. Oxid Med Cell Longev 2021;2021:6545728. [PMID: 34484567 DOI: 10.1155/2021/6545728] [Reference Citation Analysis]
694 Avtanski D, Poretsky L. Phyto-polyphenols as potential inhibitors of breast cancer metastasis. Mol Med 2018;24:29. [PMID: 30134816 DOI: 10.1186/s10020-018-0032-7] [Cited by in Crossref: 25] [Cited by in F6Publishing: 22] [Article Influence: 6.3] [Reference Citation Analysis]
695 Yu G, Yu S, Saha ML, Zhou J, Cook TR, Yung BC, Chen J, Mao Z, Zhang F, Zhou Z, Liu Y, Shao L, Wang S, Gao C, Huang F, Stang PJ, Chen X. A discrete organoplatinum(II) metallacage as a multimodality theranostic platform for cancer photochemotherapy. Nat Commun 2018;9:4335. [PMID: 30337535 DOI: 10.1038/s41467-018-06574-7] [Cited by in Crossref: 80] [Cited by in F6Publishing: 83] [Article Influence: 20.0] [Reference Citation Analysis]
696 Slania SL, Das D, Lisok A, Du Y, Jiang Z, Mease RC, Rowe SP, Nimmagadda S, Yang X, Pomper MG. Imaging of Fibroblast Activation Protein in Cancer Xenografts Using Novel (4-Quinolinoyl)-glycyl-2-cyanopyrrolidine-Based Small Molecules. J Med Chem 2021;64:4059-70. [PMID: 33730493 DOI: 10.1021/acs.jmedchem.0c02171] [Cited by in F6Publishing: 1] [Reference Citation Analysis]
697 Dalah E, Tai A, Oshima K, Hall WA, Erickson B, Li XA. PET-based Treatment Response Assessment for Neoadjuvant Chemoradiation in Pancreatic Adenocarcinoma: An Exploratory Study. Transl Oncol 2018;11:1104-9. [PMID: 30015263 DOI: 10.1016/j.tranon.2018.06.011] [Cited by in Crossref: 11] [Cited by in F6Publishing: 9] [Article Influence: 2.8] [Reference Citation Analysis]
698 Jiang X, Tomlinson IPM. Why is cancer not more common? A changing microenvironment may help to explain why, and suggests strategies for anti-cancer therapy. Open Biol 2020;10:190297. [PMID: 32289242 DOI: 10.1098/rsob.190297] [Cited by in Crossref: 2] [Cited by in F6Publishing: 2] [Article Influence: 1.0] [Reference Citation Analysis]
699 Ugel S, Facciponte JG, De Sanctis F, Facciabene A. Targeting tumor vasculature: expanding the potential of DNA cancer vaccines. Cancer Immunol Immunother 2015;64:1339-48. [DOI: 10.1007/s00262-015-1747-8] [Cited by in Crossref: 16] [Cited by in F6Publishing: 14] [Article Influence: 2.3] [Reference Citation Analysis]
700 Wang H, Cai J, Du S, Wei W, Shen X. LAMC2 modulates the acidity of microenvironments to promote invasion and migration of pancreatic cancer cells via regulating AKT-dependent NHE1 activity. Exp Cell Res 2020;391:111984. [PMID: 32246993 DOI: 10.1016/j.yexcr.2020.111984] [Cited by in Crossref: 7] [Cited by in F6Publishing: 8] [Article Influence: 3.5] [Reference Citation Analysis]
701 Pandey VK, Amin PJ, Shankar BS. COX-2 inhibitor prevents tumor induced down regulation of classical DC lineage specific transcription factor Zbtb46 resulting in immunocompetent DC and decreased tumor burden. Immunol Lett 2017;184:23-33. [PMID: 28161224 DOI: 10.1016/j.imlet.2017.01.019] [Cited by in Crossref: 7] [Cited by in F6Publishing: 7] [Article Influence: 1.4] [Reference Citation Analysis]
702 Lin CH, Jokela T, Gray J, LaBarge MA. Combinatorial Microenvironments Impose a Continuum of Cellular Responses to a Single Pathway-Targeted Anti-cancer Compound. Cell Rep 2017;21:533-45. [PMID: 29020637 DOI: 10.1016/j.celrep.2017.09.058] [Cited by in Crossref: 13] [Cited by in F6Publishing: 14] [Article Influence: 3.3] [Reference Citation Analysis]
703 Pupo M, Maggiolini M, Musti AM. GPER Mediates Non-Genomic Effects of Estrogen. Methods Mol Biol 2016;1366:471-88. [PMID: 26585158 DOI: 10.1007/978-1-4939-3127-9_37] [Cited by in Crossref: 26] [Cited by in F6Publishing: 26] [Article Influence: 4.3] [Reference Citation Analysis]
704 Mao Y, Feng Q, Zheng P, Yang L, Liu T, Xu Y, Zhu D, Chang W, Ji M, Ren L, Wei Y, He G, Xu J. Low tumor purity is associated with poor prognosis, heavy mutation burden, and intense immune phenotype in colon cancer. Cancer Manag Res 2018;10:3569-77. [PMID: 30271205 DOI: 10.2147/CMAR.S171855] [Cited by in Crossref: 30] [Cited by in F6Publishing: 23] [Article Influence: 7.5] [Reference Citation Analysis]
705 Liu Y, Jia Q, Guo Q, Wei W, Zhou J. Simultaneously activating highly selective ratiometric MRI and synergistic therapy in response to intratumoral oxidability and acidity. Biomaterials 2018;180:104-16. [DOI: 10.1016/j.biomaterials.2018.07.025] [Cited by in Crossref: 42] [Cited by in F6Publishing: 41] [Article Influence: 10.5] [Reference Citation Analysis]
706 Sereno M, Videira M, Wilhelm I, Krizbai IA, Brito MA. miRNAs in Health and Disease: A Focus on the Breast Cancer Metastatic Cascade towards the Brain. Cells 2020;9:E1790. [PMID: 32731349 DOI: 10.3390/cells9081790] [Cited by in Crossref: 3] [Cited by in F6Publishing: 3] [Article Influence: 1.5] [Reference Citation Analysis]
707 Boonyaratanakornkit V, McGowan EM, Márquez-Garbán DC, Burton LP, Hamilton N, Pateetin P, Pietras RJ. Progesterone Receptor Signaling in the Breast Tumor Microenvironment. Adv Exp Med Biol 2021;1329:443-74. [PMID: 34664251 DOI: 10.1007/978-3-030-73119-9_21] [Reference Citation Analysis]
708 Kim JH, Frantz AM, Sarver AL, Gorden Klukas BH, Lewellen M, O'Brien TD, Dickerson EB, Modiano JF. Modulation of fatty acid metabolism and immune suppression are features of in vitro tumour sphere formation in ontogenetically distinct dog cancers. Vet Comp Oncol 2018;16:E176-84. [PMID: 29152836 DOI: 10.1111/vco.12368] [Cited by in Crossref: 7] [Cited by in F6Publishing: 3] [Article Influence: 1.4] [Reference Citation Analysis]
709 Zhan X, Jia L, Niu Y, Qi H, Chen X, Zhang Q, Zhang J, Wang Y, Dong L, Wang C. Targeted depletion of tumour-associated macrophages by an alendronate-glucomannan conjugate for cancer immunotherapy. Biomaterials 2014;35:10046-57. [PMID: 25245263 DOI: 10.1016/j.biomaterials.2014.09.007] [Cited by in Crossref: 89] [Cited by in F6Publishing: 80] [Article Influence: 11.1] [Reference Citation Analysis]
710 Liu X, Xu Y, Yin L, Hou Y, Zhao S. Chitosan-Poly(Acrylic Acid) Nanoparticles Loaded with R848 and MnCl2 Inhibit Melanoma via Regulating Macrophage Polarization and Dendritic Cell Maturation. Int J Nanomedicine 2021;16:5675-92. [PMID: 34456564 DOI: 10.2147/IJN.S318363] [Reference Citation Analysis]
711 Sahin IH, Elias H, Chou JF, Capanu M, O'Reilly EM. Pancreatic adenocarcinoma: insights into patterns of recurrence and disease behavior. BMC Cancer 2018;18:769. [PMID: 30055578 DOI: 10.1186/s12885-018-4679-9] [Cited by in Crossref: 21] [Cited by in F6Publishing: 20] [Article Influence: 5.3] [Reference Citation Analysis]
712 Chitty JL, Filipe EC, Lucas MC, Herrmann D, Cox TR, Timpson P. Recent advances in understanding the complexities of metastasis. F1000Res 2018;7:F1000 Faculty Rev-1169. [PMID: 30135716 DOI: 10.12